ID   OTP_DROME               Reviewed;         409 AA.
AC   P56672; A4IJ64; Q3KN52; Q7KVQ3; Q9W2Q4;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   05-JUL-2017, entry version 133.
DE   RecName: Full=Homeobox protein orthopedia;
GN   Name=otp; ORFNames=CG10036;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM C), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=7913821; DOI=10.1016/0896-6273(94)90461-8;
RA   Simeone A., D'Apice M.R., Nigro V., Casanova J., Graziani F.,
RA   Acampora D., Avantaggiato V.;
RT   "Orthopedia, a novel homeobox-containing gene expressed in the
RT   developing CNS of both mouse and Drosophila.";
RL   Neuron 13:83-101(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS C AND E).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Carlson J.W., Chavez C., Frise E., George R.A.,
RA   Kapadia B., Pacleb J.M., Park S., Wan K.H., Yu C., Celniker S.E.;
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: May be involved in the development of the central
CC       nervous system. {ECO:0000269|PubMed:7913821}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=E;
CC         IsoId=P56672-5; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=C;
CC         IsoId=P56672-3; Sequence=VSP_026420, VSP_036997, VSP_036998;
CC   -!- TISSUE SPECIFICITY: First appears at gastrulation in the
CC       ectodermal proctodeum and later in the hindgut, anal plate, and
CC       along the CNS. {ECO:0000269|PubMed:7913821}.
CC   -!- SIMILARITY: Belongs to the paired homeobox family. Bicoid
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 is the initiator or if the
CC       sequence starts further upstream. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE013599; AAS64751.3; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31108.1; -; Genomic_DNA.
DR   EMBL; BT023887; ABA81821.1; -; mRNA.
DR   EMBL; BT030422; ABO52842.1; -; mRNA.
DR   RefSeq; NP_001036563.1; NM_001043098.2. [P56672-3]
DR   RefSeq; NP_001097388.2; NM_001103918.3. [P56672-5]
DR   UniGene; Dm.14052; -.
DR   ProteinModelPortal; P56672; -.
DR   SMR; P56672; -.
DR   BioGrid; 63008; 1.
DR   DIP; DIP-17198N; -.
DR   MINT; MINT-743840; -.
DR   STRING; 7227.FBpp0288728; -.
DR   PaxDb; P56672; -.
DR   PRIDE; P56672; -.
DR   EnsemblMetazoa; FBtr0290289; FBpp0288728; FBgn0015524. [P56672-5]
DR   GeneID; 37364; -.
DR   KEGG; dme:Dmel_CG10036; -.
DR   UCSC; CG10036-RC; d. melanogaster. [P56672-5]
DR   CTD; 23440; -.
DR   FlyBase; FBgn0015524; otp.
DR   eggNOG; KOG0490; Eukaryota.
DR   eggNOG; ENOG410YIJ3; LUCA.
DR   InParanoid; P56672; -.
DR   OrthoDB; EOG091G0KCC; -.
DR   PhylomeDB; P56672; -.
DR   GenomeRNAi; 37364; -.
DR   PRO; PR:P56672; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0015524; -.
DR   Genevisible; P56672; DM.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IDA:FlyBase.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0046331; P:lateral inhibition; IMP:FlyBase.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR009057; Homeobox-like.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR000047; HTH_motif.
DR   InterPro; IPR003654; OAR_dom.
DR   Pfam; PF00046; Homeobox; 1.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS50803; OAR; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   DNA-binding; Homeobox; Nucleus; Reference proteome.
FT   CHAIN         1    409       Homeobox protein orthopedia.
FT                                /FTId=PRO_0000049206.
FT   DNA_BIND    109    168       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   MOTIF       372    385       OAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00138}.
FT   COMPBIAS     28     98       Gly-rich.
FT   COMPBIAS     75    102       Asn-rich.
FT   COMPBIAS    324    361       Gln-rich.
FT   VAR_SEQ       1     96       Missing (in isoform C).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_026420.
FT   VAR_SEQ      97    108       NGNNNNSMQQQD -> MQQQDQHLDKNK (in isoform
FT                                C). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_036997.
FT   VAR_SEQ     223    264       Missing (in isoform C).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_036998.
SQ   SEQUENCE   409 AA;  43173 MW;  E186EFAC8C125BE9 CRC64;
     MLNNLGANVL GPKDCDLPKA ALTALHAGVN SFGQLPVGPN LADLGGGAGG GGSSGGVPVG
     GGVARLHISG GLCDNSNALN GGNGSSGNGN GNNNNGNGNN NNSMQQQDQK RHRTRFTPAQ
     LNELERCFSK THYPDIFMRE EIAMRIGLTE SRVQVWFQNR RAKWKKRKKT TNVFRTPGAL
     LPSHGLPPFG ANITNIAMGD GLCGTGMFGG DRWSVGVNPM TAGFGQLNQS SPLSSSLNSG
     LNSGINMGSA LGAGSYQHYG LNALGDSMMY QHSVGGVSCG PSGSPSATTP PNMNSCSSVT
     PPPLSAQPNS SQNELNGEPM PLHQQQQQQT HQHQQQQTHQ HHPMAPPTPT QQQQQLPQSM
     QSPSDGANDT LHSIAALRRR ASELNAIPSY LQMAPHNYEH YNSNSNSVY
//
ID   DMBT1_RABIT             Reviewed;        1594 AA.
AC   Q95218; Q95219; Q9TV20; Q9TV21; Q9TV22;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 2.
DT   10-MAY-2017, entry version 92.
DE   RecName: Full=Deleted in malignant brain tumors 1 protein;
DE   AltName: Full=Hensin;
DE   Flags: Precursor;
GN   Name=Dmbt1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae;
OC   Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 93-129;
RP   732-751 AND 1083-1090, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=8941650; DOI=10.1172/JCI119044;
RA   Takito J., Hikita C., Al-Awqati Q.;
RT   "Hensin, a new collecting duct protein involved in the in vitro
RT   plasticity of intercalated cell polarity.";
RL   J. Clin. Invest. 98:2324-2331(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2),
RP   GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=10444583;
RA   Takito J., Yan L., Ma J., Hikita C., Vijayakumar S., Warburton D.,
RA   Al-Awqati Q.;
RT   "Hensin, the polarity reversal protein, is encoded by DMBT1, a gene
RT   frequently deleted in malignant gliomas.";
RL   Am. J. Physiol. 277:F277-F289(1999).
CC   -!- FUNCTION: May play roles in mucosal defense system and cellular
CC       immune defense. May play a role in liver regeneration. May be an
CC       important factor in fate decision and differentiation of transit-
CC       amplifying ductular (oval) cells within the hepatic lineage. May
CC       function as a binding protein in saliva for the regulation of
CC       taste sensation. May play a role as an opsonin receptor for SFTPD
CC       and SPAR in macrophage tissues throughout the body, including
CC       epithelial cells lining the gastrointestinal tract. Required for
CC       terminal differentiation of columnar epithelial cells during early
CC       embryogenesis. Displays a broad calcium-dependent binding spectrum
CC       against both Gram-positive and Gram-negative bacteria, suggesting
CC       a role in defense against bacterial pathogens. Binds to a range of
CC       poly-sulfated and poly-phosphorylated ligands which may explain
CC       its broad bacterial-binding specificity. Inhibits cytoinvasion of
CC       S.enterica. Associates with the actin cytoskeleton and is involved
CC       in its remodeling during regulated exocytosis. Interacts with
CC       pancreatic zymogens in a pH-dependent manner and may act as a
CC       Golgi cargo receptor in the regulated secretory pathway of the
CC       pancreatic acinar cell (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with LGALS3. Binds SFTPD and SPAR in a calcium-
CC       dependent manner (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8941650}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q95218-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q95218-2; Sequence=VSP_034658, VSP_034659;
CC   -!- TISSUE SPECIFICITY: Expressed in small intestine, liver, stomach
CC       and kidney. Present in small intestine and in collecting tubules
CC       of kidney cortex, medulla and papilla (at protein level).
CC       {ECO:0000269|PubMed:10444583, ECO:0000269|PubMed:8941650}.
CC   -!- DOMAIN: The SRCR domains mediate binding to bacteria.
CC       {ECO:0000250}.
CC   -!- PTM: Highly N- and O-glycosylated. The O-glycans are heavily
CC       sulfated (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the DMBT1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043112; AAD02242.1; -; mRNA.
DR   EMBL; AF078900; AAD50330.1; -; Genomic_DNA.
DR   EMBL; AF078900; AAD50331.1; -; Genomic_DNA.
DR   EMBL; AF078900; AAD50332.1; -; Genomic_DNA.
DR   PIR; T30549; T30549.
DR   RefSeq; NP_001075502.1; NM_001082033.1. [Q95218-1]
DR   UniGene; Ocu.2321; -.
DR   ProteinModelPortal; Q95218; -.
DR   SMR; Q95218; -.
DR   GeneID; 100008679; -.
DR   KEGG; ocu:100008679; -.
DR   CTD; 1755; -.
DR   HOVERGEN; HBG060122; -.
DR   InParanoid; Q95218; -.
DR   KO; K13912; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; ISS:UniProtKB.
DR   GO; GO:0042589; C:zymogen granule membrane; ISS:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0035375; F:zymogen binding; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISS:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   CDD; cd00041; CUB; 2.
DR   Gene3D; 2.60.120.290; -; 2.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR001507; ZP_dom.
DR   InterPro; IPR017977; ZP_dom_CS.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF00530; SRCR; 8.
DR   Pfam; PF00100; Zona_pellucida; 1.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00202; SR; 8.
DR   SMART; SM00241; ZP; 1.
DR   SUPFAM; SSF49854; SSF49854; 2.
DR   SUPFAM; SSF56487; SSF56487; 8.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS00420; SRCR_1; 6.
DR   PROSITE; PS50287; SRCR_2; 8.
DR   PROSITE; PS00682; ZP_1; 1.
DR   PROSITE; PS51034; ZP_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Differentiation; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Protein transport; Reference proteome; Repeat; Secreted;
KW   Signal; Transport.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21   1594       Deleted in malignant brain tumors 1
FT                                protein.
FT                                /FTId=PRO_0000343684.
FT   DOMAIN       53    153       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      192    292       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      323    423       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      454    551       SRCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      582    682       SRCR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      713    813       SRCR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      821    921       SRCR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      951   1061       CUB 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1067   1170       SRCR 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1192   1301       CUB 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1310   1558       ZP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00375}.
FT   COMPBIAS     41     44       Poly-Thr.
FT   CARBOHYD    196    196       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    458    458       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    717    717       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     78    142       {ECO:0000250}.
FT   DISULFID     91    152       {ECO:0000250}.
FT   DISULFID    122    132       {ECO:0000250}.
FT   DISULFID    217    281       {ECO:0000250}.
FT   DISULFID    230    291       {ECO:0000250}.
FT   DISULFID    261    271       {ECO:0000250}.
FT   DISULFID    348    412       {ECO:0000250}.
FT   DISULFID    361    422       {ECO:0000250}.
FT   DISULFID    392    402       {ECO:0000250}.
FT   DISULFID    476    540       {ECO:0000250}.
FT   DISULFID    489    550       {ECO:0000250}.
FT   DISULFID    520    530       {ECO:0000250}.
FT   DISULFID    607    671       {ECO:0000250}.
FT   DISULFID    620    681       {ECO:0000250}.
FT   DISULFID    651    661       {ECO:0000250}.
FT   DISULFID    738    802       {ECO:0000250}.
FT   DISULFID    751    812       {ECO:0000250}.
FT   DISULFID    782    792       {ECO:0000250}.
FT   DISULFID    846    910       {ECO:0000250}.
FT   DISULFID    859    920       {ECO:0000250}.
FT   DISULFID    890    900       {ECO:0000250}.
FT   DISULFID    951    977       {ECO:0000250}.
FT   DISULFID   1004   1025       {ECO:0000250}.
FT   DISULFID   1095   1159       {ECO:0000250}.
FT   DISULFID   1108   1169       {ECO:0000250}.
FT   DISULFID   1139   1149       {ECO:0000250}.
FT   DISULFID   1192   1218       {ECO:0000250}.
FT   DISULFID   1243   1265       {ECO:0000250}.
FT   DISULFID   1479   1537       {ECO:0000250}.
FT   VAR_SEQ      45    302       EVFPSGLELRLANGGDRCQGRVEVLYQGSWGTVCDDGWDIN
FT                                DAQVVCRQLGCGMAVSAPGSARFGQGPGQIVLDDVSCSGQE
FT                                PYLWSCHHRGWLSHNCGHQEDAGVICSDAMAMTSPPPDTWP
FT                                TTVIYESTPHFPSGLELVFPSGLELRLANGSDRCQGRVEVL
FT                                YQGSWGTVCDDGWDINDAQVVCRQLGCGMAVSAPGSARFGQ
FT                                GPGQIVLDDVSCSGQEPYLWSCHHRGWLSHNCGHQEDAGVI
FT                                CSDAVPTTTPPP -> TE (in isoform 2).
FT                                {ECO:0000303|PubMed:10444583}.
FT                                /FTId=VSP_034658.
FT   VAR_SEQ     361    488       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10444583}.
FT                                /FTId=VSP_034659.
FT   CONFLICT     40     40       E -> EA (in Ref. 2; AAD50330).
FT                                {ECO:0000305}.
FT   CONFLICT     41     41       T -> A (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       S -> T (in Ref. 2; AAD50330).
FT                                {ECO:0000305}.
FT   CONFLICT    177    185       HFPSGLELV -> L (in Ref. 2; AAD50330).
FT                                {ECO:0000305}.
FT   CONFLICT    198    198       S -> G (in Ref. 2; AAD50330).
FT                                {ECO:0000305}.
FT   CONFLICT    314    314       S -> T (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    329    329       S -> G (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    575    575       H -> L (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    588    588       S -> G (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    627    627       T -> M (in Ref. 2; AAD50332/AAD50331).
FT                                {ECO:0000305}.
FT   CONFLICT    744    744       L -> I (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1594 AA;  172764 MW;  29D6BEFEAA987CC4 CRC64;
     MGISTVLALS LLWGPALSQG QWIPYTTYHD SVSSPGAPVE TTTTEVFPSG LELRLANGGD
     RCQGRVEVLY QGSWGTVCDD GWDINDAQVV CRQLGCGMAV SAPGSARFGQ GPGQIVLDDV
     SCSGQEPYLW SCHHRGWLSH NCGHQEDAGV ICSDAMAMTS PPPDTWPTTV IYESTPHFPS
     GLELVFPSGL ELRLANGSDR CQGRVEVLYQ GSWGTVCDDG WDINDAQVVC RQLGCGMAVS
     APGSARFGQG PGQIVLDDVS CSGQEPYLWS CHHRGWLSHN CGHQEDAGVI CSDAVPTTTP
     PPDTWPTTVI YESSPVFPSG LELRLANGSD RCQGRVEVLY QGSWGTVCDD GWDINDAQVV
     CRQLGCGTAV SAPGSARFGQ GPGQIVLDDV SCSGQEPYLW SCHHRGWLSH NCGHQEDAGV
     ICSDAMAMTT PLPDTWPTTV IHESTPVFPS GLELQLANGS DRCQGRVEVL YQGTVCDDGW
     DINDAQVVCR QLGCGMAVSA PGSARFGQGP GQIVLDDVSC SGQEPYLWSC HHRGWLSHNC
     GHQEDAGVIC SDAMAMTTPP PDTWPTTVIY ESTPHFPSGL ELRLANGSDR CQGRVEVLYQ
     GSWGTVCDDG WDINDAQVVC RQLGCGTAVS APGSARFGQG PGQIVLDDVS CSGQEPYLWS
     CHHRGWLSHN CGHQEDAGVI CSGAMDTTTP LPDTWPTTVI YESTPVHISG LQLRLVNGSD
     RCEGRVEVLY QGSWGTVCDD SWDLNDASVV CRQLGCGTAL SAPASAQFGQ SSGSIVLDDV
     SCSGSEPNLW SCSHRGWLSH NCGHHEDAGV VCSGPDSRLA VRLVNGSTRC QGRVEVLYRG
     SWGTVCDDSW DINDASVVCR QLGCGWAVSA PGSARFGQGS GSIFLDEVSC SGQEPYLWNC
     SHRGWLSHNC GHYEDAGVIC SDGWTTVTPP APTTDWWEPT VTTTVGPSSN CGGFLYNATG
     SFSSPSYPGY YPNNALCVWE IAVPSGYLIN LGFSQLRLEQ HSYCNFDYVE IFDGSTDSSL
     LGKICNDSGQ IFTTSSNRMT VLFRSDISVQ NTGFLAWYNS FPRDASLRLV SGNSSYGACA
     GRVEIYHGGR WGTVCDDSWD TQDAQVVCRQ LQCGDAVSAP GGAYFGSGSG PITLDDVNCS
     GTEATLWQCR SQSWFSHNCG HHEDASVICT GNYGTTTASV PNISTSNASY SCGGFLSQHS
     GRFSSPFYPG NYPNNARCVW DIEVQNNYQV TVTFTDVQLE GGCQYDYIEV FDGPYHSSPL
     IARVCDGARG SFTSSSNFLS VRFVSDGSIT RRGFQAEFYS LPSNDSTNLL CLMNHMQASV
     SRAYLQSLGF SAWELVVSGW NGNYQCQRQI TPSQVIFTIP YSGCGTIKQV DNETITYSNF
     LKAAVSSGVI KRKKDLHIHV SCRMLQDSWV HTMYIANDTI EVSEVQYSNF NVNVSFYTSS
     SFSYPVTSSP YYVDLDQNLY LQAEILHSDA SLALFVDTCV ASPNPNDFTS VTYDLIRSGC
     VRDETYRSYA QPSPRVVRFR FNSFHFLNRF PAVYLRCKMV VCRAYDYSSR CYRGCVVRSK
     RDVGSYQERV DVVLGPIQLL DPPAGKKSPG KGSP
//
ID   NETR_RAT                Reviewed;         761 AA.
AC   G3V801; Q99JC8;
DT   18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   07-JUN-2017, entry version 44.
DE   RecName: Full=Neurotrypsin;
DE            EC=3.4.21.-;
DE   AltName: Full=Serine protease 12;
DE   Flags: Precursor;
GN   Name=Prss12;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hintsch G., Sonderegger P.;
RT   "Cloning and sequencing of the cDNA encoding rat neurotrypsin.";
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T.,
RA   Smith D., Lee H.-M., Gustafson E., Cahill P., Kana A.,
RA   Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M.,
RA   Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K.,
RA   Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S.,
RA   Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J.,
RA   Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y.,
RA   Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A.,
RA   Ren Y., Song X.-Z., Li B., Liu Y., Qin X., Cawley S., Cooney A.J.,
RA   D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R.,
RA   Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A.,
RA   Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E.,
RA   Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E.,
RA   Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D.,
RA   Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M.,
RA   Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O.,
RA   Poliakov A., Huebner N., Ganten D., Goesele C., Hummel O.,
RA   Kreitler T., Lee Y.-A., Monti J., Schulz H., Zimdahl H.,
RA   Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S.,
RA   Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J.,
RA   Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E.,
RA   Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F.,
RA   Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K.,
RA   Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S.,
RA   Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M.,
RA   Clarke L., Curwen V., Durbin R.M., Eyras E., Searle S.M., Cooper G.M.,
RA   Batzoglou S., Brudno M., Sidow A., Stone E.A., Payseur B.A.,
RA   Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S.,
RA   Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G.,
RA   Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H.,
RA   Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R.,
RA   Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M.,
RA   Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H.,
RA   Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S.,
RA   Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into
RT   mammalian evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   STRUCTURE BY NMR OF 84-160, PARTIAL PROTEIN SEQUENCE, DISULFIDE BOND,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18956887; DOI=10.1021/bi800555z;
RA   Ozhogina O.A., Grishaev A., Bominaar E.L., Patthy L., Trexler M.,
RA   Llinas M.;
RT   "NMR solution structure of the neurotrypsin Kringle domain.";
RL   Biochemistry 47:12290-12298(2008).
CC   -!- FUNCTION: Plays a role in neuronal plasticity and the proteolytic
CC       action may subserve structural reorganizations associated with
CC       learning and memory operations. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ311671; CAC35028.2; -; mRNA.
DR   EMBL; CH473952; EDL82129.1; -; Genomic_DNA.
DR   RefSeq; NP_445956.1; NM_053504.1.
DR   UniGene; Rn.86653; -.
DR   PDB; 2K4R; NMR; -; A=84-160.
DR   PDB; 2K51; NMR; -; A=84-160.
DR   PDBsum; 2K4R; -.
DR   PDBsum; 2K51; -.
DR   ProteinModelPortal; G3V801; -.
DR   SMR; G3V801; -.
DR   STRING; 10116.ENSRNOP00000021116; -.
DR   MEROPS; S01.237; -.
DR   PaxDb; G3V801; -.
DR   Ensembl; ENSRNOT00000021116; ENSRNOP00000021116; ENSRNOG00000015353.
DR   GeneID; 85266; -.
DR   KEGG; rno:85266; -.
DR   CTD; 8492; -.
DR   RGD; 69238; Prss12.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00870000136382; -.
DR   HOGENOM; HOG000113767; -.
DR   InParanoid; G3V801; -.
DR   KO; K09624; -.
DR   OMA; CIKQDIG; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; G3V801; -.
DR   TreeFam; TF329295; -.
DR   PRO; PR:G3V801; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000015353; -.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043083; C:synaptic cleft; IEA:Ensembl.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:Ensembl.
DR   GO; GO:0006887; P:exocytosis; ISS:UniProtKB.
DR   GO; GO:0031638; P:zymogen activation; IEA:Ensembl.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00530; SRCR; 3.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00202; SR; 3.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF56487; SSF56487; 3.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS00420; SRCR_1; 3.
DR   PROSITE; PS50287; SRCR_2; 3.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Kringle; Protease;
KW   Reference proteome; Repeat; Secreted; Serine protease; Signal.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    761       Neurotrypsin.
FT                                /FTId=PRO_0000416843.
FT   DOMAIN       85    157       Kringle. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      166    267       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      273    373       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      386    487       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      517    760       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   REGION      505    516       Zymogen activation region. {ECO:0000250}.
FT   ACT_SITE    562    562       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    612    612       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    711    711       Charge relay system. {ECO:0000250}.
FT   SITE        516    517       Reactive bond homolog. {ECO:0000255}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    521    521       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    569    569       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     85    157       {ECO:0000269|PubMed:18956887}.
FT   DISULFID    101    141       {ECO:0000269|PubMed:18956887}.
FT   DISULFID    130    155       {ECO:0000269|PubMed:18956887}.
FT   DISULFID    191    255       {ECO:0000250}.
FT   DISULFID    204    265       {ECO:0000250}.
FT   DISULFID    235    245       {ECO:0000250}.
FT   DISULFID    298    361       {ECO:0000250}.
FT   DISULFID    311    371       {ECO:0000250}.
FT   DISULFID    341    351       {ECO:0000250}.
FT   DISULFID    411    475       {ECO:0000250}.
FT   DISULFID    424    485       {ECO:0000250}.
FT   DISULFID    455    465       {ECO:0000250}.
FT   DISULFID    505    636       {ECO:0000255}.
FT   DISULFID    547    563       {ECO:0000250}.
FT   DISULFID    651    717       {ECO:0000250}.
FT   DISULFID    680    694       {ECO:0000250}.
FT   DISULFID    707    736       {ECO:0000250}.
FT   CONFLICT    134    134       G -> D (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   CONFLICT    404    404       S -> N (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   CONFLICT    515    515       K -> T (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   CONFLICT    565    565       K -> T (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   CONFLICT    588    588       E -> G (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   CONFLICT    592    592       E -> D (in Ref. 1; CAC35028).
FT                                {ECO:0000305}.
FT   STRAND       92     95       {ECO:0000244|PDB:2K4R}.
FT   STRAND       98    101       {ECO:0000244|PDB:2K4R}.
FT   HELIX       104    106       {ECO:0000244|PDB:2K4R}.
FT   HELIX       119    121       {ECO:0000244|PDB:2K4R}.
FT   STRAND      131    134       {ECO:0000244|PDB:2K4R}.
FT   TURN        135    137       {ECO:0000244|PDB:2K4R}.
FT   STRAND      138    144       {ECO:0000244|PDB:2K4R}.
FT   STRAND      150    154       {ECO:0000244|PDB:2K4R}.
FT   STRAND      156    158       {ECO:0000244|PDB:2K4R}.
SQ   SEQUENCE   761 AA;  84220 MW;  215EE73A3CE468EA CRC64;
     MALARCVLAV ILGVLSEVAR ADPVLHSPLH RPHPSPPRSQ HAHYLPSSRR PPRTPRFPLP
     PRAPAAQRPQ LLSTRHTPPT ISRRCGAGEP WGNATNLGVP CLHWDEVPPF LERSPPASWA
     ELRGQPHNFC RSPGGAGRPW CFYRNAQGKV DWGYCDCGQG PALPVIRLVG GKSGHEGRVE
     LYHAGQWGTI CDDQWDDADA EVICRQLGLS GIAKAWHQAH FGEGSGPILL DEVRCTGNEL
     SIEQCPKSSW GEHNCGHKED AGVSCAPLTD GVIRLSGGKS VHEGRLEVYY RGQWGTVCDD
     GWTEMNTYVA CRLLGFKYGK QSSVNHFEGS SRPIWLDDVS CSGKEASFIQ CSRRQWGRHD
     CSHREDVGLT CYPDSDGHRL SPGFPIRLMD GENKREGRVE VFVSGQWGTI CDDGWTDKHA
     AVICRQLGYK GPARARTMAY FGEGKGPIHM DNVKCTGNEK ALADCVKQDI GRHNCRHSED
     AGVICDYYEK KTSGHGNKET LSSGCGLRLL HRRQKRIIGG NNSLRGAWPW QASLRLKSTH
     GDGRLLCGAT LLSSCWVLTA AHCFKRYGNN SRSYAVRVGD YHTLVPEEFE QEIGVQQIVI
     HRNYRPDSSD YDIALVRLQG SGEQCARLST HVLPACLPLW RERPQKTASN CHITGWGDTG
     RAYSRTLQQA AVPLLPKRFC KERYKGLFTG RMLCAGNLQE DNRVDSCQGD SGGPLMCEKP
     DETWVVYGVT SWGYGCGIKD TPGVYTRVPA FVPWIKSVTS L
//
ID   DMBT1_HUMAN             Reviewed;        2413 AA.
AC   Q9UGM3; A6NDG4; A6NDJ5; A8E4R5; B1ARE7; B1ARE8; B1ARE9; B1ARF0;
AC   B7Z8Y2; F8WEF7; Q59EX0; Q5JR26; Q6MZN4; Q96DU4; Q9UGM2; Q9UJ57;
AC   Q9UKJ4; Q9Y211; Q9Y4V9;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 2.
DT   05-JUL-2017, entry version 155.
DE   RecName: Full=Deleted in malignant brain tumors 1 protein;
DE   AltName: Full=Glycoprotein 340;
DE            Short=Gp-340;
DE   AltName: Full=Hensin;
DE   AltName: Full=Salivary agglutinin;
DE            Short=SAG;
DE   AltName: Full=Surfactant pulmonary-associated D-binding protein;
DE   Flags: Precursor;
GN   Name=DMBT1; Synonyms=GP340;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION AS A TUMOR
RP   SUPPRESSOR, TISSUE SPECIFICITY, AND VARIANTS THR-42 AND ALA-60.
RC   TISSUE=Lung;
RX   PubMed=9288095; DOI=10.1038/ng0997-32;
RA   Mollenhauer J., Wiemann S., Scheurlen W., Korn B., Hayashi Y.,
RA   Wilgenbus K.K., von Deimling A., Poustka A.;
RT   "DMBT1, a new member of the SRCR superfamily on chromosome 10q25.3-
RT   q26.1 is deleted in malignant brain tumours.";
RL   Nat. Genet. 17:32-39(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN MUCOSAL AND
RP   CELLULAR IMMUNE DEFENSE, TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   DEVELOPMENTAL STAGE, AND VARIANTS THR-42; LEU-54; ALA-60; MET-649;
RP   MET-780 AND SER-856.
RC   TISSUE=Trachea;
RX   PubMed=10485905; DOI=10.1073/pnas.96.19.10794;
RA   Holmskov U., Mollenhauer J., Madsen J., Vitved L., Gronlund J.,
RA   Tornoe I., Kliem A., Reid K.B.M., Poustka A., Skjodt K.;
RT   "Cloning of gp-340, a putative opsonin receptor for lung surfactant
RT   protein D.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:10794-10799(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 3), ALTERNATIVE
RP   SPLICING, AND VARIANTS THR-42; LEU-54; ALA-60; LEU-337 AND SER-856.
RC   TISSUE=Lung;
RX   PubMed=10597221; DOI=10.1038/sj.onc.1203071;
RA   Mollenhauer J., Holmskov U., Wiemann S., Krebs I., Herbertz S.,
RA   Madsen J., Kioschis P., Coy J.F., Poustka A.;
RT   "The genomic structure of the DMBT1 gene: evidence for a region with
RT   susceptibility to genomic instability.";
RL   Oncogene 18:6233-6240(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], INVOLVEMENT IN LUNG CARCINOGENESIS,
RP   AND VARIANTS THR-42; LEU-54 AND SER-856.
RX   PubMed=10551316; DOI=10.1111/j.1349-7006.1999.tb00833.x;
RA   Takeshita H., Sato M., Shiwaku H.O., Semba S., Sakurada A., Hoshi M.,
RA   Hayashi Y., Tagawa Y., Ayabe H., Horii A.;
RT   "Expression of the DMBT1 gene is frequently suppressed in human lung
RT   cancer.";
RL   Jpn. J. Cancer Res. 90:903-908(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN EPITHELIAL DIFFERENTIATION,
RP   TISSUE SPECIFICITY, ALTERNATIVE SPLICING, INVOLVEMENT IN ESOPHAGEAL
RP   CARCINOMAS, AND VARIANT SER-856.
RC   TISSUE=Small intestine;
RX   PubMed=11751412;
RA   Mollenhauer J., Herbertz S., Helmke B., Kollender G., Krebs I.,
RA   Madsen J., Holmskov U., Sorger K., Schmitt L., Wiemann S., Otto H.F.,
RA   Grone H.-J., Poustka A.;
RT   "Deleted in malignant brain tumors 1 is a versatile mucin-like
RT   molecule likely to play a differential role in digestive tract
RT   cancer.";
RL   Cancer Res. 61:8880-8886(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8), AND VARIANT
RP   LEU-54.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 36-1480 (ISOFORM 4).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1689-2413 (ISOFORM 5).
RC   TISSUE=Small intestine;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   PROTEIN SEQUENCE OF 2385-2413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Tear;
RX   PubMed=25946035; DOI=10.1021/acs.jproteome.5b00179;
RA   Azkargorta M., Soria J., Ojeda C., Guzman F., Acera A., Iloro I.,
RA   Suarez T., Elortza F.;
RT   "Human basal tear peptidome characterization by CID, HCD, and ETD
RT   followed by in silico and in vitro analyses for antimicrobial peptide
RT   identification.";
RL   J. Proteome Res. 14:2649-2658(2015).
RN   [12]
RP   INTERACTION WITH SFTPD.
RX   PubMed=9153228; DOI=10.1074/jbc.272.21.13743;
RA   Holmskov U., Lawson P., Teisner B., Tornoe I., Willis A.C., Morgan C.,
RA   Koch C., Reid K.B.;
RT   "Isolation and characterization of a new member of the scavenger
RT   receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant
RT   protein-D binding molecule.";
RL   J. Biol. Chem. 272:13743-13749(1997).
RN   [13]
RP   INTERACTION WITH SPAR.
RX   PubMed=10101009; DOI=10.1165/ajrcmb.20.4.3439;
RA   Tino M.J., Wright J.R.;
RT   "Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates
RT   alveolar macrophage migration in an SP-A-independent manner.";
RL   Am. J. Respir. Cell Mol. Biol. 20:759-768(1999).
RN   [14]
RP   INVOLVEMENT IN ESOPHAGEAL; GASTRIC AND COLON CANCERS.
RX   PubMed=9888459; DOI=10.1038/sj.bjc.6690035;
RA   Mori M., Shiraishi T., Tanaka S., Yamagata M., Mafune K., Tanaka Y.,
RA   Ueo H., Barnard G.F., Sugimachi K.;
RT   "Lack of DMBT1 expression in oesophageal, gastric and colon cancers.";
RL   Br. J. Cancer 79:211-213(1999).
RN   [15]
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=10749143;
RA   Mollenhauer J., Herbertz S., Holmskov U., Tolnay M., Krebs I.,
RA   Merlo A., Schroder H.D., Maier D., Breitling F., Wiemann S.,
RA   Groene H.-J., Poustka A.;
RT   "DMBT1 encodes a protein involved in the immune defense and in
RT   epithelial differentiation and is highly unstable in cancer.";
RL   Cancer Res. 60:1704-1710(2000).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND FUNCTION.
RC   TISSUE=Saliva;
RX   PubMed=11007786; DOI=10.1074/jbc.M006928200;
RA   Prakobphol A., Xu F., Hoang V.M., Larsson T., Bergstrom J.,
RA   Johansson I., Fraengsmyr L., Holmskov U., Leffler H., Nilsson C.,
RA   Boren T., Wright J.R., Stroemberg N., Fisher S.J.;
RT   "Salivary agglutinin, which binds Streptococcus mutans and
RT   Helicobacter pylori, is the lung scavenger receptor cysteine-rich
RT   protein gp-340.";
RL   J. Biol. Chem. 275:39860-39866(2000).
RN   [17]
RP   BACTERIAL-BINDING DOMAIN.
RX   PubMed=15355985; DOI=10.1074/jbc.M406095200;
RA   Bikker F.J., Ligtenberg A.J.M., End C., Renner M., Blaich S., Lyer S.,
RA   Wittig R., van't Hof W., Veerman E.C.I., Nazmi K.,
RA   de Blieck-Hogervorst J.M.A., Kioschis P., Nieuw Amerongen A.V.,
RA   Poustka A., Mollenhauer J.;
RT   "Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW
RT   motif in its scavenger receptor cysteine-rich domains.";
RL   J. Biol. Chem. 279:47699-47703(2004).
RN   [18]
RP   FUNCTION, INTERACTION WITH HIV-1 GP120, AND TISSUE SPECIFICITY.
RX   PubMed=16796526; DOI=10.1089/aid.2006.22.508;
RA   Wu Z., Lee S., Abrams W., Weissman D., Malamud D.;
RT   "The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1
RT   gp120 sequences and inhibits viral infection.";
RL   AIDS Res. Hum. Retroviruses 22:508-515(2006).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1712; ASN-1889 AND
RP   ASN-2188.
RC   TISSUE=Saliva;
RX   PubMed=16740002; DOI=10.1021/pr050492k;
RA   Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,
RA   Loo J.A.;
RT   "Identification of N-linked glycoproteins in human saliva by
RT   glycoprotein capture and mass spectrometry.";
RL   J. Proteome Res. 5:1493-1503(2006).
RN   [20]
RP   TISSUE SPECIFICITY.
RX   PubMed=17983803; DOI=10.1053/j.gastro.2007.08.007;
RA   Renner M., Bergmann G., Krebs I., End C., Lyer S., Hilberg F.,
RA   Helmke B., Gassler N., Autschbach F., Bikker F.,
RA   Strobel-Freidekind O., Gronert-Sum S., Benner A., Blaich S.,
RA   Wittig R., Hudler M., Ligtenberg A.J., Madsen J., Holmskov U.,
RA   Annese V., Latiano A., Schirmacher P., Amerongen A.V.N., D'Amato M.,
RA   Kioschis P., Hafner M., Poustka A., Mollenhauer J.;
RT   "DMBT1 confers mucosal protection in vivo and a deletion variant is
RT   associated with Crohn's disease.";
RL   Gastroenterology 133:1499-1509(2007).
RN   [21]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17548659; DOI=10.4049/jimmunol.178.12.8203;
RA   Rosenstiel P., Sina C., End C., Renner M., Lyer S., Till A.,
RA   Hellmig S., Nikolaus S., Foelsch U.R., Helmke B., Autschbach F.,
RA   Schirmacher P., Kioschis P., Hafner M., Poustka A., Mollenhauer J.,
RA   Schreiber S.;
RT   "Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells
RT   modulates bacterial recognition and invasion.";
RL   J. Immunol. 178:8203-8211(2007).
RN   [22]
RP   FUNCTION.
RX   PubMed=17709527; DOI=10.4049/jimmunol.179.5.3126;
RA   Stoddard E., Cannon G., Ni H., Kariko K., Capodici J., Malamud D.,
RA   Weissman D.;
RT   "gp340 expressed on human genital epithelia binds HIV-1 envelope
RT   protein and facilitates viral transmission.";
RL   J. Immunol. 179:3126-3132(2007).
RN   [23]
RP   BACTERIAL-BINDING DOMAIN.
RX   PubMed=18713006; DOI=10.1515/BC.2008.135;
RA   Leito J.T.D., Ligtenberg A.J.M., Nazmi K.,
RA   de Blieck-Hogervorst J.M.A., Veerman E.C.I., Nieuw Amerongen A.V.;
RT   "A common binding motif for various bacteria of the bacteria-binding
RT   peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin.";
RL   Biol. Chem. 389:1193-1200(2008).
RN   [24]
RP   FUNCTION.
RX   PubMed=19189310; DOI=10.1002/eji.200838689;
RA   End C., Bikker F., Renner M., Bergmann G., Lyer S., Blaich S.,
RA   Hudler M., Helmke B., Gassler N., Autschbach F., Ligtenberg A.J.M.,
RA   Benner A., Holmskov U., Schirmacher P., Nieuw Amerongen A.V.,
RA   Rosenstiel P., Sina C., Franke A., Hafner M., Kioschis P.,
RA   Schreiber S., Poustka A., Mollenhauer J.;
RT   "DMBT1 functions as pattern-recognition molecule for poly-sulfated and
RT   poly-phosphorylated ligands.";
RL   Eur. J. Immunol. 39:833-842(2009).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   VARIANTS THR-42; TRP-52; LEU-54; GLU-162; ASP-322; SER-357; SER-546;
RP   PRO-1095; THR-1102; TRP-1434; SER-1732 AND MET-2255.
RX   PubMed=12353266; DOI=10.1002/gcc.10115;
RA   Mollenhauer J., Mueller H., Kollender G., Lyer S., Diedrichs L.,
RA   Helmke B., Holmskov U., Ligtenberg T., Herbertz S., Krebs I.,
RA   Madsen J., Bikker F., Schmitt L., Wiemann S., Scheurlen W., Otto H.F.,
RA   von Deimling A., Poustka A.;
RT   "The SRCR/SID region of DMBT1 defines a complex multi-allele system
RT   representing the major basis for its variability in cancer.";
RL   Genes Chromosomes Cancer 35:242-255(2002).
RN   [27]
RP   VARIANTS THR-42; TRP-52; LEU-54; ALA-60; LEU-65; LEU-337; SER-357;
RP   GLY-364; MET-649; MET-780; TYR-1084; THR-1169; TRP-1176; MET-1545;
RP   SER-1732 AND PRO-1961.
RX   PubMed=12185598; DOI=10.1038/sj.onc.1205733;
RA   Mueller W., Mollenhauer J., Stockhammer F., Poustka A.,
RA   von Deimling A.;
RT   "Rare mutations of the DMBT1 gene in human astrocytic gliomas.";
RL   Oncogene 21:5956-5959(2002).
CC   -!- FUNCTION: May be considered as a candidate tumor suppressor gene
CC       for brain, lung, esophageal, gastric, and colorectal cancers. May
CC       play roles in mucosal defense system, cellular immune defense and
CC       epithelial differentiation. May play a role as an opsonin receptor
CC       for SFTPD and SPAR in macrophage tissues throughout the body,
CC       including epithelial cells lining the gastrointestinal tract. May
CC       play a role in liver regeneration. May be an important factor in
CC       fate decision and differentiation of transit-amplifying ductular
CC       (oval) cells within the hepatic lineage. Required for terminal
CC       differentiation of columnar epithelial cells during early
CC       embryogenesis. May function as a binding protein in saliva for the
CC       regulation of taste sensation. Binds to HIV-1 envelope protein and
CC       has been shown to both inhibit and facilitate viral transmission.
CC       Displays a broad calcium-dependent binding spectrum against both
CC       Gram-positive and Gram-negative bacteria, suggesting a role in
CC       defense against bacterial pathogens. Binds to a range of poly-
CC       sulfated and poly-phosphorylated ligands which may explain its
CC       broad bacterial-binding specificity. Inhibits cytoinvasion of
CC       S.enterica. Associates with the actin cytoskeleton and is involved
CC       in its remodeling during regulated exocytosis. Interacts with
CC       pancreatic zymogens in a pH-dependent manner and may act as a
CC       Golgi cargo receptor in the regulated secretory pathway of the
CC       pancreatic acinar cell. {ECO:0000269|PubMed:10485905,
CC       ECO:0000269|PubMed:11007786, ECO:0000269|PubMed:11751412,
CC       ECO:0000269|PubMed:16796526, ECO:0000269|PubMed:17548659,
CC       ECO:0000269|PubMed:17709527, ECO:0000269|PubMed:19189310,
CC       ECO:0000269|PubMed:9288095}.
CC   -!- SUBUNIT: Interacts with LGALS3 (By similarity). Binds SFTPD and
CC       SPAR in a calcium-dependent manner. Binds to HIV-1 glycoprotein
CC       120. {ECO:0000250, ECO:0000269|PubMed:10101009,
CC       ECO:0000269|PubMed:16796526, ECO:0000269|PubMed:9153228}.
CC   -!- INTERACTION:
CC       Q8IWL2:SFTPA1; NbExp=2; IntAct=EBI-1044970, EBI-11316418;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Note=Some isoforms
CC       may be membrane-bound. Localized to the lumenal aspect of crypt
CC       cells in the small intestine. In the colon, seen in the lumenal
CC       aspect of surface epithelial cells. Formed in the ducts of von
CC       Ebner gland, and released into the fluid bathing the taste buds
CC       contained in the taste papillae (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC         Comment=More isoforms may exist.;
CC       Name=1; Synonyms=DMBT1/8kb.2;
CC         IsoId=Q9UGM3-1; Sequence=Displayed;
CC       Name=2; Synonyms=DMBT1/6kb.1;
CC         IsoId=Q9UGM3-2; Sequence=VSP_016846, VSP_016849;
CC       Name=3; Synonyms=DMBT1/8kb.1;
CC         IsoId=Q9UGM3-3; Sequence=VSP_016847;
CC       Name=4;
CC         IsoId=Q9UGM3-4; Sequence=VSP_016848;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q9UGM3-6; Sequence=VSP_034656;
CC       Name=7;
CC         IsoId=Q9UGM3-7; Sequence=VSP_016847, VSP_034656;
CC       Name=8;
CC         IsoId=Q9UGM3-8; Sequence=VSP_034653, VSP_034654, VSP_034655;
CC       Name=5;
CC         IsoId=Q9UGM3-5; Sequence=VSP_016850;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q9UGM3-9; Sequence=VSP_053979, VSP_053980, VSP_053981;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in alveolar and macrophage
CC       tissues. In some macrophages, expression is seen on the membrane,
CC       and in other macrophages, strongly expressed in the
CC       phagosome/phagolysosome compartments. Expressed in lung, trachea,
CC       salivary gland, small intestine and stomach. In pancreas,
CC       expressed in certain cells of the islets of Langerhans. In
CC       digestive tract, confined to tissues with large epithelial
CC       surfaces. In intestinal tissue, moderately expressed in epithelial
CC       cells of the midcrypts and the crypt base. Expression is
CC       significantly elevated in intestinal tissue from patients with
CC       inflammatory bowel disease (IBD), particularly in surface
CC       epithelial and Paneth cells, but not in IBD patients with mutant
CC       NOD2. Present in crypt bases of the duodenum, in crypt tops of the
CC       colon, and in collecting ducts of the cortical kidney. Expressed
CC       in stratified squamous epithelium of vagina and in outer luminar
CC       surface and basilar region of columnar epithelial cells in cervix
CC       (at protein level). Isoform 1 is secreted to the lumen of the
CC       respiratory tract. {ECO:0000269|PubMed:10485905,
CC       ECO:0000269|PubMed:10749143, ECO:0000269|PubMed:11751412,
CC       ECO:0000269|PubMed:16796526, ECO:0000269|PubMed:17548659,
CC       ECO:0000269|PubMed:17983803, ECO:0000269|PubMed:9288095}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal lung, intestine and skin.
CC       Secreted to the extracellular matrix (ECM) in certain fetal
CC       epithelia. {ECO:0000269|PubMed:10485905,
CC       ECO:0000269|PubMed:10749143}.
CC   -!- INDUCTION: Up-regulated in intestinal epithelial cells in response
CC       to proinflammatory stimuli including TNF and bacterial
CC       lipopolysaccharides (LPS). {ECO:0000269|PubMed:17548659}.
CC   -!- DOMAIN: The SRCR domains mediate binding to bacteria. The minimal
CC       bacterial-binding site is an 11-residue repeat of GRVEVLYRGSW
CC       where VEVL and W are critical residues.
CC   -!- PTM: Highly N- and O-glycosylated. The O-glycans are heavily
CC       sulfated (By similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: The number of SRCR and SRCR-interspersed domains is
CC       polymorphic in a variety of tumors and may represent the major
CC       site of alterations in cancer.
CC   -!- DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or
CC       malignant central nervous system neoplasms derived from glial
CC       cells. They comprise astrocytomas and glioblastoma multiforme that
CC       are derived from astrocytes, oligodendrogliomas derived from
CC       oligodendrocytes and ependymomas derived from ependymocytes.
CC       Note=The gene represented in this entry is involved in disease
CC       pathogenesis. Homozygous deletions may be the predominant
CC       mechanism of DMBT1 inactivation playing a role in carcinogenesis.
CC       DMBT1 is deleted in medulloblastoma and glioblastoma cell lines;
CC       point mutations have also been reported in patients with glioma. A
CC       loss or reduction of DMBT1 expression has been seen in esophageal,
CC       gastric, lung and colorectal carcinomas as well.
CC   -!- SIMILARITY: Belongs to the DMBT1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DMBT1ID309ch10q26.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000342; CAA04019.1; -; mRNA.
DR   EMBL; AF159456; AAD49696.1; -; mRNA.
DR   EMBL; AJ243212; CAB56155.1; -; mRNA.
DR   EMBL; AJ243211; CAB63941.1; -; Genomic_DNA.
DR   EMBL; AJ243224; CAB63942.1; -; mRNA.
DR   EMBL; AB020851; BAA78577.1; -; Genomic_DNA.
DR   EMBL; AJ297935; CAC44122.1; -; mRNA.
DR   EMBL; AK304149; BAH14118.1; -; mRNA.
DR   EMBL; AL603764; CAI14487.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14488.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14489.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14490.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14491.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14492.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14493.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14494.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14495.1; -; Genomic_DNA.
DR   EMBL; AL603764; CAI14496.1; -; Genomic_DNA.
DR   EMBL; BC153299; AAI53300.1; -; mRNA.
DR   EMBL; AB209691; BAD92928.1; -; mRNA.
DR   EMBL; BX640988; CAE45995.1; -; mRNA.
DR   CCDS; CCDS44490.1; -. [Q9UGM3-1]
DR   CCDS; CCDS44491.1; -. [Q9UGM3-2]
DR   CCDS; CCDS44492.1; -. [Q9UGM3-3]
DR   PIR; A59386; A59386.
DR   RefSeq; NP_001307573.1; NM_001320644.1.
DR   RefSeq; NP_004397.2; NM_004406.2. [Q9UGM3-2]
DR   RefSeq; NP_015568.2; NM_007329.2. [Q9UGM3-1]
DR   RefSeq; NP_060049.2; NM_017579.2. [Q9UGM3-3]
DR   RefSeq; XP_011537690.1; XM_011539388.2. [Q9UGM3-6]
DR   RefSeq; XP_011537693.1; XM_011539391.2. [Q9UGM3-7]
DR   RefSeq; XP_011537707.1; XM_011539405.2. [Q9UGM3-1]
DR   UniGene; Hs.279611; -.
DR   ProteinModelPortal; Q9UGM3; -.
DR   SMR; Q9UGM3; -.
DR   BioGrid; 108095; 13.
DR   DIP; DIP-50763N; -.
DR   IntAct; Q9UGM3; 6.
DR   STRING; 9606.ENSP00000357905; -.
DR   iPTMnet; Q9UGM3; -.
DR   PhosphoSitePlus; Q9UGM3; -.
DR   BioMuta; DMBT1; -.
DR   DMDM; 85687556; -.
DR   PaxDb; Q9UGM3; -.
DR   PeptideAtlas; Q9UGM3; -.
DR   PRIDE; Q9UGM3; -.
DR   DNASU; 1755; -.
DR   Ensembl; ENST00000330163; ENSP00000327747; ENSG00000187908. [Q9UGM3-2]
DR   Ensembl; ENST00000338354; ENSP00000342210; ENSG00000187908. [Q9UGM3-1]
DR   Ensembl; ENST00000344338; ENSP00000343175; ENSG00000187908. [Q9UGM3-3]
DR   Ensembl; ENST00000368909; ENSP00000357905; ENSG00000187908. [Q9UGM3-1]
DR   Ensembl; ENST00000368955; ENSP00000357951; ENSG00000187908. [Q9UGM3-3]
DR   Ensembl; ENST00000368956; ENSP00000357952; ENSG00000187908. [Q9UGM3-2]
DR   Ensembl; ENST00000619379; ENSP00000484603; ENSG00000187908. [Q9UGM3-1]
DR   GeneID; 1755; -.
DR   KEGG; hsa:1755; -.
DR   UCSC; uc001lgk.1; human. [Q9UGM3-1]
DR   CTD; 1755; -.
DR   DisGeNET; 1755; -.
DR   GeneCards; DMBT1; -.
DR   H-InvDB; HIX0026114; -.
DR   HGNC; HGNC:2926; DMBT1.
DR   HPA; HPA040778; -.
DR   MIM; 137800; phenotype.
DR   MIM; 601969; gene.
DR   neXtProt; NX_Q9UGM3; -.
DR   OpenTargets; ENSG00000187908; -.
DR   PharmGKB; PA27376; -.
DR   eggNOG; ENOG410IHBC; Eukaryota.
DR   eggNOG; ENOG410XQVR; LUCA.
DR   GeneTree; ENSGT00870000136382; -.
DR   HOVERGEN; HBG060122; -.
DR   InParanoid; Q9UGM3; -.
DR   KO; K13912; -.
DR   OMA; NTHNCGH; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; Q9UGM3; -.
DR   TreeFam; TF329295; -.
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   ChiTaRS; DMBT1; human.
DR   GeneWiki; DMBT1; -.
DR   GenomeRNAi; 1755; -.
DR   PRO; PR:Q9UGM3; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000187908; -.
DR   Genevisible; Q9UGM3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; ISS:UniProtKB.
DR   GO; GO:0030670; C:phagocytic vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0042589; C:zymogen granule membrane; ISS:UniProtKB.
DR   GO; GO:0048306; F:calcium-dependent protein binding; TAS:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; TAS:UniProtKB.
DR   GO; GO:0008329; F:signaling pattern recognition receptor activity; TAS:UniProtKB.
DR   GO; GO:0035375; F:zymogen binding; ISS:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISS:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0030855; P:epithelial cell differentiation; TAS:UniProtKB.
DR   GO; GO:0043152; P:induction of bacterial agglutination; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; TAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00041; CUB; 2.
DR   Gene3D; 2.60.120.290; -; 2.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR001507; ZP_dom.
DR   InterPro; IPR017977; ZP_dom_CS.
DR   Pfam; PF00431; CUB; 2.
DR   Pfam; PF00530; SRCR; 14.
DR   Pfam; PF00100; Zona_pellucida; 1.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00042; CUB; 2.
DR   SMART; SM00202; SR; 14.
DR   SMART; SM00241; ZP; 1.
DR   SUPFAM; SSF49854; SSF49854; 2.
DR   SUPFAM; SSF56487; SSF56487; 14.
DR   PROSITE; PS01180; CUB; 2.
DR   PROSITE; PS00420; SRCR_1; 13.
DR   PROSITE; PS50287; SRCR_2; 14.
DR   PROSITE; PS00682; ZP_1; 1.
DR   PROSITE; PS51034; ZP_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; Complete proteome;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Host-virus interaction; Polymorphism;
KW   Protein transport; Reference proteome; Repeat; Secreted; Signal;
KW   Transport; Tumor suppressor.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   2413       Deleted in malignant brain tumors 1
FT                                protein.
FT                                /FTId=PRO_0000045387.
FT   DOMAIN      102    202       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      234    334       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      363    463       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      494    594       SRCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      602    702       SRCR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      733    833       SRCR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      862    962       SRCR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      993   1093       SRCR 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1122   1222       SRCR 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1251   1351       SRCR 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1380   1480       SRCR 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1509   1609       SRCR 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1640   1740       SRCR 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1766   1877       CUB 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     1883   1986       SRCR 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     2008   2117       CUB 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00059}.
FT   DOMAIN     2126   2381       ZP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00375}.
FT   COMPBIAS   1755   1759       Poly-Thr.
FT   CARBOHYD    566    566       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    737    737       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1712   1712       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16740002}.
FT   CARBOHYD   1745   1745       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1818   1818       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1832   1832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1842   1842       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1889   1889       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16740002}.
FT   CARBOHYD   1998   1998       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2120   2120       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2188   2188       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16740002}.
FT   CARBOHYD   2233   2233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2240   2240       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2256   2256       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    127    191       {ECO:0000250}.
FT   DISULFID    140    201       {ECO:0000250}.
FT   DISULFID    171    181       {ECO:0000250}.
FT   DISULFID    259    323       {ECO:0000250}.
FT   DISULFID    272    333       {ECO:0000250}.
FT   DISULFID    303    313       {ECO:0000250}.
FT   DISULFID    388    452       {ECO:0000250}.
FT   DISULFID    401    462       {ECO:0000250}.
FT   DISULFID    432    442       {ECO:0000250}.
FT   DISULFID    519    583       {ECO:0000250}.
FT   DISULFID    532    593       {ECO:0000250}.
FT   DISULFID    563    573       {ECO:0000250}.
FT   DISULFID    627    691       {ECO:0000250}.
FT   DISULFID    640    701       {ECO:0000250}.
FT   DISULFID    671    681       {ECO:0000250}.
FT   DISULFID    758    822       {ECO:0000250}.
FT   DISULFID    771    832       {ECO:0000250}.
FT   DISULFID    802    812       {ECO:0000250}.
FT   DISULFID    887    951       {ECO:0000250}.
FT   DISULFID    900    961       {ECO:0000250}.
FT   DISULFID    931    941       {ECO:0000250}.
FT   DISULFID   1018   1082       {ECO:0000250}.
FT   DISULFID   1031   1092       {ECO:0000250}.
FT   DISULFID   1062   1072       {ECO:0000250}.
FT   DISULFID   1147   1211       {ECO:0000250}.
FT   DISULFID   1160   1221       {ECO:0000250}.
FT   DISULFID   1191   1201       {ECO:0000250}.
FT   DISULFID   1276   1340       {ECO:0000250}.
FT   DISULFID   1289   1350       {ECO:0000250}.
FT   DISULFID   1320   1330       {ECO:0000250}.
FT   DISULFID   1405   1469       {ECO:0000250}.
FT   DISULFID   1418   1479       {ECO:0000250}.
FT   DISULFID   1449   1459       {ECO:0000250}.
FT   DISULFID   1534   1598       {ECO:0000250}.
FT   DISULFID   1547   1608       {ECO:0000250}.
FT   DISULFID   1578   1588       {ECO:0000250}.
FT   DISULFID   1665   1729       {ECO:0000250}.
FT   DISULFID   1678   1739       {ECO:0000250}.
FT   DISULFID   1709   1719       {ECO:0000250}.
FT   DISULFID   1766   1792       {ECO:0000250}.
FT   DISULFID   1819   1841       {ECO:0000250}.
FT   DISULFID   1911   1975       {ECO:0000250}.
FT   DISULFID   1924   1985       {ECO:0000250}.
FT   DISULFID   1955   1965       {ECO:0000250}.
FT   DISULFID   2008   2034       {ECO:0000250}.
FT   DISULFID   2059   2081       {ECO:0000250}.
FT   DISULFID   2302   2360       {ECO:0000250}.
FT   VAR_SEQ     201    332       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053979.
FT   VAR_SEQ     337    835       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9288095}.
FT                                /FTId=VSP_016846.
FT   VAR_SEQ     344   1360       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053980.
FT   VAR_SEQ     464    473       Missing (in isoform 3 and isoform 7).
FT                                {ECO:0000303|PubMed:10597221}.
FT                                /FTId=VSP_016847.
FT   VAR_SEQ     472    478       SPDTLPT -> RPGERPR (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034653.
FT   VAR_SEQ     479    971       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034654.
FT   VAR_SEQ     523   1408       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.9}.
FT                                /FTId=VSP_016848.
FT   VAR_SEQ    1099   1356       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034655.
FT   VAR_SEQ    1169   1169       M -> MSAPGNARFGQGSGPIVLDDVRCSGHESYLWSCPHN
FT                                GWLSHNCGHHEDAGVICSASQSQPTPSPDTWPTSHASTAGS
FT                                ESSLALRLVNGGDRCQGRVEVLYRGSWGTVCDDYWDTNDAN
FT                                VVCRQLGCGWAT (in isoform 6 and isoform
FT                                7). {ECO:0000305}.
FT                                /FTId=VSP_034656.
FT   VAR_SEQ    1170   1298       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9288095}.
FT                                /FTId=VSP_016849.
FT   VAR_SEQ    1608   1738       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053981.
FT   VAR_SEQ    1741   1761       ATQINSTTTDWWHPTTTTTAR -> G (in isoform
FT                                5). {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_016850.
FT   VARIANT      42     42       P -> T (in dbSNP:rs11523871).
FT                                {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:10551316,
FT                                ECO:0000269|PubMed:10597221,
FT                                ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:12353266,
FT                                ECO:0000269|PubMed:9288095}.
FT                                /FTId=VAR_024788.
FT   VARIANT      52     52       S -> W (in dbSNP:rs75209396).
FT                                {ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_024789.
FT   VARIANT      54     54       S -> L (in dbSNP:rs3013236).
FT                                {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:10551316,
FT                                ECO:0000269|PubMed:10597221,
FT                                ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:12353266,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024790.
FT   VARIANT      60     60       V -> A. {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:10597221,
FT                                ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:9288095}.
FT                                /FTId=VAR_024791.
FT   VARIANT      65     65       P -> L (in dbSNP:rs185045706).
FT                                {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024792.
FT   VARIANT     162    162       G -> E (in a glioma cell line;
FT                                dbSNP:rs200664624).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057981.
FT   VARIANT     322    322       N -> D (in dbSNP:rs1969620).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_044417.
FT   VARIANT     337    337       Q -> L. {ECO:0000269|PubMed:10597221,
FT                                ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024793.
FT   VARIANT     357    357       P -> S (in dbSNP:rs141757453).
FT                                {ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_024794.
FT   VARIANT     364    364       R -> G. {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024795.
FT   VARIANT     420    420       Q -> H (in a glioma sample; glioblastoma
FT                                multiforme; somatic mutation;
FT                                dbSNP:rs104894156).
FT                                /FTId=VAR_024796.
FT   VARIANT     546    546       N -> S (in a glioma cell line;
FT                                dbSNP:rs200713568).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057982.
FT   VARIANT     607    607       G -> V (in a glioma sample; pilocytic
FT                                astrocytoma).
FT                                /FTId=VAR_024797.
FT   VARIANT     649    649       T -> M (in dbSNP:rs189478437).
FT                                {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024798.
FT   VARIANT     656    656       R -> W.
FT                                /FTId=VAR_024799.
FT   VARIANT     670    670       R -> C (in dbSNP:rs2277237).
FT                                /FTId=VAR_052994.
FT   VARIANT     719    719       T -> M (in dbSNP:rs2277238).
FT                                /FTId=VAR_052995.
FT   VARIANT     780    780       T -> M (in dbSNP:rs199704744).
FT                                {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024800.
FT   VARIANT     856    856       P -> S. {ECO:0000269|PubMed:10485905,
FT                                ECO:0000269|PubMed:10551316,
FT                                ECO:0000269|PubMed:10597221,
FT                                ECO:0000269|PubMed:11751412}.
FT                                /FTId=VAR_024801.
FT   VARIANT    1084   1084       H -> Y (in dbSNP:rs2277244).
FT                                {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024802.
FT   VARIANT    1095   1095       S -> P (in dbSNP:rs200551848).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057983.
FT   VARIANT    1102   1102       S -> T (in dbSNP:rs566926424).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057984.
FT   VARIANT    1169   1169       M -> T. {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024803.
FT   VARIANT    1176   1176       R -> W (in dbSNP:rs761527369).
FT                                {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024804.
FT   VARIANT    1434   1434       R -> W. {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057985.
FT   VARIANT    1545   1545       V -> M (in dbSNP:rs189221852).
FT                                {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024805.
FT   VARIANT    1732   1732       H -> S (requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:12185598,
FT                                ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_024806.
FT   VARIANT    1860   1860       R -> L (in dbSNP:rs7099177).
FT                                /FTId=VAR_044418.
FT   VARIANT    1961   1961       T -> P. {ECO:0000269|PubMed:12185598}.
FT                                /FTId=VAR_024807.
FT   VARIANT    2255   2255       V -> M (in dbSNP:rs183135544).
FT                                {ECO:0000269|PubMed:12353266}.
FT                                /FTId=VAR_057986.
FT   CONFLICT     10     10       M -> V (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
FT   CONFLICT     13     13       L -> S (in Ref. 6; BAH14118).
FT                                {ECO:0000305}.
FT   CONFLICT     31     31       A -> T (in Ref. 8; AAI53300).
FT                                {ECO:0000305}.
FT   CONFLICT     42     42       P -> Q (in Ref. 2; AAD49696 and 8;
FT                                AAI53300). {ECO:0000305}.
FT   CONFLICT     74     74       S -> T (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT    125    125       T -> A (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       S -> T (in Ref. 6; BAH14118).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       G -> S (in Ref. 6; BAH14118).
FT                                {ECO:0000305}.
FT   CONFLICT    468    468       W -> R (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
FT   CONFLICT    594    594       S -> SDTLPTTTLPASTV (in Ref. 3;
FT                                CAB63941). {ECO:0000305}.
FT   CONFLICT    603    603       R -> G (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT    711    711       R -> G (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
FT   CONFLICT    902    902       Q -> R (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT   1034   1034       L -> P (in Ref. 1; CAA04019 and 2;
FT                                AAD49696). {ECO:0000305}.
FT   CONFLICT   1060   1060       V -> A (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   1069   1069       L -> P (in Ref. 1; CAA04019 and 2;
FT                                AAD49696). {ECO:0000305}.
FT   CONFLICT   1159   1159       V -> A (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   1204   1204       N -> D (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT   1271   1271       S -> P (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT   1295   1295       G -> S (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
FT   CONFLICT   1336   1336       L -> F (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
FT   CONFLICT   1411   1411       T -> I (in Ref. 8; AAI53300).
FT                                {ECO:0000305}.
FT   CONFLICT   1432   1432       N -> S (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT   1443   1443       V -> A (in Ref. 3; CAB63942).
FT                                {ECO:0000305}.
FT   CONFLICT   1448   1448       R -> H (in Ref. 8; AAI53300).
FT                                {ECO:0000305}.
FT   CONFLICT   1482   1482       S -> F (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   1583   1583       S -> P (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   1591   1591       N -> K (in Ref. 6; BAH14118).
FT                                {ECO:0000305}.
FT   CONFLICT   1595   1595       S -> T (in Ref. 6; BAH14118).
FT                                {ECO:0000305}.
FT   CONFLICT   1705   1705       D -> G (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   1845   1845       R -> G (in Ref. 10). {ECO:0000305}.
FT   CONFLICT   1909   1909       T -> A (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   2004   2005       TD -> N (in Ref. 2; CAB56155 and 7;
FT                                CAI14494). {ECO:0000305}.
FT   CONFLICT   2196   2196       F -> L (in Ref. 2; CAB56155).
FT                                {ECO:0000305}.
FT   CONFLICT   2380   2380       L -> S (in Ref. 8; AAI53300).
FT                                {ECO:0000305}.
FT   CONFLICT   2405   2405       P -> A (in Ref. 5; CAC44122).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2413 AA;  260735 MW;  25363E6263234F15 CRC64;
     MGISTVILEM CLLWGQVLST GGWIPRTTDY ASLIPSEVPL DPTVAEGSPF PSESTLESTV
     AEGSPISLES TLESTVAEGS LIPSESTLES TVAEGSDSGL ALRLVNGDGR CQGRVEILYR
     GSWGTVCDDS WDTNDANVVC RQLGCGWAMS APGNAWFGQG SGPIALDDVR CSGHESYLWS
     CPHNGWLSHN CGHGEDAGVI CSAAQPQSTL RPESWPVRIS PPVPTEGSES SLALRLVNGG
     DRCRGRVEVL YRGSWGTVCD DYWDTNDANV VCRQLGCGWA MSAPGNAQFG QGSGPIVLDD
     VRCSGHESYL WSCPHNGWLT HNCGHSEDAG VICSAPQSRP TPSPDTWPTS HASTAGPESS
     LALRLVNGGD RCQGRVEVLY RGSWGTVCDD SWDTSDANVV CRQLGCGWAT SAPGNARFGQ
     GSGPIVLDDV RCSGYESYLW SCPHNGWLSH NCQHSEDAGV ICSAAHSWST PSPDTLPTIT
     LPASTVGSES SLALRLVNGG DRCQGRVEVL YRGSWGTVCD DSWDTNDANV VCRQLGCGWA
     MLAPGNARFG QGSGPIVLDD VRCSGNESYL WSCPHNGWLS HNCGHSEDAG VICSGPESSL
     ALRLVNGGDR CQGRVEVLYR GSWGTVCDDS WDTNDANVVC RQLGCGWATS APGNARFGQG
     SGPIVLDDVR CSGHESYLWS CPNNGWLSHN CGHHEDAGVI CSAAQSRSTP RPDTLSTITL
     PPSTVGSESS LTLRLVNGSD RCQGRVEVLY RGSWGTVCDD SWDTNDANVV CRQLGCGWAT
     SAPGNARFGQ GSGPIVLDDV RCSGHESYLW SCPHNGWLSH NCGHHEDAGV ICSVSQSRPT
     PSPDTWPTSH ASTAGPESSL ALRLVNGGDR CQGRVEVLYR GSWGTVCDDS WDTSDANVVC
     RQLGCGWATS APGNARFGQG SGPIVLDDVR CSGYESYLWS CPHNGWLSHN CQHSEDAGVI
     CSAAHSWSTP SPDTLPTITL PASTVGSESS LALRLVNGGD RCQGRVEVLY QGSWGTVCDD
     SWDTNDANVV CRQLGCGWAM SAPGNARFGQ GSGPIVLDDV RCSGHESYLW SCPHNGWLSH
     NCGHSEDAGV ICSASQSRPT PSPDTWPTSH ASTAGSESSL ALRLVNGGDR CQGRVEVLYR
     GSWGTVCDDY WDTNDANVVC RQLGCGWAMS APGNARFGQG SGPIVLDDVR CSGHESYLWS
     CPHNGWLSHN CGHHEDAGVI CSASQSQPTP SPDTWPTSHA STAGSESSLA LRLVNGGDRC
     QGRVEVLYRG SWGTVCDDYW DTNDANVVCR QLGCGWATSA PGNARFGQGS GPIVLDDVRC
     SGHESYLWSC PHNGWLSHNC GHHEDAGVIC SASQSQPTPS PDTWPTSHAS TAGSESSLAL
     RLVNGGDRCQ GRVEVLYRGS WGTVCDDYWD TNDANVVCRQ LGCGWATSAP GNARFGQGSG
     PIVLDDVRCS GHESYLWSCP HNGWLSHNCG HHEDAGVICS ASQSQPTPSP DTWPTSRAST
     AGSESTLALR LVNGGDRCRG RVEVLYQGSW GTVCDDYWDT NDANVVCRQL GCGWAMSAPG
     NAQFGQGSGP IVLDDVRCSG HESYLWSCPH NGWLSHNCGH HEDAGVICSA AQSQSTPRPD
     TWLTTNLPAL TVGSESSLAL RLVNGGDRCR GRVEVLYRGS WGTVCDDSWD TNDANVVCRQ
     LGCGWAMSAP GNARFGQGSG PIVLDDVRCS GNESYLWSCP HKGWLTHNCG HHEDAGVICS
     ATQINSTTTD WWHPTTTTTA RPSSNCGGFL FYASGTFSSP SYPAYYPNNA KCVWEIEVNS
     GYRINLGFSN LKLEAHHNCS FDYVEIFDGS LNSSLLLGKI CNDTRQIFTS SYNRMTIHFR
     SDISFQNTGF LAWYNSFPSD ATLRLVNLNS SYGLCAGRVE IYHGGTWGTV CDDSWTIQEA
     EVVCRQLGCG RAVSALGNAY FGSGSGPITL DDVECSGTES TLWQCRNRGW FSHNCNHRED
     AGVICSGNHL STPAPFLNIT RPNTDYSCGG FLSQPSGDFS SPFYPGNYPN NAKCVWDIEV
     QNNYRVTVIF RDVQLEGGCN YDYIEVFDGP YRSSPLIARV CDGARGSFTS SSNFMSIRFI
     SDHSITRRGF RAEYYSSPSN DSTNLLCLPN HMQASVSRSY LQSLGFSASD LVISTWNGYY
     ECRPQITPNL VIFTIPYSGC GTFKQADNDT IDYSNFLTAA VSGGIIKRRT DLRIHVSCRM
     LQNTWVDTMY IANDTIHVAN NTIQVEEVQY GNFDVNISFY TSSSFLYPVT SRPYYVDLNQ
     DLYVQAEILH SDAVLTLFVD TCVASPYSND FTSLTYDLIR SGCVRDDTYG PYSSPSLRIA
     RFRFRAFHFL NRFPSVYLRC KMVVCRAYDP SSRCYRGCVL RSKRDVGSYQ EKVDVVLGPI
     QLQTPPRREE EPR
//
ID   NETR_MOUSE              Reviewed;         761 AA.
AC   O08762;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   07-JUN-2017, entry version 153.
DE   RecName: Full=Neurotrypsin;
DE            EC=3.4.21.-;
DE   AltName: Full=Brain-specific serine protease 3;
DE            Short=BSSP-3;
DE   AltName: Full=Motopsin;
DE   AltName: Full=Serine protease 12;
DE   Flags: Precursor;
GN   Name=Prss12; Synonyms=Bssp3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9245503; DOI=10.1006/mcne.1997.0616;
RA   Gschwend T.P., Krueger S.R., Kozlov S.V., Wolfer D.P., Sonderegger P.;
RT   "Neurotrypsin, a novel multidomain serine protease expressed in the
RT   nervous system.";
RL   Mol. Cell. Neurosci. 9:207-219(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9344839; DOI=10.1006/bbrc.1997.7417;
RA   Yamamura Y., Yamashiro K., Tsuruoka N., Nakazato H., Tsujimura A.,
RA   Yamaguchi N.;
RT   "Molecular cloning of a novel brain-specific serine protease with a
RT   kringle-like structure and three scavenger receptor cysteine-rich
RT   motifs.";
RL   Biochem. Biophys. Res. Commun. 239:386-392(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Plays a role in neuronal plasticity and the proteolytic
CC       action may subserve structural reorganizations associated with
CC       learning and memory operations.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Most abundant in cerebral cortex, hippocampus
CC       and amygdala.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13192; CAA73646.1; -; mRNA.
DR   EMBL; D89871; BAA23986.1; -; mRNA.
DR   EMBL; BC031429; AAH31429.1; -; mRNA.
DR   CCDS; CCDS17817.1; -.
DR   PIR; JC5759; JC5759.
DR   RefSeq; NP_032965.1; NM_008939.2.
DR   UniGene; Mm.9431; -.
DR   ProteinModelPortal; O08762; -.
DR   SMR; O08762; -.
DR   STRING; 10090.ENSMUSP00000029603; -.
DR   MEROPS; S01.237; -.
DR   PhosphoSitePlus; O08762; -.
DR   MaxQB; O08762; -.
DR   PaxDb; O08762; -.
DR   PeptideAtlas; O08762; -.
DR   PRIDE; O08762; -.
DR   Ensembl; ENSMUST00000029603; ENSMUSP00000029603; ENSMUSG00000027978.
DR   GeneID; 19142; -.
DR   KEGG; mmu:19142; -.
DR   UCSC; uc008rfl.2; mouse.
DR   CTD; 8492; -.
DR   MGI; MGI:1100881; Prss12.
DR   eggNOG; KOG3627; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00870000136382; -.
DR   HOGENOM; HOG000113767; -.
DR   HOVERGEN; HBG006465; -.
DR   InParanoid; O08762; -.
DR   KO; K09624; -.
DR   OMA; CIKQDIG; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; O08762; -.
DR   TreeFam; TF329295; -.
DR   PRO; PR:O08762; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000027978; -.
DR   CleanEx; MM_PRSS12; -.
DR   Genevisible; O08762; MM.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0043083; C:synaptic cleft; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IDA:MGI.
DR   GO; GO:0008233; F:peptidase activity; IMP:MGI.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:MGI.
DR   GO; GO:0006887; P:exocytosis; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:MGI.
DR   GO; GO:0031638; P:zymogen activation; IDA:MGI.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 3.10.250.10; -; 1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00530; SRCR; 3.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00202; SR; 3.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF56487; SSF56487; 3.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS00420; SRCR_1; 3.
DR   PROSITE; PS50287; SRCR_2; 3.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Hydrolase; Kringle;
KW   Protease; Reference proteome; Repeat; Secreted; Serine protease;
KW   Signal.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    761       Neurotrypsin.
FT                                /FTId=PRO_0000027670.
FT   DOMAIN       85    157       Kringle. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      166    267       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      273    373       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      386    487       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      517    760       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   REGION      505    516       Zymogen activation region.
FT   ACT_SITE    562    562       Charge relay system.
FT   ACT_SITE    612    612       Charge relay system.
FT   ACT_SITE    711    711       Charge relay system.
FT   SITE        516    517       Reactive bond homolog. {ECO:0000255}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    521    521       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    569    569       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     85    157       {ECO:0000250}.
FT   DISULFID    101    141       {ECO:0000250}.
FT   DISULFID    130    155       {ECO:0000250}.
FT   DISULFID    191    255       {ECO:0000250}.
FT   DISULFID    204    265       {ECO:0000250}.
FT   DISULFID    235    245       {ECO:0000250}.
FT   DISULFID    298    361       {ECO:0000250}.
FT   DISULFID    311    371       {ECO:0000250}.
FT   DISULFID    341    351       {ECO:0000250}.
FT   DISULFID    411    475       {ECO:0000250}.
FT   DISULFID    424    485       {ECO:0000250}.
FT   DISULFID    455    465       {ECO:0000250}.
FT   DISULFID    505    636       {ECO:0000255}.
FT   DISULFID    547    563       {ECO:0000250}.
FT   DISULFID    651    717       {ECO:0000250}.
FT   DISULFID    680    694       {ECO:0000250}.
FT   DISULFID    707    736       {ECO:0000250}.
SQ   SEQUENCE   761 AA;  84118 MW;  DF507B03712164E6 CRC64;
     MALARCVLAV ILGALSVVAR ADPVSRSPLH RPHPSPPRSQ HAHYLPSSRR PPRTPRFPLP
     LRIPAAQRPQ VLSTGHTPPT IPRRCGAGES WGNATNLGVP CLHWDEVPPF LERSPPASWA
     ELRGQPHNFC RSPDGSGRPW CFYRNAQGKV DWGYCDCGQG PALPVIRLVG GNSGHEGRVE
     LYHAGQWGTI CDDQWDNADA DVICRQLGLS GIAKAWHQAH FGEGSGPILL DEVRCTGNEL
     SIEQCPKSSW GEHNCGHKED AGVSCVPLTD GVIRLAGGKS THEGRLEVYY KGQWGTVCDD
     GWTEMNTYVA CRLLGFKYGK QSSVNHFDGS NRPIWLDDVS CSGKEVSFIQ CSRRQWGRHD
     CSHREDVGLT CYPDSDGHRL SPGFPIRLVD GENKKEGRVE VFVNGQWGTI CDDGWTDKHA
     AVICRQLGYK GPARARTMAY FGEGKGPIHM DNVKCTGNEK ALADCVKQDI GRHNCRHSED
     AGVICDYLEK KASSSGNKEM LSSGCGLRLL HRRQKRIIGG NNSLRGAWPW QASLRLRSAH
     GDGRLLCGAT LLSSCWVLTA AHCFKRYGNN SRSYAVRVGD YHTLVPEEFE QEIGVQQIVI
     HRNYRPDRSD YDIALVRLQG PGEQCARLST HVLPACLPLW RERPQKTASN CHITGWGDTG
     RAYSRTLQQA AVPLLPKRFC KERYKGLFTG RMLCAGNLQE DNRVDSCQGD SGGPLMCEKP
     DESWVVYGVT SWGYGCGVKD TPGVYTRVPA FVPWIKSVTS L
//
ID   NETR_TRAPH              Reviewed;         875 AA.
AC   Q5G266;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   10-MAY-2017, entry version 60.
DE   RecName: Full=Neurotrypsin;
DE            EC=3.4.21.-;
DE   AltName: Full=Serine protease 12;
DE   Flags: Precursor;
GN   Name=PRSS12;
OS   Trachypithecus phayrei (Phayre's leaf monkey).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Cercopithecidae; Colobinae; Trachypithecus.
OX   NCBI_TaxID=61618;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=15627749; DOI=10.1159/000081523;
RA   Xu H.L., Su B.;
RT   "Genetic evidence of a strong functional constraint of neurotrypsin
RT   during primate evolution.";
RL   Cytogenet. Genome Res. 108:303-309(2005).
CC   -!- FUNCTION: Plays a role in neuronal plasticity and the proteolytic
CC       action may subserve structural reorganizations associated with
CC       learning and memory operations. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY862981; AAW57543.1; -; Genomic_DNA.
DR   EMBL; AY862897; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862904; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862911; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862918; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862925; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862932; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862939; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862946; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862953; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862960; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862967; AAW57543.1; JOINED; Genomic_DNA.
DR   EMBL; AY862974; AAW57543.1; JOINED; Genomic_DNA.
DR   ProteinModelPortal; Q5G266; -.
DR   PRIDE; Q5G266; -.
DR   HOVERGEN; HBG006465; -.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0006887; P:exocytosis; ISS:UniProtKB.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 3.10.250.10; -; 1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00530; SRCR; 4.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00202; SR; 4.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF56487; SSF56487; 4.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS00420; SRCR_1; 3.
DR   PROSITE; PS50287; SRCR_2; 4.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   3: Inferred from homology;
KW   Disulfide bond; Glycoprotein; Hydrolase; Kringle; Protease; Repeat;
KW   Secreted; Serine protease; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    875       Neurotrypsin.
FT                                /FTId=PRO_0000027669.
FT   DOMAIN       93    165       Kringle. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      170    271       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      280    381       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      387    487       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      500    601       SRCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      631    874       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   REGION      619    630       Zymogen activation region.
FT   COMPBIAS     23     92       Pro-rich.
FT   ACT_SITE    676    676       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    726    726       Charge relay system. {ECO:0000250}.
FT   ACT_SITE    825    825       Charge relay system. {ECO:0000250}.
FT   SITE        630    631       Reactive bond homolog. {ECO:0000255}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    683    683       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     93    165       {ECO:0000250}.
FT   DISULFID    109    149       {ECO:0000250}.
FT   DISULFID    138    163       {ECO:0000250}.
FT   DISULFID    195    259       {ECO:0000250}.
FT   DISULFID    208    269       {ECO:0000250}.
FT   DISULFID    239    249       {ECO:0000250}.
FT   DISULFID    305    369       {ECO:0000250}.
FT   DISULFID    318    379       {ECO:0000250}.
FT   DISULFID    349    359       {ECO:0000250}.
FT   DISULFID    412    475       {ECO:0000250}.
FT   DISULFID    425    485       {ECO:0000250}.
FT   DISULFID    455    465       {ECO:0000250}.
FT   DISULFID    525    589       {ECO:0000250}.
FT   DISULFID    538    599       {ECO:0000250}.
FT   DISULFID    569    579       {ECO:0000250}.
FT   DISULFID    619    750       {ECO:0000255}.
FT   DISULFID    661    677       {ECO:0000250}.
FT   DISULFID    765    831       {ECO:0000250}.
FT   DISULFID    794    808       {ECO:0000250}.
FT   DISULFID    821    850       {ECO:0000250}.
SQ   SEQUENCE   875 AA;  97292 MW;  CAC3D2638E460D1F CRC64;
     MTLARFVLAL VLGALPEVVG FDSVLNDSLH HRHRHSPPPG PQYPYYLPTH QRPPRTRPPP
     PLPRFSRPPR ALLAQRPHAL QAGHTPRRHP WGCPPGEPWV SVTDFGAPCL RWAEVPPFLE
     RSPPASWAQL RGQRHNFCRS PDGPGRPWCF YGDARGKVDW GYCDCRHGSV RLRGGKNEFE
     GTVEVYASGV WGTVCSSHWD DSDASVICHQ LQLGGKGIAK QTPFSGLGLI PIYWSNVRCR
     GDEENILLCE KDIWQXGVCP QKMAAAVTCS FSHGPAFPII RLVGGNSVHE GRVELYHAGQ
     WGTVCDDQWD DADAEVICRQ LGLSGIAKAW HQAYFGEGSG PVMLDEVRCT GNELSIEQCP
     KSSWGEHNCG HKEDAGVSCT PLTDGVIRLA GGKGSHEGRL EVYYRGQWGT VCDDGWTELN
     TYVACRQLGF KYGKQASANH FEESTGPIWL DDVSCSGKET RFLQCSRRQW GRHDCSHRED
     VSIACYPGSE GHRLSLGFPV RLMDGENKKE GRVEVFINGQ WGTICDDGWT DKDAAVICRQ
     LGYKGPARAR TMAYFGEGKG PIHVDNVKCT GNERSLADCI KQDIGRHNCR HSEDAGVICD
     YFGKKASGNS NKESLSSVCG LRLLHRRQKR IIGGKNSLRG GWPWQVSLRL KSSHGDGRLL
     CGATLLSSCW VLTAAHCFKR YGNSTRNYAV RVGDYHTLVP EEFEEEIGVQ QIVIHREYRP
     DSSDYDIALV RLQGPEEQCA RFSSHVLPAC LPFWRERPQK TASNCYITGW GDTGRAYSRT
     LQQAAIPLLP KRFCEERYKG RFTGRMLCAG NLHEHKRVDS CQGDSGGPLM CERPGESWAV
     YGVTSWGYGC GVKDSPGVYT KVSAFVPWIK SVTKL
//
ID   C163B_HUMAN             Reviewed;        1453 AA.
AC   Q9NR16; B4E0G7; C9JHR7; E7EVK4; Q2M3B7; Q6UWC2;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   05-JUL-2017, entry version 126.
DE   RecName: Full=Scavenger receptor cysteine-rich type 1 protein M160;
DE   AltName: Full=CD163 antigen-like 1;
DE   AltName: CD_antigen=CD163b;
DE   Flags: Precursor;
GN   Name=CD163L1; Synonyms=CD163B, M160; ORFNames=UNQ6434/PRO23202;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   VARIANT MET-523.
RX   PubMed=11086079; DOI=10.4049/jimmunol.165.11.6406;
RA   Groenlund J., Vitved L., Lausen M., Skjoedt K., Holmskov U.;
RT   "Cloning of a novel scavenger receptor cysteine-rich type I
RT   transmembrane molecule (M160) expressed by human macrophages.";
RL   J. Immunol. 165:6406-6415(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-523.
RX   PubMed=20032174; DOI=10.1128/JVI.02093-09;
RA   Van Gorp H., Van Breedam W., Van Doorsselaere J., Delputte P.L.,
RA   Nauwynck H.J.;
RT   "Identification of the CD163 protein domains involved in infection of
RT   the porcine reproductive and respiratory syndrome virus.";
RL   J. Virol. 84:3101-3105(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   MET-523.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT
RP   MET-523.
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-523.
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 41-55.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1161.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000305};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000305};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=M160-alpha;
CC         IsoId=Q9NR16-1; Sequence=Displayed;
CC       Name=2; Synonyms=M160-beta;
CC         IsoId=Q9NR16-2; Sequence=VSP_016877;
CC       Name=3;
CC         IsoId=Q9NR16-3; Sequence=VSP_016875, VSP_016876;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9NR16-4; Sequence=VSP_047557;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is highly expressed in the spleen,
CC       lymph nodes, thymus, and fetal liver and weakly expressed in bone
CC       marrow and no expression was found in peripheral blood leukocytes.
CC       Isoform 1 expression is restricted to the monocyte and macrophage
CC       cell lines. Isoform 2 is only expressed in spleen.
CC       {ECO:0000269|PubMed:11086079}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF264014; AAF91396.1; -; mRNA.
DR   EMBL; GQ397482; ADB45259.1; -; mRNA.
DR   EMBL; AY358856; AAQ89215.1; -; mRNA.
DR   EMBL; AK303372; BAG64429.1; -; mRNA.
DR   EMBL; AC131205; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131206; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC104962; AAI04963.1; -; mRNA.
DR   EMBL; BC104964; AAI04965.1; -; mRNA.
DR   CCDS; CCDS73434.1; -. [Q9NR16-4]
DR   CCDS; CCDS8577.1; -. [Q9NR16-1]
DR   RefSeq; NP_001284579.1; NM_001297650.1.
DR   RefSeq; NP_777601.2; NM_174941.5.
DR   RefSeq; XP_011518918.1; XM_011520616.1. [Q9NR16-2]
DR   UniGene; Hs.631727; -.
DR   ProteinModelPortal; Q9NR16; -.
DR   SMR; Q9NR16; -.
DR   iPTMnet; Q9NR16; -.
DR   PhosphoSitePlus; Q9NR16; -.
DR   BioMuta; CD163L1; -.
DR   DMDM; 296434413; -.
DR   PaxDb; Q9NR16; -.
DR   PeptideAtlas; Q9NR16; -.
DR   PRIDE; Q9NR16; -.
DR   Ensembl; ENST00000313599; ENSP00000315945; ENSG00000177675. [Q9NR16-1]
DR   Ensembl; ENST00000416109; ENSP00000393474; ENSG00000177675. [Q9NR16-4]
DR   GeneID; 283316; -.
DR   KEGG; hsa:283316; -.
DR   UCSC; uc001qsy.4; human. [Q9NR16-1]
DR   CTD; 283316; -.
DR   DisGeNET; 283316; -.
DR   GeneCards; CD163L1; -.
DR   HGNC; HGNC:30375; CD163L1.
DR   HPA; HPA015663; -.
DR   MIM; 606079; gene.
DR   neXtProt; NX_Q9NR16; -.
DR   OpenTargets; ENSG00000177675; -.
DR   PharmGKB; PA142672145; -.
DR   eggNOG; ENOG410IHBC; Eukaryota.
DR   eggNOG; ENOG410XQVR; LUCA.
DR   GeneTree; ENSGT00870000136382; -.
DR   HOGENOM; HOG000290652; -.
DR   HOVERGEN; HBG080943; -.
DR   InParanoid; Q9NR16; -.
DR   KO; K06545; -.
DR   OMA; WINSISC; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; Q9NR16; -.
DR   TreeFam; TF329295; -.
DR   ChiTaRS; CD163L1; human.
DR   GenomeRNAi; 283316; -.
DR   PRO; PR:Q9NR16; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177675; -.
DR   CleanEx; HS_CD163L1; -.
DR   ExpressionAtlas; Q9NR16; baseline and differential.
DR   Genevisible; Q9NR16; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   Gene3D; 3.10.250.10; -; 4.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   Pfam; PF00530; SRCR; 12.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00202; SR; 12.
DR   SUPFAM; SSF56487; SSF56487; 12.
DR   PROSITE; PS00420; SRCR_1; 5.
DR   PROSITE; PS50287; SRCR_2; 12.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Membrane;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     40       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        41   1453       Scavenger receptor cysteine-rich type 1
FT                                protein M160.
FT                                /FTId=PRO_0000045392.
FT   TOPO_DOM     41   1359       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1360   1380       Helical. {ECO:0000255}.
FT   TOPO_DOM   1381   1453       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       48    148       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      155    255       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      262    362       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      369    469       SRCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      476    576       SRCR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      583    683       SRCR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      690    790       SRCR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      795    895       SRCR 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      900   1000       SRCR 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1036   1136       SRCR 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1141   1243       SRCR 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN     1246   1346       SRCR 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    120    120       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    334    334       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    377    377       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    441    441       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    548    548       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    637    637       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    972    972       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1013   1013       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1084   1084       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1104   1104       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1161   1161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1171   1171       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1318   1318       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1354   1354       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     73    137       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID     86    147       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    117    127       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    180    244       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    193    254       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    224    234       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    287    351       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    300    361       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    331    341       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    394    458       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    407    468       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    438    448       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    501    565       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    514    575       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    545    555       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    608    672       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    621    682       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    652    662       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    715    779       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    728    789       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    759    769       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    820    884       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    833    894       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    864    874       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    925    989       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    938    999       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    969    979       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1061   1125       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1074   1135       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1105   1115       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1181   1242       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1212   1222       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1271   1335       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1284   1345       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID   1315   1325       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   VAR_SEQ     148    148       Y -> YGKSLTRVGRQ (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047557.
FT   VAR_SEQ     718    727       GWGMNIAEVV -> SFLMTSSKPR (in isoform 3).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_016875.
FT   VAR_SEQ     728   1453       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_016876.
FT   VAR_SEQ    1395   1426       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11086079}.
FT                                /FTId=VSP_016877.
FT   VARIANT     523    523       L -> M (in dbSNP:rs6488268).
FT                                {ECO:0000269|PubMed:11086079,
FT                                ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:20032174}.
FT                                /FTId=VAR_059810.
FT   VARIANT     578    578       D -> N (in dbSNP:rs4072797).
FT                                /FTId=VAR_057206.
FT   VARIANT     582    582       G -> A (in dbSNP:rs4072796).
FT                                /FTId=VAR_057207.
FT   VARIANT    1055   1055       G -> S (in dbSNP:rs36206713).
FT                                /FTId=VAR_057208.
FT   VARIANT    1108   1108       M -> T (in dbSNP:rs35480970).
FT                                /FTId=VAR_057209.
FT   CONFLICT    105    105       T -> S (in Ref. 4; BAG64429).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       G -> V (in Ref. 4; BAG64429).
FT                                {ECO:0000305}.
FT   CONFLICT   1234   1234       P -> T (in Ref. 1; AAF91396 and 3;
FT                                AAQ89215). {ECO:0000305}.
FT   CONFLICT   1359   1359       H -> R (in Ref. 1; AAF91396 and 3;
FT                                AAQ89215). {ECO:0000305}.
FT   CONFLICT   1373   1373       L -> P (in Ref. 1; AAF91396 and 3;
FT                                AAQ89215). {ECO:0000305}.
SQ   SEQUENCE   1453 AA;  159239 MW;  EBF90FBEE4FDF4CE CRC64;
     MMLPQNSWHI DFGRCCCHQN LFSAVVTCIL LLNSCFLISS FNGTDLELRL VNGDGPCSGT
     VEVKFQGQWG TVCDDGWNTT ASTVVCKQLG CPFSFAMFRF GQAVTRHGKI WLDDVSCYGN
     ESALWECQHR EWGSHNCYHG EDVGVNCYGE ANLGLRLVDG NNSCSGRVEV KFQERWGTIC
     DDGWNLNTAA VVCRQLGCPS SFISSGVVNS PAVLRPIWLD DILCQGNELA LWNCRHRGWG
     NHDCSHNEDV TLTCYDSSDL ELRLVGGTNR CMGRVELKIQ GRWGTVCHHK WNNAAADVVC
     KQLGCGTALH FAGLPHLQSG SDVVWLDGVS CSGNESFLWD CRHSGTVNFD CLHQNDVSVI
     CSDGADLELR LADGSNNCSG RVEVRIHEQW WTICDQNWKN EQALVVCKQL GCPFSVFGSR
     RAKPSNEARD IWINSISCTG NESALWDCTY DGKAKRTCFR RSDAGVICSD KADLDLRLVG
     AHSPCYGRLE VKYQGEWGTV CHDRWSTRNA AVVCKQLGCG KPLHVFGMTY FKEASGPIWL
     DDVSCIGNES NIWDCEHSGW GKHNCVHRED VIVTCSGDAT WGLRLVGGSN RCSGRLEVYF
     QGRWGTVCDD GWNSKAAAVV CSQLDCPSSI IGMGLGNAST GYGKIWLDDV SCDGDESDLW
     SCRNSGWGNN DCSHSEDVGV ICSDASDMEL RLVGGSSRCA GKVEVNVQGA VGILCANGWG
     MNIAEVVCRQ LECGSAIRVS REPHFTERTL HILMSNSGCT GGEASLWDCI RWEWKQTACH
     LNMEASLICS AHRQPRLVGA DMPCSGRVEV KHADTWRSVC DSDFSLHAAN VLCRELNCGD
     AISLSVGDHF GKGNGLTWAE KFQCEGSETH LALCPIVQHP EDTCIHSREV GVVCSRYTDV
     RLVNGKSQCD GQVEINVLGH WGSLCDTHWD PEDARVLCRQ LSCGTALSTT GGKYIGERSV
     RVWGHRFHCL GNESLLDNCQ MTVLGAPPCI HGNTVSVICT GSLTQPLFPC LANVSDPYLS
     AVPEGSALIC LEDKRLRLVD GDSRCAGRVE IYHDGFWGTI CDDGWDLSDA HVVCQKLGCG
     VAFNATVSAH FGEGSGPIWL DDLNCTGMES HLWQCPSRGW GQHDCRHKED AGVICSEFTA
     LRLYSETETE SCAGRLEVFY NGTWGSVGRR NITTAIAGIV CRQLGCGENG VVSLAPLSKT
     GSGFMWVDDI QCPKTHISIW QCLSAPWERR ISSPAEETWI TCEDRIRVRG GDTECSGRVE
     IWHAGSWGTV CDDSWDLAEA EVVCQQLGCG SALAALRDAS FGQGTGTIWL DDMRCKGNES
     FLWDCHAKPW GQSDCGHKED AGVRCSGQSL KSLNASSGHL ALILSSIFGL LLLVLFILFL
     TWCRVQKQKH LPLRVSTRRR GSLEENLFHE METCLKREDP HGTRTSDDTP NHGCEDASDT
     SLLGVLPASE ATK
//
ID   C163A_HUMAN             Reviewed;        1156 AA.
AC   Q86VB7; C9JIG2; Q07898; Q07899; Q07900; Q07901; Q2VLH7;
DT   30-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   07-JUN-2017, entry version 124.
DE   RecName: Full=Scavenger receptor cysteine-rich type 1 protein M130;
DE   AltName: Full=Hemoglobin scavenger receptor;
DE   AltName: CD_antigen=CD163;
DE   Contains:
DE     RecName: Full=Soluble CD163;
DE              Short=sCD163;
DE   Flags: Precursor;
GN   Name=CD163; Synonyms=M130;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND VARIANT
RP   VAL-342.
RX   PubMed=8370408; DOI=10.1002/eji.1830230940;
RA   Law S.K.A., Micklem K.J., Shaw J.M., Zhang X.-P., Dong Y.,
RA   Willis A.C., Mason D.Y.;
RT   "A new macrophage differentiation antigen which is a member of the
RT   scavenger receptor superfamily.";
RL   Eur. J. Immunol. 23:2320-2325(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-342.
RX   PubMed=10403791; DOI=10.1006/bbrc.1999.0866;
RA   Ritter M., Buechler C., Langmann T., Schmitz G.;
RT   "Genomic organization and chromosomal localization of the human CD163
RT   (M130) gene: a member of the scavenger receptor cysteine-rich
RT   superfamily.";
RL   Biochem. Biophys. Res. Commun. 260:466-474(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANT VAL-342.
RA   Welch S.-K.W., Calvert J.G., Slade D.E., Shields S.L.;
RT   "Scavenger receptor cd163 is a cell permissive factor for infection
RT   with porcine reproductive and respiratory syndrome viruses.";
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-342.
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CLEAVAGE.
RX   PubMed=10066432; DOI=10.1006/bbrc.1999.0294;
RA   Droste A., Sorg C., Hogger P.;
RT   "Shedding of CD163, a novel regulatory mechanism for a member of the
RT   scavenger receptor cysteine-rich family.";
RL   Biochem. Biophys. Res. Commun. 256:110-113(1999).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10577520;
RA   Van den Heuvel M.M., Tensen C.P., van As J.H., Van den Berg T.K.,
RA   Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A.,
RA   Sorg C., Hoegger P., Beelen R.H.J.;
RT   "Regulation of CD 163 on human macrophages: cross-linking of CD163
RT   induces signaling and activation.";
RL   J. Leukoc. Biol. 66:858-866(1999).
RN   [8]
RP   INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10648003;
RA   Buechler C., Ritter M., Orso E., Langmann T., Klucken J., Schmitz G.;
RT   "Regulation of scavenger receptor CD163 expression in human monocytes
RT   and macrophages by pro- and antiinflammatory stimuli.";
RL   J. Leukoc. Biol. 67:97-103(2000).
RN   [9]
RP   FUNCTION, PHOSPHORYLATION, MUTAGENESIS OF THR-1072 AND SER-1084, AND
RP   INTERACTION WITH CSNK2B.
RX   PubMed=11298324;
RX   DOI=10.1002/1521-4141(200104)31:4<999::AID-IMMU999>3.0.CO;2-R;
RA   Ritter M., Buechler C., Kapinsky M., Schmitz G.;
RT   "Interaction of CD163 with the regulatory subunit of casein kinase II
RT   (CKII) and dependence of CD163 signaling on CKII and protein kinase
RT   C.";
RL   Eur. J. Immunol. 31:999-1009(2001).
RN   [10]
RP   FUNCTION, TISSUE SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11196644; DOI=10.1038/35051594;
RA   Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.-J.,
RA   Law S.K.A., Moestrup S.K.;
RT   "Identification of the haemoglobin scavenger receptor.";
RL   Nature 409:198-201(2001).
RN   [11]
RP   CLEAVAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=12296867; DOI=10.1046/j.1365-2249.2002.01963.x;
RA   Matsushita N., Kashiwagi M., Wait R., Nagayoshi R., Nakamura M.,
RA   Matsuda T., Hogger P., Guyre P.M., Nagase H., Matsuyama T.;
RT   "Elevated levels of soluble CD163 in sera and fluids from rheumatoid
RT   arthritis patients and inhibition of the shedding of CD163 by TIMP-
RT   3.";
RL   Clin. Exp. Immunol. 130:156-161(2002).
RN   [12]
RP   FUNCTION.
RX   PubMed=12208511; DOI=10.1016/S0014-5793(02)03142-3;
RA   Frings W., Dreier J., Sorg C.;
RT   "Only the soluble form of the scavenger receptor CD163 acts inhibitory
RT   on phorbol ester-activated T-lymphocytes, whereas membrane-bound
RT   protein has no effect.";
RL   FEBS Lett. 526:93-96(2002).
RN   [13]
RP   MISCELLANEOUS.
RX   PubMed=12377940;
RA   Hintz K.A., Rassias A.J., Wardwell K., Moss M.L., Morganelli P.M.,
RA   Pioli P.A., Givan A.L., Wallace P.K., Yeager M.P., Guyre P.M.;
RT   "Endotoxin induces rapid metalloproteinase-mediated shedding followed
RT   by up-regulation of the monocyte hemoglobin scavenger receptor
RT   CD163.";
RL   J. Leukoc. Biol. 72:711-717(2002).
RN   [14]
RP   RELEVANCE AS DISEASE MARKER IN INFLAMMATORY CONDITIONS.
RX   PubMed=15478309; DOI=10.1080/07853890410033171;
RA   Moestrup S.K., Moller H.J.;
RT   "CD163: a regulated hemoglobin scavenger receptor with a role in the
RT   anti-inflammatory response.";
RL   Ann. Med. 36:347-354(2004).
RN   [15]
RP   DOMAIN, AND CLEAVAGE SITES.
RX   PubMed=15448162; DOI=10.1074/jbc.M409629200;
RA   Madsen M., Moller H.J., Nielsen M.J., Jacobsen C., Graversen J.H.,
RA   van den Berg T., Moestrup S.K.;
RT   "Molecular characterization of the haptoglobin.hemoglobin receptor
RT   CD163. Ligand binding properties of the scavenger receptor cysteine-
RT   rich domain region.";
RL   J. Biol. Chem. 279:51561-51567(2004).
RN   [16]
RP   CLEAVAGE.
RX   PubMed=15075364; DOI=10.1189/jlb.1003523;
RA   Sulahian T.H., Pioli P.A., Wardwell K., Guyre P.M.;
RT   "Cross-linking of FcgammaR triggers shedding of the hemoglobin-
RT   haptoglobin scavenger receptor CD163.";
RL   J. Leukoc. Biol. 76:271-277(2004).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-105.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [18]
RP   FUNCTION, MUTAGENESIS OF TYR-1096, AND TISSUE SPECIFICITY.
RX   PubMed=16434690; DOI=10.1189/jlb.1005602;
RA   Nielsen M.J., Madsen M., Moller H.J., Moestrup S.K.;
RT   "The macrophage scavenger receptor CD163: endocytic properties of
RT   cytoplasmic tail variants.";
RL   J. Leukoc. Biol. 79:837-845(2006).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-105; ASN-140; ASN-767 AND
RP   ASN-1027.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [20]
RP   GLYCOSYLATION AT ASN-105.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Acute phase-regulated receptor involved in clearance and
CC       endocytosis of hemoglobin/haptoglobin complexes by macrophages and
CC       may thereby protect tissues from free hemoglobin-mediated
CC       oxidative damage. May play a role in the uptake and recycling of
CC       iron, via endocytosis of hemoglobin/haptoglobin and subsequent
CC       breakdown of heme. Binds hemoglobin/haptoglobin complexes in a
CC       calcium-dependent and pH-dependent manner. Exhibits a higher
CC       affinity for complexes of hemoglobin and multimeric haptoglobin of
CC       HP*1F phenotype than for complexes of hemoglobin and dimeric
CC       haptoglobin of HP*1S phenotype. Induces a cascade of intracellular
CC       signals that involves tyrosine kinase-dependent calcium
CC       mobilization, inositol triphosphate production and secretion of
CC       IL6 and CSF1. Isoform 3 exhibits the higher capacity for ligand
CC       endocytosis and the more pronounced surface expression when
CC       expressed in cells.
CC   -!- FUNCTION: After shedding, the soluble form (sCD163) may play an
CC       anti-inflammatory role, and may be a valuable diagnostic parameter
CC       for monitoring macrophage activation in inflammatory conditions.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.0 nM for hemoglobin/haptoglobin of HP*1S phenotype
CC         {ECO:0000269|PubMed:11196644};
CC         KM=0.2 nM for hemoglobin/haptoglobin of HP*1F phenotype
CC         {ECO:0000269|PubMed:11196644};
CC   -!- SUBUNIT: Interacts with CSNK2B. {ECO:0000269|PubMed:11298324}.
CC   -!- SUBCELLULAR LOCATION: Soluble CD163: Secreted
CC       {ECO:0000269|PubMed:12296867}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10577520,
CC       ECO:0000269|PubMed:10648003}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:10577520, ECO:0000269|PubMed:10648003}.
CC       Note=Isoform 1 and isoform 2 show a lower surface expression when
CC       expressed in cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long tail variant 1;
CC         IsoId=Q86VB7-1; Sequence=Displayed;
CC       Name=2; Synonyms=Long tail variant 2;
CC         IsoId=Q86VB7-2; Sequence=VSP_019014;
CC       Name=3; Synonyms=Short tail variant;
CC         IsoId=Q86VB7-3; Sequence=VSP_019015;
CC       Name=4;
CC         IsoId=Q86VB7-4; Sequence=VSP_019013, VSP_019015;
CC   -!- TISSUE SPECIFICITY: Expressed in monocytes and mature macrophages
CC       such as Kupffer cells in the liver, red pulp macrophages in the
CC       spleen, cortical macrophages in the thymus, resident bone marrow
CC       macrophages and meningeal macrophages of the central nervous
CC       system. Expressed also in blood. Isoform 1 is the lowest abundant
CC       in the blood. Isoform 2 is the lowest abundant in the liver and
CC       the spleen. Isoform 3 is the predominant isoform detected in the
CC       blood. {ECO:0000269|PubMed:10577520, ECO:0000269|PubMed:11196644,
CC       ECO:0000269|PubMed:16434690}.
CC   -!- INDUCTION: Induced by anti-inflammatory mediators such as
CC       glucocorticoids, interleukin-6/IL6 and interleukin-10/IL10;
CC       suppressed by proinflammatory mediators like bacterial
CC       lipopolysaccharides (LPS), IFNG/IFN-gamma and TNF.
CC       {ECO:0000269|PubMed:10577520, ECO:0000269|PubMed:10648003}.
CC   -!- DOMAIN: The SRCR domain 3 mediates calcium-sensitive interaction
CC       with hemoglobin/haptoglobin complexes.
CC       {ECO:0000269|PubMed:15448162}.
CC   -!- PTM: A soluble form (sCD163) is produced by proteolytic shedding
CC       which can be induced by lipopolysaccharide, phorbol ester and Fc
CC       region of immunoglobulin gamma. This cleavage is dependent on
CC       protein kinase C and tyrosine kinases and can be blocked by
CC       protease inhibitors. The shedding is inhibited by the tissue
CC       inhibitor of metalloproteinase TIMP3, and thus probably induced by
CC       membrane-bound metalloproteinases ADAMs.
CC       {ECO:0000269|PubMed:10066432, ECO:0000269|PubMed:12296867,
CC       ECO:0000269|PubMed:15075364, ECO:0000269|PubMed:15448162}.
CC   -!- PTM: Phosphorylated. {ECO:0000305|PubMed:11298324}.
CC   -!- MISCELLANEOUS: Intravenous lipopolysaccharide (LPS) produces a
CC       rapid rise of sCD163 in plasma of patient as it induces
CC       metalloproteinase-mediated shedding from monocytes surface. Long-
CC       term LPS infusion finally increases expression of the membrane-
CC       bound form on circulating monocytes.
CC   -!- MISCELLANEOUS: The soluble form (sCD163) in plasma is a novel
CC       parameter in diseases affecting macrophage function and
CC       monocyte/macrophage load in the body. The concentration of sCD163
CC       is probably reflecting the number of macrophages of the
CC       'alternative macrophage activation' phenotype with a high CD163
CC       expression playing a major role in dampening the inflammatory
CC       response and scavenging components of damaged cells. This has
CC       initiated a number of clinical studies for evaluation of sCD163 as
CC       a disease marker in inflammatory conditions e.g. infection,
CC       autoimmune disease, transplantation, atherosclerosis and cancer.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-6 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA80541.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA80542.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA80543.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA80544.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB45233.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z22968; CAA80541.1; ALT_INIT; mRNA.
DR   EMBL; Z22969; CAA80542.1; ALT_INIT; mRNA.
DR   EMBL; Z22970; CAA80543.1; ALT_INIT; mRNA.
DR   EMBL; Z22971; CAA80544.1; ALT_INIT; mRNA.
DR   EMBL; Y18388; CAB45233.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Y18389; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18390; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18391; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18392; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18393; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18394; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18395; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18396; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18397; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18398; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18399; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18400; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18401; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18402; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; Y18403; CAB45233.1; JOINED; Genomic_DNA.
DR   EMBL; DQ058615; AAY99762.1; -; mRNA.
DR   EMBL; AC131206; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC051281; AAH51281.1; -; mRNA.
DR   CCDS; CCDS53742.1; -. [Q86VB7-3]
DR   CCDS; CCDS8578.1; -. [Q86VB7-1]
DR   PIR; I38004; I38004.
DR   PIR; I38005; I38005.
DR   PIR; I38006; I38006.
DR   RefSeq; NP_004235.4; NM_004244.5. [Q86VB7-1]
DR   RefSeq; NP_981961.2; NM_203416.3. [Q86VB7-3]
DR   RefSeq; XP_016875720.1; XM_017020231.1. [Q86VB7-2]
DR   UniGene; Hs.504641; -.
DR   ProteinModelPortal; Q86VB7; -.
DR   SMR; Q86VB7; -.
DR   BioGrid; 114741; 2.
DR   IntAct; Q86VB7; 1.
DR   STRING; 9606.ENSP00000352071; -.
DR   DrugBank; DB05389; WF10.
DR   iPTMnet; Q86VB7; -.
DR   PhosphoSitePlus; Q86VB7; -.
DR   BioMuta; CD163; -.
DR   DMDM; 313104083; -.
DR   PaxDb; Q86VB7; -.
DR   PeptideAtlas; Q86VB7; -.
DR   PRIDE; Q86VB7; -.
DR   Ensembl; ENST00000359156; ENSP00000352071; ENSG00000177575. [Q86VB7-1]
DR   Ensembl; ENST00000432237; ENSP00000403885; ENSG00000177575. [Q86VB7-3]
DR   GeneID; 9332; -.
DR   KEGG; hsa:9332; -.
DR   UCSC; uc001qsz.4; human. [Q86VB7-1]
DR   CTD; 9332; -.
DR   DisGeNET; 9332; -.
DR   GeneCards; CD163; -.
DR   HGNC; HGNC:1631; CD163.
DR   HPA; CAB002432; -.
DR   HPA; HPA046404; -.
DR   HPA; HPA051974; -.
DR   MIM; 605545; gene.
DR   neXtProt; NX_Q86VB7; -.
DR   OpenTargets; ENSG00000177575; -.
DR   PharmGKB; PA26190; -.
DR   eggNOG; ENOG410IHBC; Eukaryota.
DR   eggNOG; ENOG410XQVR; LUCA.
DR   GeneTree; ENSGT00870000136382; -.
DR   HOVERGEN; HBG080943; -.
DR   InParanoid; Q86VB7; -.
DR   KO; K06545; -.
DR   OMA; NWQWGGL; -.
DR   OrthoDB; EOG091G0DF7; -.
DR   PhylomeDB; Q86VB7; -.
DR   TreeFam; TF329295; -.
DR   Reactome; R-HSA-2168880; Scavenging of heme from plasma.
DR   SIGNOR; Q86VB7; -.
DR   ChiTaRS; CD163; human.
DR   GeneWiki; CD163; -.
DR   GenomeRNAi; 9332; -.
DR   PRO; PR:Q86VB7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000177575; -.
DR   CleanEx; HS_CD163; -.
DR   ExpressionAtlas; Q86VB7; baseline and differential.
DR   Genevisible; Q86VB7; HS.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:CAFA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005044; F:scavenger receptor activity; TAS:ProtInc.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   InterPro; IPR001190; SRCR.
DR   InterPro; IPR017448; SRCR-like_dom.
DR   Pfam; PF00530; SRCR; 9.
DR   PRINTS; PR00258; SPERACTRCPTR.
DR   SMART; SM00202; SR; 9.
DR   SUPFAM; SSF56487; SSF56487; 9.
DR   PROSITE; PS00420; SRCR_1; 4.
DR   PROSITE; PS50287; SRCR_2; 9.
PE   1: Evidence at protein level;
KW   Acute phase; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; Glycoprotein; Inflammatory response; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     41       {ECO:0000255}.
FT   CHAIN        42   1156       Scavenger receptor cysteine-rich type 1
FT                                protein M130.
FT                                /FTId=PRO_0000238938.
FT   CHAIN        42      ?       Soluble CD163.
FT                                /FTId=PRO_0000238939.
FT   TOPO_DOM     42   1050       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1051   1071       Helical. {ECO:0000255}.
FT   TOPO_DOM   1072   1156       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       51    152       SRCR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      159    259       SRCR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      266    366       SRCR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      373    473       SRCR 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      478    578       SRCR 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      583    683       SRCR 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      719    819       SRCR 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      824    926       SRCR 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   DOMAIN      929   1029       SRCR 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00196}.
FT   MOTIF      1096   1099       Internalization signal.
FT   SITE        269    270       Cleavage; in calcium-free condition.
FT   SITE        281    282       Cleavage; in calcium-free condition.
FT   SITE        333    334       Cleavage; in calcium-free condition.
FT   SITE        360    361       Cleavage; in calcium-free condition.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    140    140       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    767    767       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1027   1027       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID     76    141       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID     89    151       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    120    130       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    184    248       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    197    258       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    228    238       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    291    355       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    304    365       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    335    345       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    398    462       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    411    472       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    442    452       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    503    567       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    516    577       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    547    557       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    608    672       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    621    682       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    652    662       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    744    808       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    757    818       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    788    798       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    864    925       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    895    905       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    954   1018       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    967   1028       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   DISULFID    998   1008       {ECO:0000255|PROSITE-ProRule:PRU00196}.
FT   VAR_SEQ     579    579       R -> SKTQKTSLIGSYTVKGTGLGSHSCLFLKPCLLPG
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:8370408}.
FT                                /FTId=VSP_019013.
FT   VAR_SEQ    1115   1156       ENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGN
FT                                L -> GLWVLGGSIAQGFRSVAAVEAQTFYFDKQLKKSKNV
FT                                IGSLDAYNGQE (in isoform 2).
FT                                {ECO:0000303|PubMed:8370408}.
FT                                /FTId=VSP_019014.
FT   VAR_SEQ    1115   1156       ENSHESADFSAAELISVSKFLPISGMEKEAILSHTEKENGN
FT                                L -> GGHSEPH (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:8370408,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_019015.
FT   VARIANT     342    342       I -> V (in dbSNP:rs4883263).
FT                                {ECO:0000269|PubMed:10403791,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8370408,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_026574.
FT   MUTAGEN    1072   1072       T->A: Impaired phosphorylation by PRKCA.
FT                                {ECO:0000269|PubMed:11298324}.
FT   MUTAGEN    1084   1084       S->A: Impaired phosphorylation by PRKCA.
FT                                {ECO:0000269|PubMed:11298324}.
FT   MUTAGEN    1096   1096       Y->A: Massive decrease of endocytotic
FT                                activity. {ECO:0000269|PubMed:16434690}.
SQ   SEQUENCE   1156 AA;  125451 MW;  57B49F76DA6C96EB CRC64;
     MSKLRMVLLE DSGSADFRRH FVNLSPFTIT VVLLLSACFV TSSLGGTDKE LRLVDGENKC
     SGRVEVKVQE EWGTVCNNGW SMEAVSVICN QLGCPTAIKA PGWANSSAGS GRIWMDHVSC
     RGNESALWDC KHDGWGKHSN CTHQQDAGVT CSDGSNLEMR LTRGGNMCSG RIEIKFQGRW
     GTVCDDNFNI DHASVICRQL ECGSAVSFSG SSNFGEGSGP IWFDDLICNG NESALWNCKH
     QGWGKHNCDH AEDAGVICSK GADLSLRLVD GVTECSGRLE VRFQGEWGTI CDDGWDSYDA
     AVACKQLGCP TAVTAIGRVN ASKGFGHIWL DSVSCQGHEP AIWQCKHHEW GKHYCNHNED
     AGVTCSDGSD LELRLRGGGS RCAGTVEVEI QRLLGKVCDR GWGLKEADVV CRQLGCGSAL
     KTSYQVYSKI QATNTWLFLS SCNGNETSLW DCKNWQWGGL TCDHYEEAKI TCSAHREPRL
     VGGDIPCSGR VEVKHGDTWG SICDSDFSLE AASVLCRELQ CGTVVSILGG AHFGEGNGQI
     WAEEFQCEGH ESHLSLCPVA PRPEGTCSHS RDVGVVCSRY TEIRLVNGKT PCEGRVELKT
     LGAWGSLCNS HWDIEDAHVL CQQLKCGVAL STPGGARFGK GNGQIWRHMF HCTGTEQHMG
     DCPVTALGAS LCPSEQVASV ICSGNQSQTL SSCNSSSLGP TRPTIPEESA VACIESGQLR
     LVNGGGRCAG RVEIYHEGSW GTICDDSWDL SDAHVVCRQL GCGEAINATG SAHFGEGTGP
     IWLDEMKCNG KESRIWQCHS HGWGQQNCRH KEDAGVICSE FMSLRLTSEA SREACAGRLE
     VFYNGAWGTV GKSSMSETTV GVVCRQLGCA DKGKINPASL DKAMSIPMWV DNVQCPKGPD
     TLWQCPSSPW EKRLASPSEE TWITCDNKIR LQEGPTSCSG RVEIWHGGSW GTVCDDSWDL
     DDAQVVCQQL GCGPALKAFK EAEFGQGTGP IWLNEVKCKG NESSLWDCPA RRWGHSECGH
     KEDAAVNCTD ISVQKTPQKA TTGRSSRQSS FIAVGILGVV LLAIFVALFF LTKKRRQRQR
     LAVSSRGENL VHQIQYREMN SCLNADDLDL MNSSENSHES ADFSAAELIS VSKFLPISGM
     EKEAILSHTE KENGNL
//
ID   LRP6_HUMAN              Reviewed;        1613 AA.
AC   O75581; Q17RZ2;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   07-JUN-2017, entry version 155.
DE   RecName: Full=Low-density lipoprotein receptor-related protein 6;
DE            Short=LRP-6;
DE   Flags: Precursor;
GN   Name=LRP6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-1062.
RC   TISSUE=Kidney;
RX   PubMed=9704021; DOI=10.1006/bbrc.1998.9061;
RA   Brown S.D., Twells R.C., Hey P.J., Cox R.D., Levy E.R., Soderman A.R.,
RA   Metzker M.L., Caskey C.T., Todd J.A., Hess J.F.;
RT   "Isolation and characterization of LRP6, a novel member of the low
RT   density lipoprotein receptor gene family.";
RL   Biochem. Biophys. Res. Commun. 248:879-888(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH DKK1, AND FUNCTION.
RX   PubMed=11448771; DOI=10.1016/S0960-9822(01)00290-1;
RA   Semenov M.V., Tamai K., Brott B.K., Kuhl M., Sokol S., He X.;
RT   "Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.";
RL   Curr. Biol. 11:951-961(2001).
RN   [5]
RP   INTERACTION WITH WNT1, AND FUNCTION.
RX   PubMed=11357136; DOI=10.1038/35077108;
RA   Mao B., Wu W., Li Y., Hoppe D., Stannek P., Glinka A., Niehrs C.;
RT   "LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.";
RL   Nature 411:321-325(2001).
RN   [6]
RP   INTERACTION WITH FZD5; DKK1 AND DKK2.
RX   PubMed=12857724; DOI=10.1074/jbc.M300191200;
RA   Caricasole A., Ferraro T., Iacovelli L., Barletta E., Caruso A.,
RA   Melchiorri D., Terstappen G.C., Nicoletti F.;
RT   "Functional characterization of WNT7A signaling in PC12 cells:
RT   interaction with A FZD5 x LRP6 receptor complex and modulation by
RT   Dickkopf proteins.";
RL   J. Biol. Chem. 278:37024-37031(2003).
RN   [7]
RP   INTERACTION WITH SOST, AND FUNCTION.
RX   PubMed=15778503; DOI=10.1074/jbc.M413274200;
RA   Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., Harris S.E.,
RA   Wu D.;
RT   "Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.";
RL   J. Biol. Chem. 280:19883-19887(2005).
RN   [8]
RP   INTERACTION WITH WNT1 IN THE WNT-FZD-LRP5-LRP6 COMPLEX, AND
RP   INTERACTION WITH SOST.
RX   PubMed=15908424; DOI=10.1074/jbc.M504308200;
RA   Semenov M., Tamai K., He X.;
RT   "SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.";
RL   J. Biol. Chem. 280:26770-26775(2005).
RN   [9]
RP   PHOSPHORYLATION OF PPPSP MOTIFS, PHOSPHORYLATION AT SER-1490 AND
RP   THR-1493, AND FUNCTION.
RX   PubMed=16341017; DOI=10.1038/nature04185;
RA   Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., Okamura H.,
RA   Woodgett J., He X.;
RT   "A dual-kinase mechanism for Wnt co-receptor phosphorylation and
RT   activation.";
RL   Nature 438:873-877(2005).
RN   [10]
RP   INTERACTION WITH MACF1.
RX   PubMed=16815997; DOI=10.1101/gad.1411206;
RA   Chen H.J., Lin C.M., Lin C.S., Perez-Olle R., Leung C.L., Liem R.K.;
RT   "The role of microtubule actin cross-linking factor 1 (MACF1) in the
RT   Wnt signaling pathway.";
RL   Genes Dev. 20:1933-1945(2006).
RN   [11]
RP   PHOSPHORYLATION AT SER-1420 AND SER-1430, FUNCTION, INTERACTION WITH
RP   CSNKIE AND AXIN1, IDENTIFICATION BY MASS SPECTROMETRY, AND MUTAGENESIS
RP   OF SER-1420 AND SER-1430.
RX   PubMed=16513652; DOI=10.1074/jbc.M510580200;
RA   Swiatek W., Kang H., Garcia B.A., Shabanowitz J., Coombs G.S.,
RA   Hunt D.F., Virshup D.M.;
RT   "Negative regulation of LRP6 function by casein kinase I epsilon
RT   phosphorylation.";
RL   J. Biol. Chem. 281:12233-12241(2006).
RN   [12]
RP   INTERACTION WITH RSPO1, FUNCTION, AND PHOSPHORYLATION.
RX   PubMed=17400545; DOI=10.1074/jbc.M701927200;
RA   Wei Q., Yokota C., Semenov M.V., Doble B., Woodgett J., He X.;
RT   "R-spondin1 is a high affinity ligand for LRP6 and induces LRP6
RT   phosphorylation and beta-catenin signaling.";
RL   J. Biol. Chem. 282:15903-15911(2007).
RN   [13]
RP   PROTEOLYTIC PROCESSING, AND FUNCTION.
RX   PubMed=17326769; DOI=10.1111/j.1471-4159.2007.04447.x;
RA   Mi K., Johnson G.V.;
RT   "Regulated proteolytic processing of LRP6 results in release of its
RT   intracellular domain.";
RL   J. Neurochem. 101:517-529(2007).
RN   [14]
RP   GLYCOSYLATION, PHOSPHORYLATION AT SER-1490, INTERACTION WITH AXIN1,
RP   HOMODIMERIZATION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17698587; DOI=10.1128/MCB.00773-07;
RA   Khan Z., Vijayakumar S., de la Torre T.V., Rotolo S., Bafico A.;
RT   "Analysis of endogenous LRP6 function reveals a novel feedback
RT   mechanism by which Wnt negatively regulates its receptor.";
RL   Mol. Cell. Biol. 27:7291-7301(2007).
RN   [15]
RP   INTERACTION WITH KREM1 AND DKK1.
RX   PubMed=17804805; DOI=10.1073/pnas.0702305104;
RA   Binnerts M.E., Kim K.A., Bright J.M., Patel S.M., Tran K., Zhou M.,
RA   Leung J.M., Liu Y., Lomas W.E. III, Dixon M., Hazell S.A., Wagle M.,
RA   Nie W.S., Tomasevic N., Williams J., Zhan X., Levy M.D., Funk W.D.,
RA   Abo A.;
RT   "R-Spondin1 regulates Wnt signaling by inhibiting internalization of
RT   LRP6.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14700-14705(2007).
RN   [16]
RP   PHOSPHORYLATION AT THR-1479, INTERACTION WITH AXIN1, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17569865; DOI=10.1126/science.1137065;
RA   Bilic J., Huang Y.L., Davidson G., Zimmermann T., Cruciat C.M.,
RA   Bienz M., Niehrs C.;
RT   "Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6
RT   phosphorylation.";
RL   Science 316:1619-1622(2007).
RN   [17]
RP   INTERACTION WITH AXIN1, PHOSPHORYLATION, AND MUTAGENESIS OF LEU-1485;
RP   ASN-1486; PRO-1487; PRO-1488; PRO-1489; SER-1490; PRO-1491; ALA-1492;
RP   THR-1493; GLU-1494; ARG-1495; THR-1529; THR-1530; PRO-1531; THR-1572;
RP   SER-1590 AND SER-1607.
RX   PubMed=18362152; DOI=10.1074/jbc.M800327200;
RA   MacDonald B.T., Yokota C., Tamai K., Zeng X., He X.;
RT   "Wnt signal amplification via activity, cooperativity, and regulation
RT   of multiple intracellular PPPSP motifs in the Wnt co-receptor LRP6.";
RL   J. Biol. Chem. 283:16115-16123(2008).
RN   [18]
RP   INTERACTION WITH CAPRIN2, AND PHOSPHORYLATION AT SER-1490.
RX   PubMed=18762581; DOI=10.1083/jcb.200803147;
RA   Ding Y., Xi Y., Chen T., Wang J.Y., Tao D.L., Wu Z.L., Li Y.P., Li C.,
RA   Zeng R., Li L.;
RT   "Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6
RT   phosphorylation.";
RL   J. Cell Biol. 182:865-872(2008).
RN   [19]
RP   PHOSPHORYLATION ON PPPSP MOTIFS, AND FUNCTION.
RX   PubMed=19107203; DOI=10.1371/journal.pone.0004046;
RA   Piao S., Lee S.H., Kim H., Yum S., Stamos J.L., Xu Y., Lee S.J.,
RA   Lee J., Oh S., Han J.K., Park B.J., Weis W.I., Ha N.C.;
RT   "Direct inhibition of GSK3beta by the phosphorylated cytoplasmic
RT   domain of LRP6 in Wnt/beta-catenin signaling.";
RL   PLoS ONE 3:E4046-E4046(2008).
RN   [20]
RP   PALMITOYLATION AT CYS-1394 AND CYS-1399, UBIQUITINATION AT LYS-1403,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-1394 AND CYS-1399.
RX   PubMed=18378904; DOI=10.1073/pnas.0710389105;
RA   Abrami L., Kunz B., Iacovache I., van der Goot F.G.;
RT   "Palmitoylation and ubiquitination regulate exit of the Wnt signaling
RT   protein LRP6 from the endoplasmic reticulum.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5384-5389(2008).
RN   [21]
RP   DOMAIN PPPSP MOTIF, AND PHOSPHORYLATION AT SER-1490.
RX   PubMed=20059949; DOI=10.1016/j.devcel.2009.11.006;
RA   Davidson G., Shen J., Huang Y.L., Su Y., Karaulanov E.,
RA   Bartscherer K., Hassler C., Stannek P., Boutros M., Niehrs C.;
RT   "Cell cycle control of wnt receptor activation.";
RL   Dev. Cell 17:788-799(2009).
RN   [22]
RP   PHOSPHORYLATION OF PPPSP MOTIFS, PHOSPHORYLATION AT SER-1490, AND
RP   FUNCTION.
RX   PubMed=19801552; DOI=10.1074/jbc.M109.047456;
RA   Chen M., Philipp M., Wang J., Premont R.T., Garrison T.R., Caron M.G.,
RA   Lefkowitz R.J., Chen W.;
RT   "G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt
RT   pathway.";
RL   J. Biol. Chem. 284:35040-35048(2009).
RN   [23]
RP   PHOSPHORYLATION OF PPPSP MOTIFS, AND FUNCTION.
RX   PubMed=19293931; DOI=10.1371/journal.pone.0004926;
RA   Wu G., Huang H., Garcia Abreu J., He X.;
RT   "Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated
RT   PPPSPXS motifs of Wnt coreceptor LRP6.";
RL   PLoS ONE 4:E4926-E4926(2009).
RN   [24]
RP   INTERACTION WITH WNT3A; WNT9B AND FZD8 IN THE WNT/FZD/LRP6 COMPLEX,
RP   AND INTERACTION WITH DKK1.
RX   PubMed=20093360; DOI=10.1074/jbc.M109.092130;
RA   Bourhis E., Tam C., Franke Y., Bazan J.F., Ernst J., Hwang J.,
RA   Costa M., Cochran A.G., Hannoush R.N.;
RT   "Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals
RT   multiple Wnt and Dkk1 binding sites on LRP6.";
RL   J. Biol. Chem. 285:9172-9179(2010).
RN   [25]
RP   INTERACTION WITH TMEM198.
RX   PubMed=21536646; DOI=10.1128/MCB.05103-11;
RA   Liang J., Fu Y., Cruciat C.M., Jia S., Wang Y., Tong Z., Tao Q.,
RA   Ingelfinger D., Boutros M., Meng A., Niehrs C., Wu W.;
RT   "Transmembrane protein 198 promotes LRP6 phosphorylation and Wnt
RT   signaling activation.";
RL   Mol. Cell. Biol. 31:2577-2590(2011).
RN   [26]
RP   INTERACTION WITH DAB2.
RX   PubMed=22491013; DOI=10.1038/emboj.2012.83;
RA   Jiang Y., He X., Howe P.H.;
RT   "Disabled-2 (Dab2) inhibits Wnt/beta-catenin signalling by binding
RT   LRP6 and promoting its internalization through clathrin.";
RL   EMBO J. 31:2336-2349(2012).
RN   [27]
RP   UBIQUITINATION BY ZNRF3.
RX   PubMed=22575959; DOI=10.1038/nature11019;
RA   Hao H.X., Xie Y., Zhang Y., Charlat O., Oster E., Avello M., Lei H.,
RA   Mickanin C., Liu D., Ruffner H., Mao X., Ma Q., Zamponi R.,
RA   Bouwmeester T., Finan P.M., Kirschner M.W., Porter J.A., Serluca F.C.,
RA   Cong F.;
RT   "ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive
RT   manner.";
RL   Nature 485:195-200(2012).
RN   [28]
RP   INTERACTION WITH LYPD6, AND SUBCELLULAR LOCATION.
RX   PubMed=23987510; DOI=10.1016/j.devcel.2013.07.020;
RA   Oezhan G., Sezgin E., Wehner D., Pfister A.S., Kuehl S.J.,
RA   Kagermeier-Schenk B., Kuehl M., Schwille P., Weidinger G.;
RT   "Lypd6 enhances Wnt/beta-catenin signaling by promoting Lrp6
RT   phosphorylation in raft plasma membrane domains.";
RL   Dev. Cell 26:331-345(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1490, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   INTERACTION WITH CAPRIN2, AND PHOSPHORYLATION AT SER-1490.
RX   PubMed=25331957; DOI=10.1074/jbc.M114.591636;
RA   Miao H., Jia Y., Xie S., Wang X., Zhao J., Chu Y., Zhou Z., Shi Z.,
RA   Song X., Li L.;
RT   "Structural insights into the C1q domain of Caprin-2 in canonical Wnt
RT   signaling.";
RL   J. Biol. Chem. 289:34104-34113(2014).
RN   [31]
RP   IDENTIFICATION IN A COMPLEX WITH CAPRIN2; CCNY AND CDK14, AND
RP   PHOSPHORYLATION AT SER-1490.
RX   PubMed=27821587; DOI=10.1074/jbc.M116.744607;
RA   Wang X., Jia Y., Fei C., Song X., Li L.;
RT   "Caprin-2 positively regulates CDK14/Cyclin Y-mediated LRP5/6
RT   constitutive phosphorylation.";
RL   J. Biol. Chem. 291:26427-26434(2016).
RN   [32]
RP   IDENTIFICATION IN A TERNARY COMPLEX WITH KREM1 AND LRP6.
RX   PubMed=27524201; DOI=10.1016/j.str.2016.06.020;
RA   Zebisch M., Jackson V.A., Zhao Y., Jones E.Y.;
RT   "Structure of the dual-mode wnt regulator Kremen1 and insight into
RT   ternary complex formation with LRP6 and Dickkopf.";
RL   Structure 24:1599-1605(2016).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 630-1246 IN COMPLEX WITH
RP   DKK1, SUBUNIT, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-692; ASN-859;
RP   ASN-865; ASN-926 AND ASN-1039.
RX   PubMed=22000856; DOI=10.1016/j.devcel.2011.09.003;
RA   Ahn V.E., Chu M.L., Choi H.J., Tran D., Abo A., Weis W.I.;
RT   "Structural basis of Wnt signaling inhibition by Dickkopf binding to
RT   LRP5/6.";
RL   Dev. Cell 21:862-873(2011).
RN   [34]
RP   VARIANT ADCAD2 CYS-611, AND CHARACTERIZATION OF VARIANT ADCAD2
RP   CYS-611.
RX   PubMed=17332414; DOI=10.1126/science.1136370;
RA   Mani A., Radhakrishnan J., Wang H., Mani A., Mani M.-A.,
RA   Nelson-Williams C., Carew K.S., Mane S., Najmabadi H., Wu D.,
RA   Lifton R.P.;
RT   "LRP6 mutation in a family with early coronary disease and metabolic
RT   risk factors.";
RL   Science 315:1278-1282(2007).
RN   [35]
RP   VARIANTS ADCAD2 HIS-360; SER-433 AND GLN-473, AND CHARACTERIZATION OF
RP   VARIANT ADCAD2 GLN-473.
RX   PubMed=23703864; DOI=10.1002/humu.22360;
RA   Singh R., Smith E., Fathzadeh M., Liu W., Go G.W., Subrahmanyan L.,
RA   Faramarzi S., McKenna W., Mani A.;
RT   "Rare nonconservative LRP6 mutations are associated with metabolic
RT   syndrome.";
RL   Hum. Mutat. 34:1221-1225(2013).
RN   [36]
RP   INVOLVEMENT IN STHAG7, VARIANT STHAG7 VAL-19, CHARACTERIZATION OF
RP   VARIANT STHAG7 VAL-19, AND SUBCELLULAR LOCATION.
RX   PubMed=26387593; DOI=10.1016/j.ajhg.2015.08.014;
RA   Massink M.P., Creton M.A., Spanevello F., Fennis W.M., Cune M.S.,
RA   Savelberg S.M., Nijman I.J., Maurice M.M., van den Boogaard M.J.,
RA   van Haaften G.;
RT   "Loss-of-Function Mutations in the WNT Co-receptor LRP6 Cause
RT   Autosomal-Dominant Oligodontia.";
RL   Am. J. Hum. Genet. 97:621-626(2015).
CC   -!- FUNCTION: Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers
CC       beta-catenin signaling through inducing aggregation of receptor-
CC       ligand complexes into ribosome-sized signalsomes. Cell-surface
CC       coreceptor of Wnt/beta-catenin signaling, which plays a pivotal
CC       role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor
CC       complex recruits DVL1 polymers to the plasma membrane which, in
CC       turn, recruits the AXIN1/GSK3B-complex to the cell surface
CC       promoting the formation of signalsomes and inhibiting AXIN1/GSK3-
CC       mediated phosphorylation and destruction of beta-catenin. Required
CC       for posterior patterning of the epiblast during gastrulation (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:11357136,
CC       ECO:0000269|PubMed:11448771, ECO:0000269|PubMed:15778503,
CC       ECO:0000269|PubMed:16341017, ECO:0000269|PubMed:16513652,
CC       ECO:0000269|PubMed:17326769, ECO:0000269|PubMed:17400545,
CC       ECO:0000269|PubMed:19107203, ECO:0000269|PubMed:19293931,
CC       ECO:0000269|PubMed:19801552}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Forms phosphorylated
CC       oligomer aggregates on Wnt-signaling. Forms a WNT-signaling
CC       complex formed of a WNT protein, a FZD protein and LRP5 or LRP6.
CC       Interacts (via the extracellular domain) with WNT1; the
CC       interaction is enhanced by prior formation of the Wnt/Fzd complex.
CC       Interacts (via the beta-propeller regions 3 and 4) with WNT3A.
CC       Interacts (via the beta-propeller regions 1 and 2) with WNT9B.
CC       Interacts with FZD5; the interaction forms a coreceptor complex
CC       for Wnt signaling and is inhibited by DKK1 and DRAXIN. Interacts
CC       (via beta propeller region) with DKK1; the interaction inhibits
CC       FZD5/LRP6 complex formation. Interacts with DKK2. Interacts with
CC       C1orf187/DRAXIN; the interaction inhibits Wnt signaling (By
CC       similarity). Interacts (via the phosphorylated PPPSP motifs) with
CC       AXIN1; the interaction recruits the AXIN1/GSK3B complex to cell
CC       surface LRP6 signalsomes. Interacts with GRB10; the interaction
CC       prevents AXIN1 binding, thus negatively regulating the Wnt
CC       signaling pathway (By similarity). Interacts (via the
CC       extracellular domain) with RSPO1; the interaction activates
CC       Wnt/beta-catenin signaling. Interacts (via the extracellular
CC       domain) with RSPO3 (via the cysteine rich domain); the interaction
CC       activates Wnt/beta-catenin signaling. Interacts (via the beta-
CC       propeller regions 1 and 2) with SOST; the interaction competes
CC       with DKK1 for binding for inhibiting beta-catenin signaling.
CC       Interacts with MESD; the interaction prevents the formation of
CC       LRP6 aggregates and targets LRP6 to the plasma membrane (By
CC       similarity). Interacts (via the cytoplasmic domain) with CSNKIE;
CC       the interaction phosphorylates LRP6, binds AXIN1 and inhibits
CC       AXIN1/GSK3B-mediated phosphorylation of beta-catenin. Interacts
CC       with MACF1. Interacts with DAB2; the interaction involves LRP6
CC       phosphorylation by CK2 and sequesters LRP6 towards clathrin-
CC       mediated endocytosis. Interacts with TMEM198. Interacts with
CC       CAPRIN2; the interaction promotes LRP6 phosphorylation at Ser-1490
CC       (PubMed:18762581, PubMed:25331957). Found in a complex with
CC       CAPRIN2, CCNY and CDK14 during G2/M stage; CAPRIN2 functions as a
CC       scaffold for the complex by binding to CCNY via its N terminus and
CC       to CDK14 via its C terminus (PubMed:27821587). Interacts with
CC       LYPD6 (PubMed:23987510). Forms a ternary complex with DKK1 and
CC       KREM1 (PubMed:27524201). Interacts with KREM1 in a DKK1-dependent
CC       manner (PubMed:17804805). {ECO:0000250|UniProtKB:O88572,
CC       ECO:0000269|PubMed:11357136, ECO:0000269|PubMed:11448771,
CC       ECO:0000269|PubMed:12857724, ECO:0000269|PubMed:15778503,
CC       ECO:0000269|PubMed:15908424, ECO:0000269|PubMed:16513652,
CC       ECO:0000269|PubMed:16815997, ECO:0000269|PubMed:17400545,
CC       ECO:0000269|PubMed:17569865, ECO:0000269|PubMed:17698587,
CC       ECO:0000269|PubMed:17804805, ECO:0000269|PubMed:18362152,
CC       ECO:0000269|PubMed:18762581, ECO:0000269|PubMed:20093360,
CC       ECO:0000269|PubMed:21536646, ECO:0000269|PubMed:22000856,
CC       ECO:0000269|PubMed:22491013, ECO:0000269|PubMed:23987510,
CC       ECO:0000269|PubMed:25331957, ECO:0000269|PubMed:27524201,
CC       ECO:0000269|PubMed:27821587}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-910915, EBI-910915;
CC       Q9Y4X0:AMMECR1; NbExp=5; IntAct=EBI-910915, EBI-8583355;
CC       Q9H6X2:ANTXR1; NbExp=3; IntAct=EBI-910915, EBI-905643;
CC       O35625:Axin1 (xeno); NbExp=2; IntAct=EBI-910915, EBI-2365912;
CC       O70239:Axin1 (xeno); NbExp=12; IntAct=EBI-910915, EBI-6857773;
CC       Q03135:CAV1; NbExp=3; IntAct=EBI-910915, EBI-603614;
CC       P98082:DAB2; NbExp=20; IntAct=EBI-910915, EBI-1171238;
CC       O94907:DKK1; NbExp=3; IntAct=EBI-910915, EBI-742864;
CC       Q61091:Fzd8 (xeno); NbExp=4; IntAct=EBI-910915, EBI-6171689;
CC       P49840:GSK3A; NbExp=2; IntAct=EBI-910915, EBI-1044067;
CC       P49841:GSK3B; NbExp=4; IntAct=EBI-910915, EBI-373586;
CC       Q5S007:LRRK2; NbExp=4; IntAct=EBI-910915, EBI-5323863;
CC       Q9ERE7:Mesdc2 (xeno); NbExp=2; IntAct=EBI-910915, EBI-6662606;
CC       Q9BQB4:SOST; NbExp=2; IntAct=EBI-910915, EBI-5746563;
CC       P04426:Wnt1 (xeno); NbExp=2; IntAct=EBI-910915, EBI-1570911;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26387593};
CC       Single-pass type I membrane protein. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:26387593}. Membrane raft
CC       {ECO:0000269|PubMed:23987510}. Note=On Wnt signaling, undergoes a
CC       cycle of caveolin- or clathrin-mediated endocytosis and plasma
CC       membrane location. Released from the endoplasmic reticulum on
CC       palmitoylation. Mono-ubiquitination retains it in the endoplasmic
CC       reticulum in the absence of palmitoylation. On Wnt signaling,
CC       phosphorylated, aggregates and colocalizes with AXIN1 and GSK3B at
CC       the plasma membrane in LRP6-signalsomes. Chaperoned to the plasma
CC       membrane by MESD (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely coexpressed with LRP5 during
CC       embryogenesis and in adult tissues.
CC   -!- INDUCTION: Decreased levels on WNT3A stimulation.
CC       {ECO:0000269|PubMed:17698587}.
CC   -!- DOMAIN: The YWTD-EGF-like domains 1 and 2 are required for the
CC       interaction with Wnt-frizzled complex. The YWTD-EGF-like domains 3
CC       and 4 are required for the interaction with DKK1.
CC       {ECO:0000269|PubMed:20059949}.
CC   -!- DOMAIN: The PPPSP motifs play a central role in signal
CC       transduction by being phosphorylated, leading to activate the Wnt
CC       signaling pathway. {ECO:0000269|PubMed:20059949}.
CC   -!- PTM: Dual phosphorylation of cytoplasmic PPPSP motifs sequentially
CC       by GSK3 and CK1 is required for AXIN1-binding, and subsequent
CC       stabilization and activation of beta-catenin via preventing GSK3-
CC       mediated phosphorylation of beta-catenin. Phosphorylated, in
CC       vitro, by GRK5/6 within and outside the PPPSP motifs.
CC       Phosphorylation at Ser-1490 by CDK14 during G2/M phase leads to
CC       regulation of the Wnt signaling pathway during the cell cycle.
CC       Phosphorylation by GSK3B is induced by RPSO1 binding and inhibited
CC       by DKK1. Phosphorylated, in vitro, by casein kinase I on Thr-1479.
CC       {ECO:0000269|PubMed:16341017, ECO:0000269|PubMed:16513652,
CC       ECO:0000269|PubMed:17400545, ECO:0000269|PubMed:17569865,
CC       ECO:0000269|PubMed:17698587, ECO:0000269|PubMed:18362152,
CC       ECO:0000269|PubMed:19107203, ECO:0000269|PubMed:19293931,
CC       ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20059949}.
CC   -!- PTM: Undergoes gamma-secretase-dependent regulated intramembrane
CC       proteolysis (RIP). The extracellular domain is first released by
CC       shedding, and then, through the action of gamma-secretase, the
CC       intracellular domain (ICD) is released into the cytoplasm where it
CC       is free to bind to GSK3B and to activate canonical Wnt signaling.
CC   -!- PTM: Palmitoylation on the two sites near the transmembrane domain
CC       leads to release of LRP6 from the endoplasmic reticulum.
CC       {ECO:0000269|PubMed:18378904}.
CC   -!- PTM: Mono-ubiquitinated which retains LRP6 in the endoplasmic
CC       reticulum. Ubiquitinated by ZNRF3, leading to its degradation by
CC       the proteasome. {ECO:0000269|PubMed:18378904,
CC       ECO:0000269|PubMed:22575959}.
CC   -!- PTM: N-glycosylation is required for cell surface location.
CC       {ECO:0000269|PubMed:17698587, ECO:0000269|PubMed:22000856}.
CC   -!- DISEASE: Coronary artery disease, autosomal dominant, 2 (ADCAD2)
CC       [MIM:610947]: A common heart disease characterized by reduced or
CC       absent blood flow in one or more of the arteries that encircle and
CC       supply the heart. Its most important complication is acute
CC       myocardial infarction. {ECO:0000269|PubMed:17332414,
CC       ECO:0000269|PubMed:23703864}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Tooth agenesis, selective, 7 (STHAG7) [MIM:616724]: An
CC       autosomal dominant form of selective tooth agenesis, a common
CC       anomaly characterized by the congenital absence of one or more
CC       teeth. Selective tooth agenesis without associated systemic
CC       disorders has sometimes been divided into 2 types: oligodontia,
CC       defined as agenesis of 6 or more permanent teeth, and hypodontia,
CC       defined as agenesis of less than 6 teeth. The number in both cases
CC       does not include absence of third molars (wisdom teeth).
CC       {ECO:0000269|PubMed:26387593}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the LDLR family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF074264; AAC33006.1; -; mRNA.
DR   EMBL; AC007537; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC117136; AAI17137.1; -; mRNA.
DR   EMBL; BC126405; AAI26406.1; -; mRNA.
DR   CCDS; CCDS8647.1; -.
DR   PIR; JE0272; JE0272.
DR   RefSeq; NP_002327.2; NM_002336.2.
DR   RefSeq; XP_006719141.1; XM_006719078.3.
DR   UniGene; Hs.584775; -.
DR   UniGene; Hs.658913; -.
DR   PDB; 3S2K; X-ray; 2.80 A; A/B=630-1246.
DR   PDB; 3S8V; X-ray; 3.10 A; A/B=629-1243.
DR   PDB; 3S8Z; X-ray; 2.80 A; A=629-1243.
DR   PDB; 3S94; X-ray; 2.80 A; A/B=20-630.
DR   PDB; 3SOB; X-ray; 1.90 A; B=20-335.
DR   PDB; 3SOQ; X-ray; 1.90 A; A=20-326.
DR   PDB; 3SOV; X-ray; 1.27 A; A=20-326.
DR   PDB; 4A0P; X-ray; 1.90 A; A=629-1244.
DR   PDB; 4DG6; X-ray; 2.90 A; A=20-635.
DR   PDB; 4NM5; X-ray; 2.30 A; C=1568-1575.
DR   PDB; 4NM7; X-ray; 2.30 A; C=1603-1610.
DR   PDB; 5AIR; X-ray; 2.53 A; A/B=1565-1575.
DR   PDB; 5FWW; X-ray; 3.50 A; A=630-1246.
DR   PDB; 5GJE; EM; 21.00 A; A=20-630, B=631-1246.
DR   PDBsum; 3S2K; -.
DR   PDBsum; 3S8V; -.
DR   PDBsum; 3S8Z; -.
DR   PDBsum; 3S94; -.
DR   PDBsum; 3SOB; -.
DR   PDBsum; 3SOQ; -.
DR   PDBsum; 3SOV; -.
DR   PDBsum; 4A0P; -.
DR   PDBsum; 4DG6; -.
DR   PDBsum; 4NM5; -.
DR   PDBsum; 4NM7; -.
DR   PDBsum; 5AIR; -.
DR   PDBsum; 5FWW; -.
DR   PDBsum; 5GJE; -.
DR   ProteinModelPortal; O75581; -.
DR   SMR; O75581; -.
DR   BioGrid; 110219; 42.
DR   DIP; DIP-29884N; -.
DR   IntAct; O75581; 27.
DR   MINT; MINT-3369849; -.
DR   STRING; 9606.ENSP00000261349; -.
DR   iPTMnet; O75581; -.
DR   PhosphoSitePlus; O75581; -.
DR   SwissPalm; O75581; -.
DR   BioMuta; LRP6; -.
DR   EPD; O75581; -.
DR   MaxQB; O75581; -.
DR   PaxDb; O75581; -.
DR   PeptideAtlas; O75581; -.
DR   PRIDE; O75581; -.
DR   Ensembl; ENST00000261349; ENSP00000261349; ENSG00000070018.
DR   Ensembl; ENST00000628182; ENSP00000486315; ENSG00000281324.
DR   GeneID; 4040; -.
DR   KEGG; hsa:4040; -.
DR   UCSC; uc001rah.6; human.
DR   CTD; 4040; -.
DR   DisGeNET; 4040; -.
DR   GeneCards; LRP6; -.
DR   H-InvDB; HIX0036693; -.
DR   HGNC; HGNC:6698; LRP6.
DR   HPA; CAB004490; -.
DR   HPA; HPA029925; -.
DR   MalaCards; LRP6; -.
DR   MIM; 603507; gene.
DR   MIM; 610947; phenotype.
DR   MIM; 616724; phenotype.
DR   neXtProt; NX_O75581; -.
DR   OpenTargets; ENSG00000070018; -.
DR   Orphanet; 94062; Coronary artery disease - hyperlipidemia - hypertension - diabetes - osteoporosis.
DR   PharmGKB; PA30456; -.
DR   eggNOG; ENOG410IPT4; Eukaryota.
DR   eggNOG; ENOG410XSY5; LUCA.
DR   GeneTree; ENSGT00760000118968; -.
DR   HOGENOM; HOG000230697; -.
DR   HOVERGEN; HBG049167; -.
DR   InParanoid; O75581; -.
DR   KO; K03068; -.
DR   OMA; WQELDQP; -.
DR   OrthoDB; EOG091G0178; -.
DR   PhylomeDB; O75581; -.
DR   TreeFam; TF315253; -.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-3772470; Negative regulation of TCF-dependent signaling by WNT ligand antagonists.
DR   Reactome; R-HSA-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5340588; RNF mutants show enhanced WNT signaling and proliferation.
DR   SignaLink; O75581; -.
DR   SIGNOR; O75581; -.
DR   ChiTaRS; LRP6; human.
DR   EvolutionaryTrace; O75581; -.
DR   GeneWiki; LRP6; -.
DR   GenomeRNAi; 4040; -.
DR   PRO; PR:O75581; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000070018; -.
DR   CleanEx; HS_LRP6; -.
DR   ExpressionAtlas; O75581; baseline and differential.
DR   Genevisible; O75581; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1990909; C:Wnt signalosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990851; C:Wnt-Frizzled-LRP5/6 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034185; F:apolipoprotein binding; IBA:GO_Central.
DR   GO; GO:1904928; F:coreceptor activity involved in canonical Wnt signaling pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0071936; F:coreceptor activity involved in Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0005109; F:frizzled binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019210; F:kinase inhibitor activity; IMP:BHF-UCL.
DR   GO; GO:0005041; F:low-density lipoprotein receptor activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0019534; F:toxin transporter activity; IMP:BHF-UCL.
DR   GO; GO:0042813; F:Wnt-activated receptor activity; IBA:GO_Central.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:BHF-UCL.
DR   GO; GO:0090245; P:axis elongation involved in somitogenesis; IBA:GO_Central.
DR   GO; GO:1904886; P:beta-catenin destruction complex disassembly; TAS:Reactome.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0044335; P:canonical Wnt signaling pathway involved in neural crest cell differentiation; IC:BHF-UCL.
DR   GO; GO:0044340; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; IC:BHF-UCL.
DR   GO; GO:0071397; P:cellular response to cholesterol; IMP:BHF-UCL.
DR   GO; GO:0021587; P:cerebellum morphogenesis; IBA:GO_Central.
DR   GO; GO:0021987; P:cerebral cortex development; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0060026; P:convergent extension; IBA:GO_Central.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0009880; P:embryonic pattern specification; IBA:GO_Central.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IBA:GO_Central.
DR   GO; GO:0035261; P:external genitalia morphogenesis; IBA:GO_Central.
DR   GO; GO:0060325; P:face morphogenesis; IBA:GO_Central.
DR   GO; GO:1904948; P:midbrain dopaminergic neuron differentiation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0030917; P:midbrain-hindbrain boundary development; IBA:GO_Central.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IMP:BHF-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:BHF-UCL.
DR   GO; GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0014033; P:neural crest cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0014029; P:neural crest formation; IDA:BHF-UCL.
DR   GO; GO:0001843; P:neural tube closure; IBA:GO_Central.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IBA:GO_Central.
DR   GO; GO:0060021; P:palate development; IBA:GO_Central.
DR   GO; GO:0003344; P:pericardium morphogenesis; IBA:GO_Central.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0045787; P:positive regulation of cell cycle; IMP:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:BHF-UCL.
DR   GO; GO:2000055; P:positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL.
DR   GO; GO:0090009; P:primitive streak formation; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0090118; P:receptor-mediated endocytosis involved in cholesterol transport; IBA:GO_Central.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IBA:GO_Central.
DR   GO; GO:0060535; P:trachea cartilage morphogenesis; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0044332; P:Wnt signaling pathway involved in dorsal/ventral axis specification; IDA:BHF-UCL.
DR   GO; GO:1904953; P:Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0090244; P:Wnt signaling pathway involved in somitogenesis; IBA:GO_Central.
DR   Gene3D; 2.120.10.30; -; 4.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR000033; LDLR_classB_rpt.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR017049; LRP5/6.
DR   Pfam; PF00057; Ldl_recept_a; 3.
DR   Pfam; PF00058; Ldl_recept_b; 11.
DR   PIRSF; PIRSF036314; LDL_recpt-rel_p5/6; 1.
DR   PRINTS; PR00261; LDLRECEPTOR.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00192; LDLa; 3.
DR   SMART; SM00135; LY; 20.
DR   SUPFAM; SSF57424; SSF57424; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS01209; LDLRA_1; 3.
DR   PROSITE; PS50068; LDLRA_2; 3.
DR   PROSITE; PS51120; LDLRB; 19.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Developmental protein;
KW   Disease mutation; Disulfide bond; EGF-like domain; Endocytosis;
KW   Endoplasmic reticulum; Glycoprotein; Isopeptide bond; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation; Wnt signaling pathway.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   1613       Low-density lipoprotein receptor-related
FT                                protein 6.
FT                                /FTId=PRO_0000017330.
FT   TOPO_DOM     20   1370       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1371   1393       Helical. {ECO:0000255}.
FT   TOPO_DOM   1394   1613       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       63    106       LDL-receptor class B 1.
FT   REPEAT      107    149       LDL-receptor class B 2.
FT   REPEAT      150    193       LDL-receptor class B 3.
FT   REPEAT      194    236       LDL-receptor class B 4.
FT   REPEAT      237    276       LDL-receptor class B 5.
FT   DOMAIN      282    324       EGF-like 1.
FT   REPEAT      372    414       LDL-receptor class B 6.
FT   REPEAT      415    457       LDL-receptor class B 7.
FT   REPEAT      458    501       LDL-receptor class B 8.
FT   REPEAT      502    542       LDL-receptor class B 9.
FT   REPEAT      543    584       LDL-receptor class B 10.
FT   DOMAIN      588    628       EGF-like 2.
FT   REPEAT      674    716       LDL-receptor class B 11.
FT   REPEAT      717    759       LDL-receptor class B 12.
FT   REPEAT      760    802       LDL-receptor class B 13.
FT   REPEAT      803    842       LDL-receptor class B 14.
FT   REPEAT      843    885       LDL-receptor class B 15.
FT   DOMAIN      889    930       EGF-like 3.
FT   REPEAT      977   1025       LDL-receptor class B 16.
FT   REPEAT     1026   1068       LDL-receptor class B 17.
FT   REPEAT     1069   1113       LDL-receptor class B 18.
FT   REPEAT     1114   1156       LDL-receptor class B 19.
FT   REPEAT     1157   1198       LDL-receptor class B 20.
FT   DOMAIN     1203   1244       EGF-like 4.
FT   DOMAIN     1248   1286       LDL-receptor class A 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1287   1323       LDL-receptor class A 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DOMAIN     1325   1361       LDL-receptor class A 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   REGION       20    275       Beta-propeller 1.
FT   REGION      328    589       Beta-propeller 2.
FT   REGION      631    890       Beta-propeller 3.
FT   REGION      933   1202       Beta-propeller 4.
FT   MOTIF      1487   1493       PPPSP motif A.
FT   MOTIF      1527   1534       PPPSP motif B.
FT   MOTIF      1568   1575       PPPSP motif C.
FT   MOTIF      1588   1593       PPPSP motif D.
FT   MOTIF      1603   1610       PPPSP motif E.
FT   MOD_RES    1420   1420       Phosphoserine; by CK1.
FT                                {ECO:0000269|PubMed:16513652}.
FT   MOD_RES    1430   1430       Phosphoserine; by CK1.
FT                                {ECO:0000269|PubMed:16513652}.
FT   MOD_RES    1479   1479       Phosphothreonine.
FT                                {ECO:0000269|PubMed:17569865}.
FT   MOD_RES    1490   1490       Phosphoserine; by CDK14, GRK5 and GRK6.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:16341017,
FT                                ECO:0000269|PubMed:17698587,
FT                                ECO:0000269|PubMed:18762581,
FT                                ECO:0000269|PubMed:19801552,
FT                                ECO:0000269|PubMed:20059949,
FT                                ECO:0000269|PubMed:25331957,
FT                                ECO:0000269|PubMed:27821587}.
FT   MOD_RES    1493   1493       Phosphothreonine; by CK1.
FT                                {ECO:0000269|PubMed:16341017}.
FT   LIPID      1394   1394       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:18378904}.
FT   LIPID      1399   1399       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:18378904}.
FT   CARBOHYD     42     42       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    281    281       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    433    433       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    486    486       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    692    692       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22000856}.
FT   CARBOHYD    859    859       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22000856}.
FT   CARBOHYD    865    865       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22000856}.
FT   CARBOHYD    926    926       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22000856}.
FT   CARBOHYD   1039   1039       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:22000856}.
FT   DISULFID    286    297       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    293    308       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    310    323       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    592    603       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    599    612       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    614    627       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID    893    904       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID    900    914       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID    916    929       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID   1207   1218       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID   1214   1228       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID   1230   1243       {ECO:0000255|PROSITE-ProRule:PRU00124,
FT                                ECO:0000269|PubMed:22000856}.
FT   DISULFID   1249   1263       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1256   1276       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1270   1285       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1288   1300       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1295   1313       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1307   1322       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1326   1338       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1333   1351       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   DISULFID   1345   1360       {ECO:0000255|PROSITE-ProRule:PRU00124}.
FT   CROSSLNK   1403   1403       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18378904}.
FT   VARIANT      19     19       A -> V (in STHAG7; impairs Wnt signaling;
FT                                prevents transport to plasma membrane
FT                                location; dbSNP:rs864309648).
FT                                {ECO:0000269|PubMed:26387593}.
FT                                /FTId=VAR_076207.
FT   VARIANT     360    360       R -> H (in ADCAD2; dbSNP:rs141212743).
FT                                {ECO:0000269|PubMed:23703864}.
FT                                /FTId=VAR_076208.
FT   VARIANT     433    433       N -> S (in ADCAD2; dbSNP:rs397515473).
FT                                {ECO:0000269|PubMed:23703864}.
FT                                /FTId=VAR_076209.
FT   VARIANT     473    473       R -> Q (in ADCAD2; impairs Wnt signaling;
FT                                dbSNP:rs397515474).
FT                                {ECO:0000269|PubMed:23703864}.
FT                                /FTId=VAR_076210.
FT   VARIANT     483    483       V -> I (in dbSNP:rs7975614).
FT                                /FTId=VAR_030349.
FT   VARIANT     611    611       R -> C (in ADCAD2; impairs Wnt signaling
FT                                in vitro; dbSNP:rs121918313).
FT                                {ECO:0000269|PubMed:17332414}.
FT                                /FTId=VAR_034701.
FT   VARIANT     817    817       S -> C (in dbSNP:rs2302686).
FT                                /FTId=VAR_030350.
FT   VARIANT    1062   1062       V -> I (in dbSNP:rs2302685).
FT                                {ECO:0000269|PubMed:9704021}.
FT                                /FTId=VAR_024520.
FT   VARIANT    1401   1401       R -> H (in dbSNP:rs34815107).
FT                                /FTId=VAR_034702.
FT   MUTAGEN    1394   1394       C->A: Some reduction of palmitoylation,
FT                                little change in plasma membrane location
FT                                in the presence of MESD nor in Wnt-
FT                                signaling activity. Completely abolishes
FT                                palmitoylation, no plasma membrane
FT                                location, greatly reduced Wnt-signaling
FT                                activity but no effect on ubiquitination;
FT                                when associated with A-1399. Exhibits
FT                                full Wnt-signaling activity and no change
FT                                in plasma membrane location; when
FT                                associated with A-1399 and R-1403.
FT                                {ECO:0000269|PubMed:18378904}.
FT   MUTAGEN    1399   1399       C->A: Some reduction of palmitoylation,
FT                                and little change in plasma membrane
FT                                location in the presence of MESD nor in
FT                                Wnt-signaling activity. Completely
FT                                abolishes palmitoylation, no plasma
FT                                membrane location, greatly reduced Wnt-
FT                                signaling activity but no effect on
FT                                ubiquitination; when associated with A-
FT                                1394. Exhibits full Wnt-signaling
FT                                activity and no change in plasma membrane
FT                                location in the in presence of MESD; when
FT                                associated with A-1394 and R-1403.
FT                                {ECO:0000269|PubMed:18378904}.
FT   MUTAGEN    1403   1403       K->R: Abolishes ubiquitination, no change
FT                                in plasma membrane location in the
FT                                presence of MESD but greatly reduced Wnt-
FT                                signaling activity. Exhibits full Wnt-
FT                                signaling activity and no change in
FT                                plasma membrane location; when associated
FT                                with A-1394 and A-1399.
FT   MUTAGEN    1420   1420       S->A: Enhanced AXIN1 binding and
FT                                increased beta-catenin activity by 2.2-
FT                                fold. Further enhanced AXIN1 binding and
FT                                increases beta-catenin activity by 3.3-
FT                                fold; when associated with A-1430.
FT                                {ECO:0000269|PubMed:16513652}.
FT   MUTAGEN    1430   1430       S->A: Enhanced AXIN1 binding. Further
FT                                enhanced AXIN1 binding and increases
FT                                beta-catenin activity by 3.3-fold; when
FT                                associated with A-1420.
FT                                {ECO:0000269|PubMed:16513652}.
FT   MUTAGEN    1485   1485       L->A: No change in the phosphorylation
FT                                state of PPPSP motif. Some reduction in
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1486   1486       N->A: No change in the phosphorylation
FT                                state of PPPSP motif. Increased Wnt/beta-
FT                                catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1487   1487       P->A: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1487   1487       P->C: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1488   1488       P->A: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1489   1489       P->A: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1490   1490       S->A: Greatly reduced phosphorylation of
FT                                PPPSP motif A. Greatly reduced Wnt/beta-
FT                                catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1490   1490       S->T: Some loss of phosphorylation of
FT                                PPPSP motif A. Little reduction in
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1491   1491       P->A: Greatly reduced phosphorylation of
FT                                PPPSP motif A. Greatly reduced Wnt/beta-
FT                                catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1492   1492       A->G: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1493   1493       T->A: No change in the phosphorylation
FT                                state of PPPSP motif A. Greatly reduced
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1494   1494       E->A: No change in the phosphorylation
FT                                state of PPPSP motif A. Little reduction
FT                                of Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1495   1495       R->A: No change in the phosphorylation
FT                                state of PPPSP motif. No reduction of
FT                                Wnt/beta-catenin signaling.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1529   1529       T->A: No effect on the phosphorylation
FT                                state of PPPSP motif B.
FT                                {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1530   1530       T->A: Abolishes phosphorylation of PPPSP
FT                                motif B. Reduced Wnt/beta-catenin
FT                                signaling. {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1531   1531       P->A: Abolishes phosphorylation of PPPSP
FT                                motif B. Reduced Wnt/beta-catenin
FT                                signaling. {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1572   1572       T->A: Abolishes Wnt/beta-catenin
FT                                signaling. {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1590   1590       S->A: Abolishes Wnt/beta-catenin
FT                                signaling. {ECO:0000269|PubMed:18362152}.
FT   MUTAGEN    1607   1607       S->A: Abolishes Wnt/beta-catenin
FT                                signaling. {ECO:0000269|PubMed:18362152}.
FT   STRAND       22     26       {ECO:0000244|PDB:3SOV}.
FT   STRAND       28     35       {ECO:0000244|PDB:3SOV}.
FT   HELIX        36     38       {ECO:0000244|PDB:3SOB}.
FT   STRAND       44     59       {ECO:0000244|PDB:3SOV}.
FT   HELIX        60     62       {ECO:0000244|PDB:3SOV}.
FT   STRAND       64     69       {ECO:0000244|PDB:3SOV}.
FT   TURN         70     73       {ECO:0000244|PDB:3SOV}.
FT   STRAND       74     79       {ECO:0000244|PDB:3SOV}.
FT   STRAND       82     84       {ECO:0000244|PDB:3SOV}.
FT   STRAND       88     92       {ECO:0000244|PDB:3SOV}.
FT   STRAND       99    103       {ECO:0000244|PDB:3SOV}.
FT   TURN        104    107       {ECO:0000244|PDB:3SOV}.
FT   STRAND      108    113       {ECO:0000244|PDB:3SOV}.
FT   TURN        114    117       {ECO:0000244|PDB:3SOV}.
FT   STRAND      118    123       {ECO:0000244|PDB:3SOV}.
FT   STRAND      130    133       {ECO:0000244|PDB:3SOV}.
FT   STRAND      138    146       {ECO:0000244|PDB:3SOV}.
FT   HELIX       147    149       {ECO:0000244|PDB:3SOV}.
FT   STRAND      151    156       {ECO:0000244|PDB:3SOV}.
FT   STRAND      158    160       {ECO:0000244|PDB:3SOV}.
FT   STRAND      162    167       {ECO:0000244|PDB:3SOV}.
FT   STRAND      174    177       {ECO:0000244|PDB:3SOV}.
FT   STRAND      184    190       {ECO:0000244|PDB:3SOV}.
FT   TURN        191    194       {ECO:0000244|PDB:3SOV}.
FT   STRAND      195    200       {ECO:0000244|PDB:3SOV}.
FT   TURN        201    204       {ECO:0000244|PDB:3SOV}.
FT   STRAND      205    210       {ECO:0000244|PDB:3SOV}.
FT   STRAND      217    220       {ECO:0000244|PDB:3SOV}.
FT   STRAND      227    233       {ECO:0000244|PDB:3SOV}.
FT   STRAND      236    241       {ECO:0000244|PDB:3SOV}.
FT   TURN        242    245       {ECO:0000244|PDB:3SOV}.
FT   STRAND      246    251       {ECO:0000244|PDB:3SOV}.
FT   TURN        252    254       {ECO:0000244|PDB:3SOV}.
FT   STRAND      259    262       {ECO:0000244|PDB:3SOV}.
FT   STRAND      271    274       {ECO:0000244|PDB:3SOV}.
FT   HELIX       276    278       {ECO:0000244|PDB:3SOV}.
FT   TURN        285    289       {ECO:0000244|PDB:3SOV}.
FT   HELIX       290    292       {ECO:0000244|PDB:3SOV}.
FT   STRAND      294    299       {ECO:0000244|PDB:3SOV}.
FT   STRAND      305    309       {ECO:0000244|PDB:3SOV}.
FT   STRAND      328    337       {ECO:0000244|PDB:3S94}.
FT   STRAND      339    346       {ECO:0000244|PDB:3S94}.
FT   STRAND      360    368       {ECO:0000244|PDB:3S94}.
FT   TURN        369    372       {ECO:0000244|PDB:3S94}.
FT   STRAND      373    378       {ECO:0000244|PDB:3S94}.
FT   TURN        379    382       {ECO:0000244|PDB:3S94}.
FT   STRAND      383    388       {ECO:0000244|PDB:3S94}.
FT   STRAND      389    391       {ECO:0000244|PDB:4DG6}.
FT   STRAND      395    398       {ECO:0000244|PDB:3S94}.
FT   STRAND      407    411       {ECO:0000244|PDB:3S94}.
FT   TURN        412    415       {ECO:0000244|PDB:3S94}.
FT   STRAND      416    421       {ECO:0000244|PDB:3S94}.
FT   TURN        422    425       {ECO:0000244|PDB:3S94}.
FT   STRAND      426    431       {ECO:0000244|PDB:3S94}.
FT   STRAND      438    441       {ECO:0000244|PDB:3S94}.
FT   STRAND      447    454       {ECO:0000244|PDB:3S94}.
FT   TURN        455    458       {ECO:0000244|PDB:3S94}.
FT   STRAND      459    464       {ECO:0000244|PDB:3S94}.
FT   STRAND      466    468       {ECO:0000244|PDB:3S94}.
FT   STRAND      470    475       {ECO:0000244|PDB:3S94}.
FT   STRAND      482    485       {ECO:0000244|PDB:3S94}.
FT   STRAND      492    498       {ECO:0000244|PDB:3S94}.
FT   TURN        499    502       {ECO:0000244|PDB:3S94}.
FT   STRAND      503    508       {ECO:0000244|PDB:3S94}.
FT   TURN        509    512       {ECO:0000244|PDB:3S94}.
FT   STRAND      513    521       {ECO:0000244|PDB:3S94}.
FT   STRAND      525    529       {ECO:0000244|PDB:3S94}.
FT   STRAND      538    541       {ECO:0000244|PDB:3S94}.
FT   STRAND      544    548       {ECO:0000244|PDB:3S94}.
FT   STRAND      555    562       {ECO:0000244|PDB:3S94}.
FT   STRAND      565    569       {ECO:0000244|PDB:3S94}.
FT   STRAND      575    584       {ECO:0000244|PDB:3S94}.
FT   HELIX       591    593       {ECO:0000244|PDB:3S94}.
FT   HELIX       595    598       {ECO:0000244|PDB:3S94}.
FT   STRAND      600    606       {ECO:0000244|PDB:3S94}.
FT   STRAND      609    613       {ECO:0000244|PDB:3S94}.
FT   STRAND      633    638       {ECO:0000244|PDB:4A0P}.
FT   STRAND      641    648       {ECO:0000244|PDB:4A0P}.
FT   STRAND      653    655       {ECO:0000244|PDB:4A0P}.
FT   STRAND      664    670       {ECO:0000244|PDB:4A0P}.
FT   TURN        671    674       {ECO:0000244|PDB:4A0P}.
FT   STRAND      675    680       {ECO:0000244|PDB:4A0P}.
FT   TURN        681    684       {ECO:0000244|PDB:4A0P}.
FT   STRAND      685    690       {ECO:0000244|PDB:4A0P}.
FT   STRAND      697    700       {ECO:0000244|PDB:4A0P}.
FT   STRAND      709    713       {ECO:0000244|PDB:4A0P}.
FT   TURN        714    717       {ECO:0000244|PDB:4A0P}.
FT   STRAND      718    723       {ECO:0000244|PDB:4A0P}.
FT   TURN        724    727       {ECO:0000244|PDB:4A0P}.
FT   STRAND      728    733       {ECO:0000244|PDB:4A0P}.
FT   STRAND      740    743       {ECO:0000244|PDB:4A0P}.
FT   STRAND      750    756       {ECO:0000244|PDB:4A0P}.
FT   TURN        757    760       {ECO:0000244|PDB:4A0P}.
FT   STRAND      761    766       {ECO:0000244|PDB:4A0P}.
FT   STRAND      768    770       {ECO:0000244|PDB:4A0P}.
FT   STRAND      772    777       {ECO:0000244|PDB:4A0P}.
FT   STRAND      784    787       {ECO:0000244|PDB:4A0P}.
FT   STRAND      791    799       {ECO:0000244|PDB:4A0P}.
FT   TURN        800    803       {ECO:0000244|PDB:4A0P}.
FT   STRAND      804    809       {ECO:0000244|PDB:4A0P}.
FT   TURN        810    813       {ECO:0000244|PDB:4A0P}.
FT   STRAND      814    819       {ECO:0000244|PDB:4A0P}.
FT   STRAND      826    830       {ECO:0000244|PDB:4A0P}.
FT   STRAND      835    841       {ECO:0000244|PDB:4A0P}.
FT   STRAND      844    849       {ECO:0000244|PDB:4A0P}.
FT   TURN        850    853       {ECO:0000244|PDB:4A0P}.
FT   STRAND      854    859       {ECO:0000244|PDB:4A0P}.
FT   TURN        860    862       {ECO:0000244|PDB:4A0P}.
FT   STRAND      867    870       {ECO:0000244|PDB:4A0P}.
FT   STRAND      878    882       {ECO:0000244|PDB:4A0P}.
FT   HELIX       884    886       {ECO:0000244|PDB:4A0P}.
FT   TURN        892    896       {ECO:0000244|PDB:4A0P}.
FT   HELIX       897    899       {ECO:0000244|PDB:4A0P}.
FT   STRAND      901    907       {ECO:0000244|PDB:4A0P}.
FT   TURN        908    910       {ECO:0000244|PDB:4A0P}.
FT   STRAND      911    915       {ECO:0000244|PDB:4A0P}.
FT   STRAND      933    940       {ECO:0000244|PDB:4A0P}.
FT   STRAND      943    947       {ECO:0000244|PDB:4A0P}.
FT   STRAND      967    973       {ECO:0000244|PDB:4A0P}.
FT   TURN        974    977       {ECO:0000244|PDB:4A0P}.
FT   STRAND      978    983       {ECO:0000244|PDB:4A0P}.
FT   TURN        984    987       {ECO:0000244|PDB:4A0P}.
FT   STRAND      988    993       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1000   1003       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1016   1022       {ECO:0000244|PDB:4A0P}.
FT   TURN       1023   1026       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1027   1032       {ECO:0000244|PDB:4A0P}.
FT   TURN       1033   1036       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1037   1042       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1047   1052       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1059   1065       {ECO:0000244|PDB:4A0P}.
FT   TURN       1066   1069       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1070   1077       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1080   1087       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1094   1097       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1104   1110       {ECO:0000244|PDB:4A0P}.
FT   TURN       1111   1114       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1115   1120       {ECO:0000244|PDB:4A0P}.
FT   TURN       1121   1124       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1125   1130       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1137   1140       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1147   1153       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1156   1161       {ECO:0000244|PDB:4A0P}.
FT   TURN       1162   1165       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1166   1171       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1174   1176       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1179   1182       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1188   1194       {ECO:0000244|PDB:4A0P}.
FT   HELIX      1199   1204       {ECO:0000244|PDB:4A0P}.
FT   TURN       1206   1209       {ECO:0000244|PDB:4A0P}.
FT   HELIX      1210   1213       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1215   1220       {ECO:0000244|PDB:4A0P}.
FT   TURN       1222   1224       {ECO:0000244|PDB:3S8Z}.
FT   STRAND     1226   1229       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1234   1236       {ECO:0000244|PDB:4A0P}.
FT   STRAND     1238   1241       {ECO:0000244|PDB:3S8Z}.
SQ   SEQUENCE   1613 AA;  180429 MW;  413D2CF70A5D8B5C CRC64;
     MGAVLRSLLA CSFCVLLRAA PLLLYANRRD LRLVDATNGK ENATIVVGGL EDAAAVDFVF
     SHGLIYWSDV SEEAIKRTEF NKTESVQNVV VSGLLSPDGL ACDWLGEKLY WTDSETNRIE
     VSNLDGSLRK VLFWQELDQP RAIALDPSSG FMYWTDWGEV PKIERAGMDG SSRFIIINSE
     IYWPNGLTLD YEEQKLYWAD AKLNFIHKSN LDGTNRQAVV KGSLPHPFAL TLFEDILYWT
     DWSTHSILAC NKYTGEGLRE IHSDIFSPMD IHAFSQQRQP NATNPCGIDN GGCSHLCLMS
     PVKPFYQCAC PTGVKLLENG KTCKDGATEL LLLARRTDLR RISLDTPDFT DIVLQLEDIR
     HAIAIDYDPV EGYIYWTDDE VRAIRRSFID GSGSQFVVTA QIAHPDGIAV DWVARNLYWT
     DTGTDRIEVT RLNGTMRKIL ISEDLEEPRA IVLDPMVGYM YWTDWGEIPK IERAALDGSD
     RVVLVNTSLG WPNGLALDYD EGKIYWGDAK TDKIEVMNTD GTGRRVLVED KIPHIFGFTL
     LGDYVYWTDW QRRSIERVHK RSAEREVIID QLPDLMGLKA TNVHRVIGSN PCAEENGGCS
     HLCLYRPQGL RCACPIGFEL ISDMKTCIVP EAFLLFSRRA DIRRISLETN NNNVAIPLTG
     VKEASALDFD VTDNRIYWTD ISLKTISRAF MNGSALEHVV EFGLDYPEGM AVDWLGKNLY
     WADTGTNRIE VSKLDGQHRQ VLVWKDLDSP RALALDPAEG FMYWTEWGGK PKIDRAAMDG
     SERTTLVPNV GRANGLTIDY AKRRLYWTDL DTNLIESSNM LGLNREVIAD DLPHPFGLTQ
     YQDYIYWTDW SRRSIERANK TSGQNRTIIQ GHLDYVMDIL VFHSSRQSGW NECASSNGHC
     SHLCLAVPVG GFVCGCPAHY SLNADNRTCS APTTFLLFSQ KSAINRMVID EQQSPDIILP
     IHSLRNVRAI DYDPLDKQLY WIDSRQNMIR KAQEDGSQGF TVVVSSVPSQ NLEIQPYDLS
     IDIYSRYIYW TCEATNVINV TRLDGRSVGV VLKGEQDRPR AVVVNPEKGY MYFTNLQERS
     PKIERAALDG TEREVLFFSG LSKPIALALD SRLGKLFWAD SDLRRIESSD LSGANRIVLE
     DSNILQPVGL TVFENWLYWI DKQQQMIEKI DMTGREGRTK VQARIAQLSD IHAVKELNLQ
     EYRQHPCAQD NGGCSHICLV KGDGTTRCSC PMHLVLLQDE LSCGEPPTCS PQQFTCFTGE
     IDCIPVAWRC DGFTECEDHS DELNCPVCSE SQFQCASGQC IDGALRCNGD ANCQDKSDEK
     NCEVLCLIDQ FRCANGQCIG KHKKCDHNVD CSDKSDELDC YPTEEPAPQA TNTVGSVIGV
     IVTIFVSGTV YFICQRMLCP RMKGDGETMT NDYVVHGPAS VPLGYVPHPS SLSGSLPGMS
     RGKSMISSLS IMGGSSGPPY DRAHVTGASS SSSSSTKGTY FPAILNPPPS PATERSHYTM
     EFGYSSNSPS THRSYSYRPY SYRHFAPPTT PCSTDVCDSD YAPSRRMTSV ATAKGYTSDL
     NYDSEPVPPP PTPRSQYLSA EENYESCPPS PYTERSYSHH LYPPPPSPCT DSS
//
ID   PTPRS_HUMAN             Reviewed;        1948 AA.
AC   Q13332; O75255; O75870; Q15718; Q16341; Q2M3R7;
DT   19-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   07-JUN-2017, entry version 175.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase S;
DE            Short=R-PTP-S;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:8524829, ECO:0000305|PubMed:8992885};
DE   AltName: Full=Receptor-type tyrosine-protein phosphatase sigma;
DE            Short=R-PTP-sigma;
DE   Flags: Precursor;
GN   Name=PTPRS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, FUNCTION,
RP   INTERACTION WITH PPFIA1, ALTERNATIVE SPLICING, TISSUE SPECIFICITY, AND
RP   VARIANT ARG-1457.
RC   TISSUE=Fetal brain;
RX   PubMed=8524829; DOI=10.1073/pnas.92.25.11686;
RA   Pulido R., Serra-Pages C., Tang M., Streuli M.;
RT   "The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-
RT   tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma
RT   isoforms are expressed in a tissue-specific manner and associate with
RT   the LAR-interacting protein LIP.1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:11686-11690(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, ALTERNATIVE SPLICING, AND VARIANT ARG-1457.
RX   PubMed=8992885; DOI=10.1002/jbmr.5650110415;
RA   Endo N., Rutledge S.J., Opas E.E., Vogel R., Rodan G.A., Schmidt A.;
RT   "Human protein tyrosine phosphatase-sigma: alternative splicing and
RT   inhibition by bisphosphonates.";
RL   J. Bone Miner. Res. 11:535-543(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-1457.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ARG-1457.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1503-1589.
RX   PubMed=1370651;
RA   Adachi M., Sekiya M., Arimura Y., Takekawa M., Itoh F., Hinoda Y.,
RA   Imai K., Yachi A.;
RT   "Protein-tyrosine phosphatase expression in pre-B cell NALM-6.";
RL   Cancer Res. 52:737-740(1992).
RN   [7]
RP   INTERACTION WITH PPFIA1; PPFIA2 AND PPFIA3.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=26231120; DOI=10.1016/j.immuni.2015.07.009;
RA   Bunin A., Sisirak V., Ghosh H.S., Grajkowska L.T., Hou Z.E., Miron M.,
RA   Yang C., Ceribelli M., Uetani N., Chaperot L., Plumas J., Hendriks W.,
RA   Tremblay M.L., Haecker H., Staudt L.M., Green P.H., Bhagat G.,
RA   Reizis B.;
RT   "Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human
RT   and murine plasmacytoid dendritic cells.";
RL   Immunity 43:277-288(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1365-1948.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
RN   [13] {ECO:0000244|PDB:2YD2, ECO:0000244|PDB:2YD3, ECO:0000244|PDB:2YD9}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 30-235, FUNCTION, AND
RP   DISULFIDE BONDS.
RX   PubMed=21454754; DOI=10.1126/science.1200840;
RA   Coles C.H., Shen Y., Tenney A.P., Siebold C., Sutton G.C., Lu W.,
RA   Gallagher J.T., Jones E.Y., Flanagan J.G., Aricescu A.R.;
RT   "Proteoglycan-specific molecular switch for RPTPsigma clustering and
RT   neuronal extension.";
RL   Science 332:484-488(2011).
RN   [14] {ECO:0000244|PDB:4BPC}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1367-1948, AND ACTIVE SITE.
RX   PubMed=23820885; DOI=10.1007/s10059-013-0033-x;
RA   Jeon T.J., Chien P.N., Chun H.J., Ryu S.E.;
RT   "Structure of the catalytic domain of protein tyrosine phosphatase
RT   sigma in the sulfenic acid form.";
RL   Mol. Cells 36:55-61(2013).
RN   [15] {ECO:0000244|PDB:4PBX}
RP   X-RAY CRYSTALLOGRAPHY (3.15 ANGSTROMS) OF 30-614, STRUCTURE BY
RP   ELECTRON MICROSCOPY, INTERACTION WITH NTRK3, GLYCOSYLATION AT ASN-263
RP   AND ASN-308, DISULFIDE BONDS, AND MUTAGENESIS OF ARG-97; ARG-100;
RP   TYR-233 AND 241-ARG-ARG-242.
RX   PubMed=25385546; DOI=10.1038/ncomms6209;
RA   Coles C.H., Mitakidis N., Zhang P., Elegheert J., Lu W., Stoker A.W.,
RA   Nakagawa T., Craig A.M., Jones E.Y., Aricescu A.R.;
RT   "Structural basis for extracellular cis and trans RPTPsigma signal
RT   competition in synaptogenesis.";
RL   Nat. Commun. 5:5209-5209(2014).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-996.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Cell surface receptor that binds to glycosaminoglycans,
CC       including chondroitin sulfate proteoglycans and heparan sulfate
CC       proteoglycan (PubMed:21454754). Binding to chondroitin sulfate and
CC       heparan sulfate proteoglycans has opposite effects on PTPRS
CC       oligomerization and regulation of neurite outgrowth. Contributes
CC       to the inhibition of neurite and axonal outgrowth by chondroitin
CC       sulfate proteoglycans, also after nerve transection. Plays a role
CC       in stimulating neurite outgrowth in response to the heparan
CC       sulfate proteoglycan GPC2. Required for normal brain development,
CC       especially for normal development of the pituitary gland and the
CC       olfactory bulb. Functions as tyrosine phosphatase
CC       (PubMed:8524829). Mediates dephosphorylation of NTRK1, NTRK2 and
CC       NTRK3 (By similarity). Plays a role in down-regulation of
CC       signaling cascades that lead to the activation of Akt and MAP
CC       kinases (By similarity). Down-regulates TLR9-mediated activation
CC       of NF-kappa-B, as well as production of TNF, interferon alpha and
CC       interferon beta (PubMed:26231120). {ECO:0000250|UniProtKB:B0V2N1,
CC       ECO:0000250|UniProtKB:F1NWE3, ECO:0000269|PubMed:21454754,
CC       ECO:0000269|PubMed:26231120, ECO:0000269|PubMed:8524829}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000269|PubMed:8524829, ECO:0000305|PubMed:8992885}.
CC   -!- SUBUNIT: Binding to large heparan sulfate proteoglycan structures
CC       promotes oligomerization. Binding to chondroitin sulfate
CC       proteoglycan does not lead to oligomerization (By similarity).
CC       Interacts (via Ig-like domains) with NTRK3 (PubMed:25385546).
CC       Interacts (via Ig-like domains) with NTRK1, but does not form
CC       detectable complexes with NTRK2 (By similarity). Interacts with
CC       PPFIA1, PPFIA2 and PPFIA3 (PubMed:8524829, PubMed:9624153).
CC       {ECO:0000250|UniProtKB:B0V2N1, ECO:0000250|UniProtKB:Q64605,
CC       ECO:0000269|PubMed:8524829, ECO:0000269|PubMed:9624153}.
CC   -!- INTERACTION:
CC       Q16849:PTPRN; NbExp=5; IntAct=EBI-711536, EBI-728153;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26231120};
CC       Single-pass type I membrane protein {ECO:0000305}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:B0V2N1}. Perikaryon
CC       {ECO:0000250|UniProtKB:B0V2N1}. Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q64605}.
CC       Cell junction, synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q64605}. Cell junction, synapse,
CC       postsynaptic cell membrane, postsynaptic density
CC       {ECO:0000250|UniProtKB:Q64605}. Note=Is rapidly internalized when
CC       dendritic cells are stimulated with the TLR9 ligand cytidine-
CC       phosphate-guanosine (CpG) (PubMed:26231120). Detected in a
CC       punctate pattern along neurites and axon growth cones (By
CC       similarity). {ECO:0000250|UniProtKB:B0V2N1,
CC       ECO:0000269|PubMed:26231120}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=PTPS;
CC         IsoId=Q13332-1; Sequence=Displayed;
CC       Name=PTPS-MEA;
CC         IsoId=Q13332-2; Sequence=VSP_050021;
CC       Name=PTPS-MEB;
CC         IsoId=Q13332-3; Sequence=VSP_050022, VSP_050026, VSP_050027;
CC       Name=PTPS-MEC;
CC         IsoId=Q13332-4; Sequence=VSP_050024;
CC       Name=PTPS-F4-7;
CC         IsoId=Q13332-5; Sequence=VSP_050023, VSP_050025;
CC       Name=2;
CC         IsoId=Q13332-6; Sequence=VSP_050021, VSP_050022, VSP_050024,
CC                                  VSP_050026, VSP_050027;
CC       Name=3;
CC         IsoId=Q13332-7; Sequence=VSP_050021, VSP_050022, VSP_050023,
CC                                  VSP_050025, VSP_050026, VSP_050027;
CC   -!- TISSUE SPECIFICITY: Detected in peripheral blood plasmacytoid
CC       dendritic cells (at protein level) (PubMed:26231120). Detected in
CC       all tissues tested except for placenta and liver (PubMed:8524829,
CC       PubMed:8992885). Detected in peripheral blood plasmacytoid
CC       dendritic cells (PubMed:26231120). {ECO:0000269|PubMed:26231120,
CC       ECO:0000269|PubMed:8524829, ECO:0000269|PubMed:8992885}.
CC   -!- PTM: A cleavage occurs, separating the extracellular domain from
CC       the transmembrane segment. This process called 'ectodomain
CC       shedding' is thought to be involved in receptor desensitization,
CC       signal transduction and/or membrane localization (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2A subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50567.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35234; AAC50299.1; -; mRNA.
DR   EMBL; U40317; AAC50567.1; ALT_FRAME; mRNA.
DR   EMBL; AC005335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005790; AAC62832.1; -; Genomic_DNA.
DR   EMBL; AC005338; AAC27825.1; -; Genomic_DNA.
DR   EMBL; AC005788; AAC62834.1; -; Genomic_DNA.
DR   EMBL; AC118535; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW69176.1; -; Genomic_DNA.
DR   EMBL; BC104812; AAI04813.1; -; mRNA.
DR   EMBL; BC143287; AAI43288.1; -; mRNA.
DR   EMBL; S78080; AAB21146.2; -; mRNA.
DR   CCDS; CCDS12139.1; -. [Q13332-7]
DR   CCDS; CCDS12140.1; -. [Q13332-6]
DR   CCDS; CCDS45930.1; -. [Q13332-1]
DR   RefSeq; NP_002841.3; NM_002850.3. [Q13332-1]
DR   RefSeq; NP_570923.2; NM_130853.2. [Q13332-7]
DR   RefSeq; NP_570924.2; NM_130854.2. [Q13332-6]
DR   RefSeq; NP_570925.2; NM_130855.2.
DR   RefSeq; XP_005259663.1; XM_005259606.2. [Q13332-6]
DR   RefSeq; XP_005259666.1; XM_005259609.1. [Q13332-7]
DR   RefSeq; XP_016882554.1; XM_017027065.1. [Q13332-2]
DR   RefSeq; XP_016882555.1; XM_017027066.1. [Q13332-2]
DR   RefSeq; XP_016882556.1; XM_017027067.1. [Q13332-2]
DR   UniGene; Hs.744928; -.
DR   PDB; 2FH7; X-ray; 2.00 A; A=1365-1948.
DR   PDB; 2YD2; X-ray; 2.55 A; A=30-244.
DR   PDB; 2YD3; X-ray; 2.30 A; A=30-235.
DR   PDB; 2YD9; X-ray; 2.60 A; A=30-334.
DR   PDB; 4BPC; X-ray; 2.10 A; A=1367-1948.
DR   PDB; 4PBX; X-ray; 3.15 A; A=30-614.
DR   PDBsum; 2FH7; -.
DR   PDBsum; 2YD2; -.
DR   PDBsum; 2YD3; -.
DR   PDBsum; 2YD9; -.
DR   PDBsum; 4BPC; -.
DR   PDBsum; 4PBX; -.
DR   ProteinModelPortal; Q13332; -.
DR   SMR; Q13332; -.
DR   BioGrid; 111766; 49.
DR   IntAct; Q13332; 17.
DR   MINT; MINT-1349588; -.
DR   STRING; 9606.ENSP00000349932; -.
DR   BindingDB; Q13332; -.
DR   ChEMBL; CHEMBL2396508; -.
DR   DrugBank; DB00630; Alendronic acid.
DR   DrugBank; DB01077; Etidronic acid.
DR   GuidetoPHARMACOLOGY; 1866; -.
DR   DEPOD; Q13332; -.
DR   iPTMnet; Q13332; -.
DR   PhosphoSitePlus; Q13332; -.
DR   BioMuta; PTPRS; -.
DR   DMDM; 317373519; -.
DR   MaxQB; Q13332; -.
DR   PaxDb; Q13332; -.
DR   PeptideAtlas; Q13332; -.
DR   PRIDE; Q13332; -.
DR   DNASU; 5802; -.
DR   Ensembl; ENST00000587303; ENSP00000467537; ENSG00000105426. [Q13332-1]
DR   Ensembl; ENST00000588012; ENSP00000465443; ENSG00000105426. [Q13332-6]
DR   Ensembl; ENST00000592099; ENSP00000467398; ENSG00000105426. [Q13332-7]
DR   GeneID; 5802; -.
DR   KEGG; hsa:5802; -.
DR   UCSC; uc002mbv.3; human. [Q13332-1]
DR   CTD; 5802; -.
DR   DisGeNET; 5802; -.
DR   GeneCards; PTPRS; -.
DR   HGNC; HGNC:9681; PTPRS.
DR   HPA; HPA054747; -.
DR   MIM; 601576; gene.
DR   neXtProt; NX_Q13332; -.
DR   OpenTargets; ENSG00000105426; -.
DR   PharmGKB; PA34026; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00760000118900; -.
DR   HOGENOM; HOG000010250; -.
DR   HOVERGEN; HBG053758; -.
DR   InParanoid; Q13332; -.
DR   KO; K06778; -.
DR   OMA; VPGQPMN; -.
DR   OrthoDB; EOG091G11WG; -.
DR   PhylomeDB; Q13332; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-388844; Receptor protein tyrosine phosphatases interactions.
DR   Reactome; R-HSA-8849932; SALM protein interactions at the synapses.
DR   SIGNOR; Q13332; -.
DR   ChiTaRS; PTPRS; human.
DR   EvolutionaryTrace; Q13332; -.
DR   GeneWiki; PTPRS; -.
DR   GenomeRNAi; 5802; -.
DR   PRO; PR:Q13332; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105426; -.
DR   CleanEx; HS_PTPRS; -.
DR   ExpressionAtlas; Q13332; baseline and differential.
DR   Genevisible; Q13332; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; ISS:UniProtKB.
DR   GO; GO:0030285; C:integral component of synaptic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0022038; P:corpus callosum development; IEA:Ensembl.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0030517; P:negative regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISS:UniProtKB.
DR   GO; GO:0048671; P:negative regulation of collateral sprouting; ISS:UniProtKB.
DR   GO; GO:0061000; P:negative regulation of dendritic spine development; ISS:UniProtKB.
DR   GO; GO:0032687; P:negative regulation of interferon-alpha production; IMP:UniProtKB.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0034164; P:negative regulation of toll-like receptor 9 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   CDD; cd00063; FN3; 8.
DR   Gene3D; 2.60.40.10; -; 12.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 7.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 8.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 8.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Complete proteome;
KW   Cytoplasmic vesicle; Disulfide bond; Glycoprotein; Heparin-binding;
KW   Hydrolase; Immunoglobulin domain; Membrane; Polymorphism;
KW   Postsynaptic cell membrane; Protein phosphatase; Receptor;
KW   Reference proteome; Repeat; Signal; Synapse; Synaptosome;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30   1948       Receptor-type tyrosine-protein
FT                                phosphatase S.
FT                                /FTId=PRO_0000025462.
FT   TOPO_DOM     30   1282       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1283   1303       Helical. {ECO:0000255}.
FT   TOPO_DOM   1304   1948       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       33    123       Ig-like C2-type 1.
FT   DOMAIN      135    233       Ig-like C2-type 2.
FT   DOMAIN      245    327       Ig-like C2-type 3.
FT   DOMAIN      334    424       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      429    523       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      527    616       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      621    718       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      723    831       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      832    930       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      931   1033       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1036   1120       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1393   1648       Tyrosine-protein phosphatase 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   DOMAIN     1680   1939       Tyrosine-protein phosphatase 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION       68     72       Important for binding to
FT                                glycosaminoglycan chains.
FT                                {ECO:0000250|UniProtKB:B0V2N1}.
FT   REGION     1589   1595       Substrate binding. {ECO:0000250}.
FT   COMPBIAS    641    644       Poly-Pro.
FT   ACT_SITE   1589   1589       Phosphocysteine intermediate.
FT                                {ECO:0000305|PubMed:23820885}.
FT   ACT_SITE   1880   1880       Phosphocysteine intermediate.
FT                                {ECO:0000250}.
FT   BINDING    1557   1557       Substrate. {ECO:0000250}.
FT   BINDING    1633   1633       Substrate. {ECO:0000250}.
FT   SITE       1197   1198       Cleavage. {ECO:0000250}.
FT   CARBOHYD    263    263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PBX,
FT                                ECO:0000269|PubMed:25385546}.
FT   CARBOHYD    308    308       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4PBX,
FT                                ECO:0000269|PubMed:25385546}.
FT   CARBOHYD    733    733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    940    940       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     54    107       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:21454754,
FT                                ECO:0000269|PubMed:25385546}.
FT   DISULFID    156    216       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    266    311       {ECO:0000244|PDB:2YD2,
FT                                ECO:0000244|PDB:2YD3,
FT                                ECO:0000244|PDB:2YD9,
FT                                ECO:0000244|PDB:4PBX,
FT                                ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     190    198       Missing (in isoform PTPS-MEA, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050021.
FT   VAR_SEQ     236    239       Missing (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050022.
FT   VAR_SEQ     617   1034       Missing (in isoform PTPS-F4-7 and isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050023.
FT   VAR_SEQ     784    792       Missing (in isoform PTPS-MEC and isoform
FT                                2). {ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050024.
FT   VAR_SEQ    1035   1035       V -> I (in isoform PTPS-F4-7 and isoform
FT                                3). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_050025.
FT   VAR_SEQ    1350   1365       Missing (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050026.
FT   VAR_SEQ    1366   1366       S -> G (in isoform PTPS-MEB, isoform 2
FT                                and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8992885}.
FT                                /FTId=VSP_050027.
FT   VARIANT     996    996       T -> M (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs775778266).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035649.
FT   VARIANT    1457   1457       C -> R (in dbSNP:rs4807697).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8524829,
FT                                ECO:0000269|PubMed:8992885,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_047277.
FT   MUTAGEN      97     97       R->A: Abolishes interaction with NTRK3;
FT                                when associated with A-100.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     100    100       R->A: Abolishes interaction with NTRK3;
FT                                when associated with A-97.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     233    233       Y->S: Abolishes interaction with NTRK3.
FT                                {ECO:0000269|PubMed:25385546}.
FT   MUTAGEN     241    242       RR->AA: Decreases interaction with NTRK3.
FT                                {ECO:0000269|PubMed:25385546}.
FT   CONFLICT     48     48       G -> R (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    428    429       SA -> RP (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    742    745       RSPA -> LGPV (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT    765    766       GA -> RR (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    768    768       A -> G (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT    910    910       R -> P (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   CONFLICT    995    995       L -> V (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1195   1196       SL -> TV (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1310   1313       Missing (in Ref. 3; AAC62834).
FT                                {ECO:0000305}.
FT   CONFLICT   1431   1431       S -> F (in Ref. 1; AAC50299).
FT                                {ECO:0000305}.
FT   CONFLICT   1546   1546       E -> D (in Ref. 6; AAB21146).
FT                                {ECO:0000305}.
FT   CONFLICT   1587   1587       V -> A (in Ref. 6; AAB21146).
FT                                {ECO:0000305}.
FT   CONFLICT   1705   1705       N -> K (in Ref. 2; AAC50567).
FT                                {ECO:0000305}.
FT   STRAND       31     37       {ECO:0000244|PDB:2YD3}.
FT   STRAND       42     45       {ECO:0000244|PDB:2YD3}.
FT   STRAND       50     60       {ECO:0000244|PDB:2YD3}.
FT   STRAND       63     68       {ECO:0000244|PDB:2YD3}.
FT   TURN         69     71       {ECO:0000244|PDB:4PBX}.
FT   STRAND       75     83       {ECO:0000244|PDB:2YD3}.
FT   HELIX        84     86       {ECO:0000244|PDB:2YD3}.
FT   STRAND       88     93       {ECO:0000244|PDB:2YD3}.
FT   TURN         98    101       {ECO:0000244|PDB:2YD3}.
FT   STRAND      103    111       {ECO:0000244|PDB:2YD3}.
FT   STRAND      114    125       {ECO:0000244|PDB:2YD3}.
FT   HELIX       127    129       {ECO:0000244|PDB:2YD3}.
FT   STRAND      136    139       {ECO:0000244|PDB:2YD3}.
FT   STRAND      144    147       {ECO:0000244|PDB:2YD3}.
FT   STRAND      152    154       {ECO:0000244|PDB:2YD3}.
FT   STRAND      157    159       {ECO:0000244|PDB:2YD3}.
FT   STRAND      165    170       {ECO:0000244|PDB:2YD3}.
FT   HELIX       177    179       {ECO:0000244|PDB:2YD3}.
FT   TURN        180    182       {ECO:0000244|PDB:2YD3}.
FT   STRAND      183    186       {ECO:0000244|PDB:2YD3}.
FT   STRAND      201    205       {ECO:0000244|PDB:2YD3}.
FT   HELIX       208    210       {ECO:0000244|PDB:2YD3}.
FT   STRAND      212    220       {ECO:0000244|PDB:2YD3}.
FT   STRAND      223    226       {ECO:0000244|PDB:2YD3}.
FT   STRAND      230    235       {ECO:0000244|PDB:2YD3}.
FT   STRAND      243    249       {ECO:0000244|PDB:2YD9}.
FT   STRAND      254    256       {ECO:0000244|PDB:4PBX}.
FT   STRAND      262    272       {ECO:0000244|PDB:2YD9}.
FT   STRAND      275    280       {ECO:0000244|PDB:2YD9}.
FT   STRAND      288    290       {ECO:0000244|PDB:2YD9}.
FT   STRAND      293    300       {ECO:0000244|PDB:2YD9}.
FT   STRAND      307    315       {ECO:0000244|PDB:2YD9}.
FT   STRAND      318    327       {ECO:0000244|PDB:2YD9}.
FT   STRAND      339    343       {ECO:0000244|PDB:4PBX}.
FT   STRAND      348    351       {ECO:0000244|PDB:4PBX}.
FT   STRAND      361    370       {ECO:0000244|PDB:4PBX}.
FT   STRAND      377    382       {ECO:0000244|PDB:4PBX}.
FT   STRAND      384    389       {ECO:0000244|PDB:4PBX}.
FT   STRAND      397    405       {ECO:0000244|PDB:4PBX}.
FT   STRAND      410    413       {ECO:0000244|PDB:4PBX}.
FT   STRAND      417    420       {ECO:0000244|PDB:4PBX}.
FT   STRAND      431    441       {ECO:0000244|PDB:4PBX}.
FT   STRAND      443    448       {ECO:0000244|PDB:4PBX}.
FT   STRAND      457    466       {ECO:0000244|PDB:4PBX}.
FT   HELIX       472    474       {ECO:0000244|PDB:4PBX}.
FT   STRAND      475    479       {ECO:0000244|PDB:4PBX}.
FT   STRAND      482    488       {ECO:0000244|PDB:4PBX}.
FT   STRAND      496    507       {ECO:0000244|PDB:4PBX}.
FT   STRAND      516    524       {ECO:0000244|PDB:4PBX}.
FT   STRAND      529    537       {ECO:0000244|PDB:4PBX}.
FT   STRAND      540    546       {ECO:0000244|PDB:4PBX}.
FT   STRAND      554    562       {ECO:0000244|PDB:4PBX}.
FT   TURN        563    565       {ECO:0000244|PDB:4PBX}.
FT   STRAND      569    573       {ECO:0000244|PDB:4PBX}.
FT   STRAND      577    581       {ECO:0000244|PDB:4PBX}.
FT   STRAND      589    598       {ECO:0000244|PDB:4PBX}.
FT   STRAND      601    605       {ECO:0000244|PDB:4PBX}.
FT   STRAND      609    612       {ECO:0000244|PDB:4PBX}.
FT   HELIX      1375   1377       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1378   1398       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1409   1412       {ECO:0000244|PDB:2FH7}.
FT   TURN       1414   1416       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1417   1419       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1429   1431       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1432   1434       {ECO:0000244|PDB:2FH7}.
FT   TURN       1442   1445       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1446   1454       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1457   1464       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1469   1471       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1472   1481       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1486   1489       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1493   1495       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1507   1513       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1516   1525       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1527   1538       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1545   1552       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1557   1560       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1562   1564       {ECO:0000244|PDB:4BPC}.
FT   HELIX      1565   1577       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1585   1594       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1595   1612       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1617   1625       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1635   1650       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1658   1660       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1661   1668       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1676   1678       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1679   1685       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1698   1701       {ECO:0000244|PDB:2FH7}.
FT   TURN       1703   1705       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1706   1708       {ECO:0000244|PDB:2FH7}.
FT   TURN       1718   1720       {ECO:0000244|PDB:2FH7}.
FT   TURN       1728   1730       {ECO:0000244|PDB:2FH7}.
FT   TURN       1731   1734       {ECO:0000244|PDB:4BPC}.
FT   STRAND     1737   1741       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1744   1746       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1750   1753       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1758   1760       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1761   1770       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1775   1778       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1782   1784       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1796   1798       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1800   1802       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1805   1814       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1816   1827       {ECO:0000244|PDB:2FH7}.
FT   TURN       1828   1830       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1833   1841       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1846   1848       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1854   1869       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1876   1884       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1885   1903       {ECO:0000244|PDB:2FH7}.
FT   STRAND     1904   1906       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1908   1915       {ECO:0000244|PDB:2FH7}.
FT   TURN       1916   1918       {ECO:0000244|PDB:2FH7}.
FT   HELIX      1926   1941       {ECO:0000244|PDB:2FH7}.
SQ   SEQUENCE   1948 AA;  217041 MW;  E8BFA76CA410C457 CRC64;
     MAPTWGPGMV SVVGPMGLLV VLLVGGCAAE EPPRFIKEPK DQIGVSGGVA SFVCQATGDP
     KPRVTWNKKG KKVNSQRFET IEFDESAGAV LRIQPLRTPR DENVYECVAQ NSVGEITVHA
     KLTVLREDQL PSGFPNIDMG PQLKVVERTR TATMLCAASG NPDPEITWFK DFLPVDPSAS
     NGRIKQLRSE TFESTPIRGA LQIESSEETD QGKYECVATN SAGVRYSSPA NLYVRELREV
     RRVAPRFSIL PMSHEIMPGG NVNITCVAVG SPMPYVKWMQ GAEDLTPEDD MPVGRNVLEL
     TDVKDSANYT CVAMSSLGVI EAVAQITVKS LPKAPGTPMV TENTATSITI TWDSGNPDPV
     SYYVIEYKSK SQDGPYQIKE DITTTRYSIG GLSPNSEYEI WVSAVNSIGQ GPPSESVVTR
     TGEQAPASAP RNVQARMLSA TTMIVQWEEP VEPNGLIRGY RVYYTMEPEH PVGNWQKHNV
     DDSLLTTVGS LLEDETYTVR VLAFTSVGDG PLSDPIQVKT QQGVPGQPMN LRAEARSETS
     ITLSWSPPRQ ESIIKYELLF REGDHGREVG RTFDPTTSYV VEDLKPNTEY AFRLAARSPQ
     GLGAFTPVVR QRTLQSKPSA PPQDVKCVSV RSTAILVSWR PPPPETHNGA LVGYSVRYRP
     LGSEDPEPKE VNGIPPTTTQ ILLEALEKWT QYRITTVAHT EVGPGPESSP VVVRTDEDVP
     SAPPRKVEAE ALNATAIRVL WRSPAPGRQH GQIRGYQVHY VRMEGAEARG PPRIKDVMLA
     DAQWETDDTA EYEMVITNLQ PETAYSITVA AYTMKGDGAR SKPKVVVTKG AVLGRPTLSV
     QQTPEGSLLA RWEPPAGTAE DQVLGYRLQF GREDSTPLAT LEFPPSEDRY TASGVHKGAT
     YVFRLAARSR GGLGEEAAEV LSIPEDTPRG HPQILEAAGN ASAGTVLLRW LPPVPAERNG
     AIVKYTVAVR EAGALGPARE TELPAAAEPG AENALTLQGL KPDTAYDLQV RAHTRRGPGP
     FSPPVRYRTF LRDQVSPKNF KVKMIMKTSV LLSWEFPDNY NSPTPYKIQY NGLTLDVDGR
     TTKKLITHLK PHTFYNFVLT NRGSSLGGLQ QTVTAWTAFN LLNGKPSVAP KPDADGFIMV
     YLPDGQSPVP VQSYFIVMVP LRKSRGGQFL TPLGSPEDMD LEELIQDISR LQRRSLRHSR
     QLEVPRPYIA ARFSVLPPTF HPGDQKQYGG FDNRGLEPGH RYVLFVLAVL QKSEPTFAAS
     PFSDPFQLDN PDPQPIVDGE EGLIWVIGPV LAVVFIICIV IAILLYKNKP DSKRKDSEPR
     TKCLLNNADL APHHPKDPVE MRRINFQTPD SGLRSPLREP GFHFESMLSH PPIPIADMAE
     HTERLKANDS LKLSQEYESI DPGQQFTWEH SNLEVNKPKN RYANVIAYDH SRVILQPIEG
     IMGSDYINAN YVDGYRCQNA YIATQGPLPE TFGDFWRMVW EQRSATIVMM TRLEEKSRIK
     CDQYWPNRGT ETYGFIQVTL LDTIELATFC VRTFSLHKNG SSEKREVRQF QFTAWPDHGV
     PEYPTPFLAF LRRVKTCNPP DAGPIVVHCS AGVGRTGCFI VIDAMLERIK PEKTVDVYGH
     VTLMRSQRNY MVQTEDQYSF IHEALLEAVG CGNTEVPARS LYAYIQKLAQ VEPGEHVTGM
     ELEFKRLANS KAHTSRFISA NLPCNKFKNR LVNIMPYEST RVCLQPIRGV EGSDYINASF
     IDGYRQQKAY IATQGPLAET TEDFWRMLWE NNSTIVVMLT KLREMGREKC HQYWPAERSA
     RYQYFVVDPM AEYNMPQYIL REFKVTDARD GQSRTVRQFQ FTDWPEQGVP KSGEGFIDFI
     GQVHKTKEQF GQDGPISVHC SAGVGRTGVF ITLSIVLERM RYEGVVDIFQ TVKMLRTQRP
     AMVQTEDEYQ FCYQAALEYL GSFDHYAT
//
ID   MATN3_CHICK             Reviewed;         452 AA.
AC   O42401;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   07-JUN-2017, entry version 112.
DE   RecName: Full=Matrilin-3;
DE   Flags: Precursor;
GN   Name=MATN3;
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes;
OC   Phasianidae; Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cartilage;
RX   PubMed=9350998; DOI=10.1016/S0014-5793(97)01126-5;
RA   Belluoccio D., Trueb B.;
RT   "Matrilin-3 from chicken cartilage.";
RL   FEBS Lett. 415:212-216(1997).
CC   -!- FUNCTION: Major component of the extracellular matrix of cartilage
CC       and may play a role in the formation of extracellular filamentous
CC       networks.
CC   -!- SUBUNIT: Can form homooligomers (monomers, dimers, trimers and
CC       tetramers) and heterooligomers with matrilin-1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expression is restricted to cartilaginous
CC       tissues.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000055; CAA03885.1; -; mRNA.
DR   RefSeq; NP_990403.1; NM_205072.1.
DR   UniGene; Gga.3587; -.
DR   ProteinModelPortal; O42401; -.
DR   SMR; O42401; -.
DR   STRING; 9031.ENSGALP00000026536; -.
DR   PaxDb; O42401; -.
DR   Ensembl; ENSGALT00000036867; ENSGALP00000036079; ENSGALG00000016478.
DR   GeneID; 395954; -.
DR   KEGG; gga:395954; -.
DR   CTD; 4148; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00760000119000; -.
DR   HOGENOM; HOG000263415; -.
DR   HOVERGEN; HBG056906; -.
DR   InParanoid; O42401; -.
DR   KO; K19467; -.
DR   OMA; RFQETFC; -.
DR   OrthoDB; EOG091G04O4; -.
DR   PhylomeDB; O42401; -.
DR   Reactome; R-GGA-3000178; ECM proteoglycans.
DR   Reactome; R-GGA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-GGA-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:O42401; -.
DR   Proteomes; UP000000539; Chromosome 3.
DR   Bgee; ENSGALG00000016478; -.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR030765; Matrilin_3.
DR   InterPro; IPR019466; Matrilin_coiled-coil_trimer.
DR   InterPro; IPR002035; VWF_A.
DR   PANTHER; PTHR11132:SF154; PTHR11132:SF154; 1.
DR   Pfam; PF07645; EGF_CA; 3.
DR   Pfam; PF10393; Matrilin_ccoil; 1.
DR   Pfam; PF00092; VWA; 1.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00179; EGF_CA; 4.
DR   SMART; SM01279; Matrilin_ccoil; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF58002; SSF58002; 1.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50234; VWFA; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil; Complete proteome; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    452       Matrilin-3.
FT                                /FTId=PRO_0000007659.
FT   DOMAIN       54    229       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      235    275       EGF-like 1.
FT   DOMAIN      276    316       EGF-like 2.
FT   DOMAIN      317    357       EGF-like 3.
FT   DOMAIN      358    398       EGF-like 4.
FT   COILED      419    451       {ECO:0000255}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    239    250       {ECO:0000250}.
FT   DISULFID    246    259       {ECO:0000250}.
FT   DISULFID    261    274       {ECO:0000250}.
FT   DISULFID    280    291       {ECO:0000250}.
FT   DISULFID    287    300       {ECO:0000250}.
FT   DISULFID    302    315       {ECO:0000250}.
FT   DISULFID    321    332       {ECO:0000250}.
FT   DISULFID    328    341       {ECO:0000250}.
FT   DISULFID    343    356       {ECO:0000250}.
FT   DISULFID    362    373       {ECO:0000250}.
FT   DISULFID    369    382       {ECO:0000250}.
FT   DISULFID    384    397       {ECO:0000250}.
SQ   SEQUENCE   452 AA;  49622 MW;  2D65324CEAED4CFB CRC64;
     MRRALGTLGC CLALLLPLLP AARGVPHRHR RQPLGSGLGR HGAADTACKN RPLDLVFIID
     SSRSVRPEEF EKVKIFLSKM IDTLDVGERT TRVAVMNYAS TVKVEFPLRT YFDKASMKEA
     VSRIQPLSAG TMTGLAIQAA MDEVFTEEMG TRPANFNIPK VVIIVTDGRP QDQVENVAAN
     ARTAGIEIYA VGVGRADMQS LRIMASEPLD EHVFYVETYG VIEKLTSKFR ETFCAANTCA
     LGTHDCEQVC VSNDGSYLCD CYEGYTLNPD KRTCSAVDVC APGRHECDQI CVSNNGSYVC
     ECFEGYTLNP DKKTCSAMDV CAPGRHDCAQ VCRRNGGSYS CDCFEGFTLN PDKKTCSAVD
     VCAPGRHDCE QVCVRDDLFY TCDCYQGYVL NPDKKTCSRA TTSSLVTDEE ACKCEAIAAL
     QDSVTSRLEA LSTKLDEVSQ KLQAYQDRQQ VV
//
ID   VWA7_MOUSE              Reviewed;         891 AA.
AC   Q9JHA8; Q9Z1Q8;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   07-JUN-2017, entry version 94.
DE   RecName: Full=von Willebrand factor A domain-containing protein 7;
DE   AltName: Full=Protein G7c;
DE   Flags: Precursor;
GN   Name=Vwa7; Synonyms=D17h6s56e-3, G7c;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=10803853; DOI=10.1007/s002510050634;
RA   Snoek M., Albertella M.R., van Kooij M., Wixon J., van Vugt H.,
RA   de Groot K., Campbell R.D.;
RT   "G7c, a novel gene in the mouse and human major histocompatibility
RT   complex class III region, possibly controlling lung tumor
RT   susceptibility.";
RL   Immunogenetics 51:383-386(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=B10.A;
RX   PubMed=11797099; DOI=10.1007/s00251-001-0381-0;
RA   van Kooij M., de Groot K., van Vugt H., Aten J., Snoek M.;
RT   "Genotype versus phenotype: conflicting results in mapping a lung
RT   tumor susceptibility locus to the G7c recombination interval in the
RT   mouse MHC class III region.";
RL   Immunogenetics 53:656-661(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=129;
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed at low level in many tissues.
CC       {ECO:0000269|PubMed:10803853}.
CC   -!- MISCELLANEOUS: Recombinatorial hotspot within the class III
CC       region.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC84152.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF134319; AAF61401.1; -; mRNA.
DR   EMBL; AF134318; AAF69177.1; -; Genomic_DNA.
DR   EMBL; AF397035; AAL14453.1; -; Genomic_DNA.
DR   EMBL; AF397036; AAL14461.1; -; Genomic_DNA.
DR   EMBL; AF109905; AAC84152.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS28672.1; -.
DR   RefSeq; NP_613048.1; NM_138582.1.
DR   RefSeq; XP_017172986.1; XM_017317497.1.
DR   UniGene; Mm.390966; -.
DR   UniGene; Mm.56895; -.
DR   ProteinModelPortal; Q9JHA8; -.
DR   STRING; 10090.ENSMUSP00000007245; -.
DR   iPTMnet; Q9JHA8; -.
DR   PhosphoSitePlus; Q9JHA8; -.
DR   PaxDb; Q9JHA8; -.
DR   PRIDE; Q9JHA8; -.
DR   Ensembl; ENSMUST00000007245; ENSMUSP00000007245; ENSMUSG00000007030.
DR   GeneID; 27762; -.
DR   UCSC; uc008cfa.1; mouse.
DR   CTD; 80737; -.
DR   MGI; MGI:1306798; Vwa7.
DR   eggNOG; KOG4475; Eukaryota.
DR   eggNOG; ENOG410ZN3C; LUCA.
DR   GeneTree; ENSGT00390000011517; -.
DR   HOGENOM; HOG000043087; -.
DR   HOVERGEN; HBG080564; -.
DR   InParanoid; Q9JHA8; -.
DR   OMA; WEIQVTA; -.
DR   OrthoDB; EOG091G13UP; -.
DR   PhylomeDB; Q9JHA8; -.
DR   TreeFam; TF329905; -.
DR   PRO; PR:Q9JHA8; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   Bgee; ENSMUSG00000007030; -.
DR   CleanEx; MM_D17H6S56E-3; -.
DR   ExpressionAtlas; Q9JHA8; baseline and differential.
DR   Genevisible; Q9JHA8; MM.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR002035; VWF_A.
DR   SUPFAM; SSF53300; SSF53300; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Glycoprotein; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    891       von Willebrand factor A domain-containing
FT                                protein 7.
FT                                /FTId=PRO_0000231632.
FT   DOMAIN      314    499       VWFA.
FT   COMPBIAS    455    458       Poly-Arg.
FT   COMPBIAS    705    710       Poly-Gly.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   891 AA;  95984 MW;  1EA26B5121118720 CRC64;
     MLPVEVPLSH LGPPILLLLQ LLLPPTSAFF PNIWSLLAAP GSVTHQDLTE EAALNVTLVL
     FLEQPHPGRP RLHVEDYRGR TLLADDIFAA YFGPGFSSRR FRAALGEVSR ANAAQDFLPA
     FKSNPDLHFD AERLVQGRTR LVGALRETLV AARALEYTLA RQRLGAALHA LQDFYSHSNW
     VELGERQPHP HLLWPRQELW SLAQVGDPTC SDCEGLSCPG NMLDSTLLTS GYFGMHPPKP
     PGKCSHGGHF DQSSSQPPRG GINKDSTSPS FSPHHKLHLQ AAEVALLASI EAFSLLRSRL
     GDKAFSRLLD ITPASSLSFV LDTTGSMGEE INAAKIQARR IVEQRQGSPM EPVFYILVPF
     HDPGFGPVFT TSDPDSFWQK LNEIHALGGG DEPEMCLSAL ELALLHTPPL SDIFVFTDAS
     PKDALLTNRV ESLTRERRCR VTFLVTEDPS RTGGRRRREA LSPLRFEPYE AIARASGGEV
     IFTKDQYIQD VAAIVGESMA GLVTLPLDPP VFTPGEPCVF SVDSLLWQVT VRMHGDISSF
     WIKSPAGVSQ GPEEGIGPLG HTRRFGQFWT VTMTDPPRTG TWEIQVAAAG TPRVRVQAQT
     SLDFLFHFGI SVEDGPHPGL YPLTQPVAGL QTQLLVEVTG LTSRQKLVGG QPQFSHVVLR
     RVPEGTQLGR VSLEPVGPPV RGLLAASLPP TLLSVSSPFS LELVGQGGGG ESLRRTAPQP
     CSVAPVLLEL SGPPDFLTPG SKAPLSLHIV SFSGPQDLDL RTSVNPSFSL TSNLSRARLG
     LNESAWGRLW LEVPDSAAPD SVVMVTVTAA GQGASQVPPT HAFLRLLVLA QSSKDQLDGP
     AHSAAPVLPP VSPALLPSTL VTQGRAGGGM AGKAWWGTVG GVLFLLGCTS W
//
ID   CO6A6_HUMAN             Reviewed;        2263 AA.
AC   A6NMZ7; A7DZQ0; A7DZQ1; A7DZQ2; Q69YT0;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   20-MAY-2008, sequence version 2.
DT   10-MAY-2017, entry version 90.
DE   RecName: Full=Collagen alpha-6(VI) chain;
DE   Flags: Precursor;
GN   Name=COL6A6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=18276594; DOI=10.1074/jbc.M709540200;
RA   Gara S.K., Grumati P., Urciuolo A., Bonaldo P., Kobbe B., Koch M.,
RA   Paulsson M., Wagener R.;
RT   "Three novel collagen VI chains with high homology to the alpha 3
RT   chain.";
RL   J. Biol. Chem. 283:10658-10670(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1364-2263 (ISOFORM 2).
RC   TISSUE=Lymph node;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-198; ASN-275; ASN-288;
RP   ASN-298; ASN-930; ASN-988 AND ASN-1290.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Collagen VI acts as a cell-binding protein.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Trimers composed of three different chains: alpha-1(VI),
CC       alpha-2(VI), and alpha-3(VI) or alpha-5(VI) or alpha-6(VI).
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}. Note=Deposed in the extracellular matrix of
CC       skeletal muscle. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A6NMZ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A6NMZ7-2; Sequence=VSP_033914, VSP_033915;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Prolines at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the type VI collagen family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AM774225; CAO81741.1; -; mRNA.
DR   EMBL; AM774226; CAO81739.1; -; mRNA.
DR   EMBL; AM774227; CAO81740.1; -; mRNA.
DR   EMBL; AC093006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC128683; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL713792; CAH10639.2; -; mRNA.
DR   CCDS; CCDS46911.1; -. [A6NMZ7-1]
DR   RefSeq; NP_001096078.1; NM_001102608.1. [A6NMZ7-1]
DR   RefSeq; XP_005247178.1; XM_005247121.4. [A6NMZ7-1]
DR   RefSeq; XP_011510727.1; XM_011512425.2. [A6NMZ7-1]
DR   RefSeq; XP_011510728.1; XM_011512426.2. [A6NMZ7-1]
DR   RefSeq; XP_011510730.1; XM_011512428.2. [A6NMZ7-1]
DR   RefSeq; XP_016861200.1; XM_017005711.1. [A6NMZ7-1]
DR   RefSeq; XP_016861201.1; XM_017005712.1. [A6NMZ7-1]
DR   RefSeq; XP_016861202.1; XM_017005713.1. [A6NMZ7-1]
DR   RefSeq; XP_016861203.1; XM_017005714.1. [A6NMZ7-1]
DR   RefSeq; XP_016861204.1; XM_017005715.1. [A6NMZ7-1]
DR   UniGene; Hs.591282; -.
DR   UniGene; Hs.596805; -.
DR   ProteinModelPortal; A6NMZ7; -.
DR   SMR; A6NMZ7; -.
DR   STRING; 9606.ENSP00000351310; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   iPTMnet; A6NMZ7; -.
DR   PhosphoSitePlus; A6NMZ7; -.
DR   BioMuta; COL6A6; -.
DR   EPD; A6NMZ7; -.
DR   MaxQB; A6NMZ7; -.
DR   PaxDb; A6NMZ7; -.
DR   PRIDE; A6NMZ7; -.
DR   Ensembl; ENST00000358511; ENSP00000351310; ENSG00000206384. [A6NMZ7-1]
DR   GeneID; 131873; -.
DR   KEGG; hsa:131873; -.
DR   UCSC; uc010htl.4; human. [A6NMZ7-1]
DR   CTD; 131873; -.
DR   GeneCards; COL6A6; -.
DR   H-InvDB; HIX0003677; -.
DR   HGNC; HGNC:27023; COL6A6.
DR   HPA; HPA045239; -.
DR   MIM; 616613; gene.
DR   neXtProt; NX_A6NMZ7; -.
DR   OpenTargets; ENSG00000206384; -.
DR   PharmGKB; PA165697087; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410Y0KT; LUCA.
DR   GeneTree; ENSGT00760000119000; -.
DR   HOGENOM; HOG000111864; -.
DR   HOVERGEN; HBG107743; -.
DR   InParanoid; A6NMZ7; -.
DR   KO; K06238; -.
DR   OMA; FQVTNAM; -.
DR   OrthoDB; EOG091G006Y; -.
DR   PhylomeDB; A6NMZ7; -.
DR   TreeFam; TF318242; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   ChiTaRS; COL6A6; human.
DR   GenomeRNAi; 131873; -.
DR   PRO; PR:A6NMZ7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000206384; -.
DR   ExpressionAtlas; A6NMZ7; baseline and differential.
DR   Genevisible; A6NMZ7; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IDA:MGI.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0030574; P:collagen catabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.410; -; 9.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR002035; VWF_A.
DR   Pfam; PF01391; Collagen; 1.
DR   Pfam; PF00092; VWA; 8.
DR   SMART; SM00327; VWA; 9.
DR   SUPFAM; SSF53300; SSF53300; 9.
DR   PROSITE; PS50234; VWFA; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Collagen; Complete proteome;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20   2263       Collagen alpha-6(VI) chain.
FT                                /FTId=PRO_5000266306.
FT   DOMAIN       27    206       VWFA 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      229    411       VWFA 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      436    606       VWFA 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      622    791       VWFA 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      809    982       VWFA 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN     1000   1171       VWFA 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN     1187   1371       VWFA 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN     1757   1937       VWFA 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN     1965   2166       VWFA 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   REGION       20   1391       Nonhelical region.
FT   REGION     1392   1725       Triple-helical region.
FT   REGION     1726   2263       Nonhelical region.
FT   MOTIF      1508   1510       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    288    288       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    298    298       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    347    347       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    520    520       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    930    930       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    988    988       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1290   1290       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ    1512   1520       GAPGVDSSI -> VSARAANWS (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_033914.
FT   VAR_SEQ    1521   2263       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_033915.
FT   VARIANT     345    345       E -> K (in dbSNP:rs4613427).
FT                                /FTId=VAR_043609.
FT   VARIANT     370    370       A -> T (in dbSNP:rs9830253).
FT                                /FTId=VAR_043610.
FT   VARIANT     461    461       E -> A (in dbSNP:rs11921769).
FT                                /FTId=VAR_043611.
FT   VARIANT     556    556       P -> S (in dbSNP:rs59021909).
FT                                /FTId=VAR_061120.
FT   VARIANT    1739   1739       R -> Q (in dbSNP:rs16830494).
FT                                /FTId=VAR_043612.
FT   VARIANT    1799   1799       H -> R (in dbSNP:rs7614116).
FT                                /FTId=VAR_043613.
FT   CONFLICT   1429   1429       A -> V (in Ref. 3; CAH10639).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2263 AA;  247173 MW;  EED4F30ABAED7F30 CRC64;
     MMLLILFLVI ICSHISVNQD SGPEYADVVF LVDSSDRLGS KSFPFVKMFI TKMISSLPIE
     ADKYRVALAQ YSDKLHSEFH LSTFKGRSPM LNHLRKNFGF IGGSLQIGKA LQEAHRTYFS
     APANGRDKKQ FPPILVVLAS SESEDNVEEA SKALRKDGVK IISVGVQKAS EENLKAMATS
     QFHFNLRTVR DLSMFSQNMT HIIKDVIKYK EGAVDDIFVE ACQGPSMADV VFLLDMSING
     SEENFDYLKG FLEESVSALD IKENCMRVGL VAYSNETKVI NSLSMGINKS EVLQHIQNLS
     PRTGKAYTGA AIKKLRKEVF SARNGSRKNQ GVPQIAVLVT HRDSEDNVTK AAVNLRREGV
     TIFTLGIEGA SDTQLEKIAS HPAEQYVSKL KTFADLAAHN QTFLKKLRNQ ITHTVSVFSE
     RTETLKSGCV DTEEADIYLL IDGSGSTQAT DFHEMKTFLS EVVGMFNIAP HKVRVGAVQY
     ADSWDLEFEI NKYSNKQDLG KAIENIRQMG GNTNTGAALN FTLSLLQKAK KQRGNKVPCH
     LVVLTNGMSK DSILEPANRL REEHIRVYAI GIKEANQTQL REIAGEEKRV YYVHDFDALK
     DIRNQVVQEI CTEEACKEMK ADIMFLVDSS GSIGPENFSK MKTFMKNLVS KSQIGPDRVQ
     IGVVQFSDIN KEEFQLNRFM SQSDISNAID QMAHIGQTTL TGSALSFVSQ YFSPTKGARP
     NIRKFLILIT DGEAQDIVKE PAVVLRQEGV IIYSVGVFGS NVTQLEEISG RPEMVFYVEN
     FDILQRIEDD LVFGICSPRE ECKRIEVLDV VFVIDSSGSI DYDEYNIMKD FMIGLVKKAD
     VGKNQVRFGA LKYADDPEVL FYLDDFGTKL EVISVLQNDQ AMGGSTYTAE ALGFSDHMFT
     EARGSRLNKG VPQVLIVITD GESHDADKLN ATAKALRDKG ILVLAVGIDG ANPVELLAMA
     GSSDKYFFVE TFGGLKGIFS DVTASVCNSS KVDCEIDKVD LVFLMDGSTS IQPNDFKKMK
     EFLASVVQDF DVSLNRVRIG AAQFSDTYHP EFPLGTFIGE KEISFQIENI KQIFGNTHIG
     AALREVEHYF RPDMGSRINT GTPQVLLVLT DGQSQDEVAQ AAEALRHRGI DIYSVGIGDV
     DDQQLIQITG TAEKKLTVHN FDELKKVNKR IVRNICTTAG ESNCFVDVVV GFDVSTQEKG
     QTLLEGQPWM ETYLQDILRA ISSLNGVSCE VGTETQVSVA FQVTNAMEKY SPKFEIYSEN
     ILNSLKDITV KGPSLLNANL LDSLWDTFQN KSAARGKVVL LFSDGLDDDV EKLEQKSDEL
     RKEGLNALIT VALDGPADSS DLADLPYIEF GKGFEYRTQL SIGMRELGSR LSKQLVNVAE
     RTCCCLFCKC IGGDGTMGDP GPPGKRGPPG FKGSEGYLGE EGIAGERGAP GPVGEQGTKG
     CYGTKGPKGN RGLNGQEGEV GENGIDGLNG EQGDNGLPGR KGEKGDEGSQ GSPGKRGTPG
     DRGAKGLRGD PGAPGVDSSI EGPTGLKGER GRQGRRGWPG PPGTPGSRRK TAAHGRRGHT
     GPQGTAGIPG PDGLEGSLGL KGPQGPRGEA GVKGEKGGVG SKGPQGPPGP GGEAGNQGRL
     GSQGNKGEPG DLGEKGAVGF PGPRGLQGND GSPGYGSVGR KGAKGQEGFP GESGPKGEIG
     DPGGPGETGL KGARGKMISA GLPGEMGSPG EPGPPGRKGV KGAKGLASFS TCELIQYVRD
     RSPGRHGKPE CPVHPTELVF ALDHSRDVTE QEFERMKEMM AFLVRDIKVR ENSCPVGAHI
     AILSYNSHAR HLVRFSDAYK KSQLLREIET IPYERSSASR EIGRAMRFIS RNVFKRTLPG
     AHTRKIATFF SSGQSADAHS ITTAAMEFGA LEIIPVVITF SNVPSVRRAF AIDDTGTFQV
     IVVPSGADYI PALERLQRCT FCYDVCKPDA SCDQARPPPV QSYMDAAFLL DASRNMGSAE
     FEDIRAFLGA LLDHFEITPE PETSVTGDRV ALLSHAPPDF LPNTQKSPVR AEFNLTTYRS
     KRLMKRHVHE SVKQLNGDAF IGHALQWTLD NVFLSTPNLR RNKVIFVISA GETSHLDGEI
     LKKESLRAKC QGYALFVFSL GPIWDDKELE DLASHPLDHH LVQLGRIHKP DHSYGVKFVK
     SFINSIRRAI NKYPPINLKI KCNRLNSIDP KQPPRPFRSF VPGPLKATLK EDVLQKAKFF
     QDKKYLSRVA RSGRDDAIQN FMRSTSHTFK NGRMIESAPK QHD
//
ID   COMA1_HUMAN             Reviewed;        1626 AA.
AC   Q8NFW1; B7ZMH0; C9K0G4; Q8IVT9;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   07-JUN-2017, entry version 126.
DE   RecName: Full=Collagen alpha-1(XXII) chain;
DE   Flags: Precursor;
GN   Name=COL22A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT GLY-320.
RC   TISSUE=Cartilage;
RX   PubMed=15016833; DOI=10.1074/jbc.M400536200;
RA   Koch M., Schulze J., Hansen U., Ashwodt T., Keene D.R., Brunken W.J.,
RA   Burgeson R.E., Bruckner P., Bruckner-Tuderman L.;
RT   "A novel marker of tissue junctions, collagen XXII.";
RL   J. Biol. Chem. 279:22514-22521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 753-1626 (ISOFORMS 2/3), AND VARIANTS
RP   GLY-320 AND ASP-938.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Acts as a cell adhesion ligand for skin epithelial cells
CC       and fibroblasts.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix. Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NFW1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NFW1-2; Sequence=VSP_031087;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8NFW1-3; Sequence=VSP_038200, VSP_031087;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Restrictive expression is observed at tissue
CC       junctions such as the myotendinous junction in skeletal and heart
CC       muscle, the articular cartilage-synovial fluid junction, or the
CC       border between the anagen hair follicle and the dermis in the
CC       skin. It is deposited in the basement membrane zone of the
CC       myotendinous junction and the hair follicle and associated with
CC       the extrafibrillar matrix in cartilage.
CC       {ECO:0000269|PubMed:15016833}.
CC   -!- SIMILARITY: Belongs to the fibril-associated collagens with
CC       interrupted helices (FACIT) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF406780; AAN03620.1; -; mRNA.
DR   EMBL; AC068476; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105130; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC115720; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP006262; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC042075; AAH42075.1; -; mRNA.
DR   EMBL; BC144535; AAI44536.1; -; mRNA.
DR   CCDS; CCDS6376.1; -. [Q8NFW1-1]
DR   RefSeq; NP_690848.1; NM_152888.2. [Q8NFW1-1]
DR   RefSeq; XP_011515185.1; XM_011516883.2. [Q8NFW1-2]
DR   UniGene; Hs.117169; -.
DR   ProteinModelPortal; Q8NFW1; -.
DR   SMR; Q8NFW1; -.
DR   STRING; 9606.ENSP00000303153; -.
DR   iPTMnet; Q8NFW1; -.
DR   PhosphoSitePlus; Q8NFW1; -.
DR   BioMuta; COL22A1; -.
DR   DMDM; 296434458; -.
DR   PaxDb; Q8NFW1; -.
DR   PeptideAtlas; Q8NFW1; -.
DR   PRIDE; Q8NFW1; -.
DR   DNASU; 169044; -.
DR   Ensembl; ENST00000303045; ENSP00000303153; ENSG00000169436. [Q8NFW1-1]
DR   Ensembl; ENST00000435777; ENSP00000387655; ENSG00000169436. [Q8NFW1-3]
DR   GeneID; 169044; -.
DR   KEGG; hsa:169044; -.
DR   UCSC; uc003yvd.3; human. [Q8NFW1-1]
DR   CTD; 169044; -.
DR   DisGeNET; 169044; -.
DR   GeneCards; COL22A1; -.
DR   H-InvDB; HIX0034283; -.
DR   HGNC; HGNC:22989; COL22A1.
DR   HPA; HPA024830; -.
DR   MIM; 610026; gene.
DR   neXtProt; NX_Q8NFW1; -.
DR   OpenTargets; ENSG00000169436; -.
DR   PharmGKB; PA134914705; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00840000129701; -.
DR   HOGENOM; HOG000085653; -.
DR   HOVERGEN; HBG106599; -.
DR   InParanoid; Q8NFW1; -.
DR   KO; K16630; -.
DR   OMA; GCKNVHY; -.
DR   OrthoDB; EOG091G002N; -.
DR   PhylomeDB; Q8NFW1; -.
DR   TreeFam; TF332934; -.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   GenomeRNAi; 169044; -.
DR   PRO; PR:Q8NFW1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000169436; -.
DR   CleanEx; HS_COL22A1; -.
DR   ExpressionAtlas; Q8NFW1; baseline and differential.
DR   Genevisible; Q8NFW1; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR002035; VWF_A.
DR   Pfam; PF01391; Collagen; 13.
DR   Pfam; PF00092; VWA; 1.
DR   SMART; SM00210; TSPN; 1.
DR   SMART; SM00327; VWA; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   PROSITE; PS50234; VWFA; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Collagen; Complete proteome; Cytoplasm;
KW   Extracellular matrix; Glycoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL        1     27       {ECO:0000255}.
FT   CHAIN        28   1626       Collagen alpha-1(XXII) chain.
FT                                /FTId=PRO_0000317615.
FT   DOMAIN       38    213       VWFA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00219}.
FT   DOMAIN      239    427       Laminin G-like.
FT   DOMAIN      481    520       Collagen-like 1.
FT   DOMAIN      526    565       Collagen-like 2.
FT   DOMAIN      566    625       Collagen-like 3.
FT   DOMAIN      657    708       Collagen-like 4.
FT   DOMAIN      714    773       Collagen-like 5.
FT   DOMAIN      774    833       Collagen-like 6.
FT   DOMAIN      868    922       Collagen-like 7.
FT   DOMAIN      925    984       Collagen-like 8.
FT   DOMAIN     1047   1095       Collagen-like 9.
FT   DOMAIN     1118   1155       Collagen-like 10.
FT   DOMAIN     1156   1215       Collagen-like 11.
FT   DOMAIN     1249   1308       Collagen-like 12.
FT   DOMAIN     1315   1374       Collagen-like 13.
FT   DOMAIN     1387   1446       Collagen-like 14.
FT   DOMAIN     1495   1550       Collagen-like 15.
FT   DOMAIN     1575   1604       Collagen-like 16.
FT   COMPBIAS    161    165       Poly-Ala.
FT   COMPBIAS    451   1607       Pro-rich.
FT   COMPBIAS    481   1603       Gly-rich.
FT   CARBOHYD    375    375       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     341    627       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038200.
FT   VAR_SEQ    1005   1024       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031087.
FT   VARIANT     320    320       S -> G (in dbSNP:rs2292927).
FT                                {ECO:0000269|PubMed:15016833,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038562.
FT   VARIANT     703    703       P -> T (in dbSNP:rs10111520).
FT                                /FTId=VAR_038563.
FT   VARIANT     938    938       A -> D (in dbSNP:rs4909444).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038564.
FT   CONFLICT    753    767       GKDGPNGPPGPPGTK -> CILAAKTAPGLKQLN (in
FT                                Ref. 2; AAH42075). {ECO:0000305}.
SQ   SEQUENCE   1626 AA;  161145 MW;  91018ABA2DD670EC CRC64;
     MAGLRGNAVA GLLWMLLLWS GGGGCQAQRA GCKSVHYDLV FLLDTSSSVG KEDFEKVRQW
     VANLVDTFEV GPDRTRVGVV RYSDRPTTAF ELGLFGSQEE VKAAARRLAY HGGNTNTGDA
     LRYITARSFS PHAGGRPRDR AYKQVAILLT DGRSQDLVLD AAAAAHRAGI RIFAVGVGEA
     LKEELEEIAS EPKSAHVFHV SDFNAIDKIR GKLRRRLCEN VLCPSVRVEG DRFKHTNGGT
     KEITGFDLMD LFSVKEILGK RENGAQSSYV RMGSFPVVQS TEDVFPQGLP DEYAFVTTFR
     FRKTSRKEDW YIWQVIDQYS IPQVSIRLDG ENKAVEYNAV GAMKDAVRVV FRGSRVNDLF
     DRDWHKMALS IQAQNVSLHI DCALVQTLPI EERENIDIQG KTVIGKRLYD SVPIDFDLQR
     IVIYCDSRHA ELETCCDIPS GPCQVTVVTE PPPPPPPQRP PTPGSEQIGF LKTINCSCPA
     GEKGEMGVAG PMGLPGPKGD IGAIGPVGAP GPKGEKGDVG IGPFGQGEKG EKGSLGLPGP
     PGRDGSKGMR GEPGELGEPG LPGEVGMRGP QGPPGLPGPP GRVGAPGLQG ERGEKGTRGE
     KGERGLDGFP GKPGDTGQQG RPGPSGVAGP QGEKGDVGPA GPPGVPGSVV QQEGLKGEQG
     APGPRGHQGA PGPPGARGPI GPEGRDGPPG LQGLRGKKGD MGPPGIPGLL GLQGPPGPPG
     VPGPPGPGGS PGLPGEIGFP GKPGPPGPTG PPGKDGPNGP PGPPGTKGEP GERGEDGLPG
     KPGLRGEIGE QGLAGRPGEK GEAGLPGAPG FPGVRGEKGD QGEKGELGLP GLKGDRGEKG
     EAGPAGPPGL PGTTSLFTPH PRMPGEQGPK GEKGDPGLPG EPGLQGRPGE LGPQGPTGPP
     GAKGQEGAHG APGAAGNPGA PGHVGAPGPS GPPGSVGAPG LRGTPGKDGE RGEKGAAGEE
     GSPGPVGPRG DPGAPGLPGP PGKGKDGEPG LRGSPGLPGP LGTKAACGKV RGSENCALGG
     QCVKGDRGAP GIPGSPGSRG DPGIGVAGPP GPSGPPGDKG SPGSRGLPGF PGPQGPAGRD
     GAPGNPGERG PPGKPGLSSL LSPGDINLLA KDVCNDCPPG PPGLPGLPGF KGDKGVPGKP
     GREGTEGKKG EAGPPGLPGP PGIAGPQGSQ GERGADGEVG QKGDQGHPGV PGFMGPPGNP
     GPPGADGIAG AAGPPGIQGS PGKEGPPGPQ GPSGLPGIPG EEGKEGRDGK PGPPGEPGKA
     GEPGLPGPEG ARGPPGFKGH TGDSGAPGPR GESGAMGLPG QEGLPGKDGD TGPTGPQGPQ
     GPRGPPGKNG SPGSPGEPGP SGTPGQKGSK GENGSPGLPG FLGPRGPPGE PGEKGVPGKE
     GVPGKPGEPG FKGERGDPGI KGDKGPPGGK GQPGDPGIPG HKGHTGLMGP QGLPGENGPV
     GPPGPPGQPG FPGLRGESPS METLRRLIQE ELGKQLETRL AYLLAQMPPA YMKSSQGRPG
     PPGPPGKDGL PGRAGPMGEP GRPGQGGLEG PSGPIGPKGE RGAKGDPGAP GVGLRGEMGP
     PGIPGQPGEP GYAKDGLPGI PGPQGETGPA GHPGLPGPPG PPGQCDPSQC AYFASLAARP
     GNVKGP
//
ID   FCN1_PIG                Reviewed;         326 AA.
AC   Q29042;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 83.
DE   RecName: Full=Ficolin-1;
DE   AltName: Full=Ficolin-A;
DE   AltName: Full=Ficolin-alpha;
DE   Flags: Precursor;
GN   Name=FCN1;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Suina; Suidae;
OC   Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=7686157;
RA   Ichijo H., Hellman U., Wernstedt C., Gonez L.J., Claesson-Welsh L.,
RA   Heldin C.H., Miyazono K.;
RT   "Molecular cloning and characterization of ficolin, a multimeric
RT   protein with fibrinogen- and collagen-like domains.";
RL   J. Biol. Chem. 268:14505-14513(1993).
CC   -!- FUNCTION: Extracellular lectin functioning as a pattern-
CC       recognition receptor in innate immunity. Binds the sugar moieties
CC       of pathogen-associated molecular patterns (PAMPs) displayed on
CC       microbes and activates the lectin pathway of the complement
CC       system. May also activate monocytes through a G protein-coupled
CC       receptor, FFAR2, inducing the secretion of interleukin-8/IL-8.
CC       Binds preferentially to 9-O-acetylated 2-6-linked sialic acid
CC       derivatives and to various glycans containing sialic acid engaged
CC       in a 2-3 linkage (By similarity). {ECO:0000250|UniProtKB:O00602}.
CC   -!- SUBUNIT: Homotrimer. Interacts with elastin/ELN. Interacts (via
CC       Fibrinogen C-terminal domain) with FFAR2. Interacts with CRP; may
CC       regulate monocyte activation by FCN1.
CC       {ECO:0000250|UniProtKB:O00602}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:O00602}.
CC       Cell membrane {ECO:0000250|UniProtKB:O00602}; Peripheral membrane
CC       protein {ECO:0000250|UniProtKB:O00602}; Extracellular side
CC       {ECO:0000250|UniProtKB:O00602}. Note=Found on the monocyte and
CC       granulocyte surface. {ECO:0000250|UniProtKB:O00602}.
CC   -!- TISSUE SPECIFICITY: Most abundantly expressed in placenta and
CC       lung. {ECO:0000269|PubMed:7686157}.
CC   -!- DOMAIN: The fibrinogen C-terminal domain mediates calcium-
CC       dependent binding to carbohydrates and tethering to the cell
CC       surface in monocytes and granulocytes. The domain undergoes a
CC       conformational switch at pH under 6.2, and looses its
CC       carbohydrate-binding ability. {ECO:0000250|UniProtKB:O00602}.
CC   -!- SIMILARITY: Belongs to the ficolin lectin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12345; AAC69641.1; -; mRNA.
DR   PIR; B47172; B47172.
DR   RefSeq; NP_999325.1; NM_214160.2.
DR   UniGene; Ssc.16008; -.
DR   ProteinModelPortal; Q29042; -.
DR   SMR; Q29042; -.
DR   STRING; 9823.ENSSSCP00000023182; -.
DR   PaxDb; Q29042; -.
DR   PeptideAtlas; Q29042; -.
DR   PRIDE; Q29042; -.
DR   GeneID; 397316; -.
DR   KEGG; ssc:397316; -.
DR   CTD; 2219; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   HOVERGEN; HBG001644; -.
DR   InParanoid; Q29042; -.
DR   KO; K10104; -.
DR   Proteomes; UP000008227; Unplaced.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF01391; Collagen; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Collagen; Complete proteome; Disulfide bond;
KW   Glycoprotein; Immunity; Innate immunity; Lectin; Membrane;
KW   Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     29       {ECO:0000250}.
FT   CHAIN        30    326       Ficolin-1.
FT                                /FTId=PRO_0000269570.
FT   DOMAIN       55     93       Collagen-like.
FT   DOMAIN      109    326       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   REGION      115    154       A domain; contributes to trimerization.
FT                                {ECO:0000250}.
FT   REGION      155    243       B domain; contributes to trimerization.
FT                                {ECO:0000250}.
FT   REGION      282    284       Carbohydrate-binding.
FT                                {ECO:0000250|UniProtKB:O00602}.
FT   REGION      317    326       P domain. {ECO:0000250|UniProtKB:O00602}.
FT   METAL       262    262       Calcium. {ECO:0000250|UniProtKB:O00602}.
FT   METAL       264    264       Calcium. {ECO:0000250|UniProtKB:O00602}.
FT   SITE        300    300       Mediates specificity for sialic acids.
FT                                {ECO:0000250|UniProtKB:O00602}.
FT   SITE        312    312       Mediates specificity for sialic acids.
FT                                {ECO:0000250|UniProtKB:O00602}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    313    313       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    111    139       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    118    146       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    270    283       {ECO:0000255|PROSITE-ProRule:PRU00739}.
SQ   SEQUENCE   326 AA;  35246 MW;  170A5E9EA1E8F310 CRC64;
     MELSRVAVAL GPTGQLLLFL SFQTLAAQAA DTCPEVKVVG LEGSDKLSIL RGCPGLPGAA
     GPKGEAGANG PKGERGSPGV VGKAGPAGPK GDRGEKGARG EKGEPGQLQS CATGPRTCKE
     LLTRGHFLSG WHTIYLPDCQ PLTVLCDMDT DGGGWTVFQR RSDGSVDFYR DWAAYKRGFG
     SQLGEFWLGN DHIHALTAQG TSELRVDLVD FEGNHQFAKY RSFQVAGEAE KYKLVLGGFL
     EGNAGDSLSS HRDQFFSTKD QDNDNHSGNC AEQYHGAWWY NACHSSNLNG RYLRGLHTSY
     ANGVNWRSGR GYNYSYQVSE MKVRLT
//
ID   FIBA_PARPA              Reviewed;         282 AA.
AC   P19477;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   07-JUN-2017, entry version 51.
DE   RecName: Full=Fibrinogen-like protein A;
DE            Short=FREP-A;
DE   Flags: Precursor;
OS   Parastichopus parvimensis (Warty sea cucumber) (Stichopus
OS   parvimensis).
OC   Eukaryota; Metazoa; Echinodermata; Eleutherozoa; Echinozoa;
OC   Holothuroidea; Aspidochirotacea; Aspidochirotida; Stichopodidae;
OC   Apostichopus.
OX   NCBI_TaxID=1902835;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Soft tissues;
RX   PubMed=2315305; DOI=10.1073/pnas.87.6.2097;
RA   Xu X., Doolittle R.F.;
RT   "Presence of a vertebrate fibrinogen-like sequence in an echinoderm.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2097-2101(1990).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M31326; AAA29962.1; -; mRNA.
DR   PIR; A35084; A35084.
DR   ProteinModelPortal; P19477; -.
DR   SMR; P19477; -.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Signal.
FT   SIGNAL        1     24
FT   CHAIN        25    282       Fibrinogen-like protein A.
FT                                /FTId=PRO_0000009104.
FT   DOMAIN       61    281       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID     17     17       Interchain (with gamma chain).
FT                                {ECO:0000250|UniProtKB:P14448}.
FT   DISULFID     21     21       Interchain (with beta chain).
FT                                {ECO:0000250|UniProtKB:P14448}.
FT   DISULFID     56     56       Interchain (with beta chain).
FT                                {ECO:0000250|UniProtKB:P14448}.
FT   DISULFID     70    101       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    224    240       {ECO:0000255|PROSITE-ProRule:PRU00739}.
SQ   SEQUENCE   282 AA;  32281 MW;  07326C8865B7D3A2 CRC64;
     MFSFIMKAAI LLILVGCISF CISSEPLNES EITFEREERS LADPAGRQKR QSGLSCPKRI
     SHSPEYPRDC YDILQSCSGQ SPPSGQYYIQ PDGGNLIKVY CDMETDEGGW TVFQRRIDGT
     INFYRSWSYY QTGFGNLNTE FWLGNDNIHY LTSQGDYELR VELNNTLGNH YYAKYNKFRI
     GDSFSEYLLV LGAYSGTAGD SLAYHNTMRF STYDNDNDVY SINCASHSSY GRGAWWYKSC
     LLSNLNGQYY DYSGAPSIYW SYLPGDNDQI PFAEMKLRNR SI
//
ID   FBCD1_XENTR             Reviewed;         457 AA.
AC   Q0P4P2;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 1.
DT   10-MAY-2017, entry version 53.
DE   RecName: Full=Fibrinogen C domain-containing protein 1;
GN   Name=fibcd1;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Acetyl group-binding receptor which shows a calcium-
CC       dependent binding to acetylated structures such as chitin, some N-
CC       acetylated carbohydrates, and amino acids. {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer; disulfide-linked. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II
CC       membrane protein {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC121964; AAI21965.1; -; mRNA.
DR   RefSeq; NP_001072519.1; NM_001079051.1.
DR   UniGene; Str.53999; -.
DR   ProteinModelPortal; Q0P4P2; -.
DR   SMR; Q0P4P2; -.
DR   STRING; 8364.ENSXETP00000003088; -.
DR   PaxDb; Q0P4P2; -.
DR   GeneID; 779974; -.
DR   KEGG; xtr:779974; -.
DR   CTD; 84929; -.
DR   Xenbase; XB-GENE-483361; fibcd1.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   HOGENOM; HOG000037127; -.
DR   HOVERGEN; HBG001644; -.
DR   InParanoid; Q0P4P2; -.
DR   Proteomes; UP000008143; Unassembled WGS sequence.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008061; F:chitin binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR020837; Fibrinogen_CS.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00514; FIBRINOGEN_C_1; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Chitin-binding; Complete proteome; Disulfide bond;
KW   Glycoprotein; Membrane; Metal-binding; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    457       Fibrinogen C domain-containing protein 1.
FT                                /FTId=PRO_0000294320.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     55    457       Extracellular. {ECO:0000255}.
FT   DOMAIN      231    454       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   METAL       389    389       Calcium. {ECO:0000250}.
FT   METAL       391    391       Calcium. {ECO:0000250}.
FT   SITE        401    401       Implicated in ligand binding.
FT                                {ECO:0000250}.
FT   SITE        411    411       Implicated in ligand binding.
FT                                {ECO:0000250}.
FT   SITE        427    427       Implicated in ligand binding.
FT                                {ECO:0000250}.
FT   SITE        428    428       Implicated in ligand binding.
FT                                {ECO:0000250}.
FT   CARBOHYD    233    233       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    240    269       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    397    410       {ECO:0000255|PROSITE-ProRule:PRU00739}.
SQ   SEQUENCE   457 AA;  50966 MW;  16F2E2C0BB45651C CRC64;
     MGSDRWKNIG GAPQMEDSVQ DKSQRKGCGY ILCTVLLSVA VLLAVTVTGA VLFMNHYHAP
     STEPPPVITT NMEDPNALVT IERADSSHIN IFIDPNCPDP FPRLEGLQSA LLSALADHDS
     EQKVAGGKER ALLTSLSDQV AQMVSQVARQ RADWENVKKV QNGLGAEIGA LKNEQGRLIK
     LLSEGQSHVA QLGSSVSEVL ETVQRELGSG RPRVKADLQR APSRSSRPRG CANGSKPRDC
     YDIYMSGQQE DGVYSVFPIH YPSGFQVFCD MTTDGGGWTV FQRREDGSVN FFQGWEQYRD
     GFGKLTGEHW LGLQRIHLLT MQTHYQLRID LEDFENATAY ALYNTFGVGL FSVNPEEDGY
     PITISDYTGT AGDSLGKHSG MKFTTKDMDN DHSENNCASF YHGAWWYRNC HTSNLNGQYL
     RGHHASYADG IEWSSWTGWQ YSLKFTEMKI RPQREEN
//
ID   TENR_HUMAN              Reviewed;        1358 AA.
AC   Q92752; C9J563; Q15568; Q5R3G0;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   07-JUN-2017, entry version 152.
DE   RecName: Full=Tenascin-R;
DE            Short=TN-R;
DE   AltName: Full=Janusin;
DE   AltName: Full=Restrictin;
DE   Flags: Precursor;
GN   Name=TNR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   VARIANT VAL-17.
RC   TISSUE=Brain;
RX   PubMed=8626505; DOI=10.1074/jbc.271.14.8157;
RA   Carnemolla B., Leprini A., Borsi L., Querze G., Urbini S., Zardi L.;
RT   "Human tenascin-R: complete primary structure, pre-mRNA alternative
RT   splicing and gene localization on chromosome 1q23-q24.";
RL   J. Biol. Chem. 271:8157-8160(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-17.
RC   TISSUE=Brain;
RA   Williams H., Schachner M., Wang B., Goodfellow P., Kenwrick S.;
RT   "Isolation of the gene for neural cell adhesion molecule tenascin-R
RT   and fine mapping relative to loci in 1q25-31.";
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT THR-36 AND THR-37, AND
RP   STRUCTURE OF CARBOHYDRATES.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
CC   -!- FUNCTION: Neural extracellular matrix (ECM) protein involved in
CC       interactions with different cells and matrix components. These
CC       interactions can influence cellular behavior by either evoking a
CC       stable adhesion and differentiation, or repulsion and inhibition
CC       of neurite growth. Binding to cell surface gangliosides inhibits
CC       RGD-dependent integrin-mediated cell adhesion and results in an
CC       inhibition of PTK2/FAK1 (FAK) phosphorylation and cell detachment.
CC       Binding to membrane surface sulfatides results in a
CC       oligodendrocyte adhesion and differentiation. Interaction with
CC       CNTN1 induces a repulsion of neurons and an inhibition of neurite
CC       outgrowth. Interacts with SCN2B may play a crucial role in
CC       clustering and regulation of activity of sodium channels at nodes
CC       of Ranvier. TNR-linked chondroitin sulfate glycosaminoglycans are
CC       involved in the interaction with FN1 and mediate inhibition of
CC       cell adhesion and neurite outgrowth. The highly regulated addition
CC       of sulfated carbohydrate structure may modulate the adhesive
CC       properties of TNR over the course of development and during
CC       synapse maintenance (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms oligomers. Interacts with CNTN1, TNC, and FN1.
CC       Interacts with BCAN and ACAN in a calcium-dependent manner.
CC       Interacts with SCN2B, PTPRZ1, and CSPG3 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92752-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92752-2; Sequence=VSP_012993;
CC   -!- TISSUE SPECIFICITY: Brain specific. {ECO:0000269|PubMed:8626505}.
CC   -!- DOMAIN: The EGF-like domains mediate interaction with CNTN1. The
CC       fibronectin type-III domains 3-5 mediate interaction with BCAN.
CC       The fibronectin type-III domains 1-2 and 7-9 mediate interaction
CC       with SCN2B (By similarity). {ECO:0000250}.
CC   -!- PTM: Contains N-linked oligosaccharides, O-linked sialylated
CC       structures and O-linked chondroitin sulfate glycosaminoglycans.
CC       Contains N-linked oligosaccharides with a sulfated carbohydrate
CC       structure (By similarity). O-glycosylated on Thr-36 or Thr-37 with
CC       a core 1 or possibly core 8 glycan. {ECO:0000250,
CC       ECO:0000269|PubMed:19838169}.
CC   -!- SIMILARITY: Belongs to the tenascin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z67996; CAA91947.1; -; mRNA.
DR   EMBL; X98085; CAA66709.1; -; mRNA.
DR   EMBL; AL021919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL023285; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136530; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z94057; CAI21650.1; -; Genomic_DNA.
DR   EMBL; Z94055; CAI21650.1; JOINED; Genomic_DNA.
DR   EMBL; Z94055; CAI19943.1; -; Genomic_DNA.
DR   EMBL; Z94057; CAI19943.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS1318.1; -. [Q92752-1]
DR   RefSeq; NP_003276.3; NM_003285.2. [Q92752-1]
DR   RefSeq; XP_016857707.1; XM_017002218.1. [Q92752-1]
DR   RefSeq; XP_016857708.1; XM_017002219.1. [Q92752-1]
DR   UniGene; Hs.659864; -.
DR   ProteinModelPortal; Q92752; -.
DR   SMR; Q92752; -.
DR   BioGrid; 112997; 10.
DR   IntAct; Q92752; 1.
DR   STRING; 9606.ENSP00000263525; -.
DR   iPTMnet; Q92752; -.
DR   PhosphoSitePlus; Q92752; -.
DR   SwissPalm; Q92752; -.
DR   BioMuta; TNR; -.
DR   DMDM; 311033534; -.
DR   PaxDb; Q92752; -.
DR   PeptideAtlas; Q92752; -.
DR   PRIDE; Q92752; -.
DR   Ensembl; ENST00000263525; ENSP00000263525; ENSG00000116147. [Q92752-1]
DR   Ensembl; ENST00000367674; ENSP00000356646; ENSG00000116147. [Q92752-1]
DR   GeneID; 7143; -.
DR   KEGG; hsa:7143; -.
DR   UCSC; uc009wwu.2; human. [Q92752-1]
DR   CTD; 7143; -.
DR   DisGeNET; 7143; -.
DR   GeneCards; TNR; -.
DR   H-InvDB; HIX0028854; -.
DR   HGNC; HGNC:11953; TNR.
DR   HPA; CAB022343; -.
DR   HPA; HPA027134; -.
DR   HPA; HPA027150; -.
DR   HPA; HPA029859; -.
DR   MIM; 601995; gene.
DR   neXtProt; NX_Q92752; -.
DR   OpenTargets; ENSG00000116147; -.
DR   PharmGKB; PA36642; -.
DR   eggNOG; KOG1225; Eukaryota.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   GeneTree; ENSGT00830000128240; -.
DR   HOGENOM; HOG000234355; -.
DR   HOVERGEN; HBG008949; -.
DR   InParanoid; Q92752; -.
DR   KO; K06252; -.
DR   OMA; KDSVMVS; -.
DR   OrthoDB; EOG091G03M1; -.
DR   PhylomeDB; Q92752; -.
DR   TreeFam; TF329915; -.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   GeneWiki; Tenascin-R; -.
DR   GenomeRNAi; 7143; -.
DR   PRO; PR:Q92752; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116147; -.
DR   CleanEx; HS_TNR; -.
DR   ExpressionAtlas; Q92752; baseline and differential.
DR   Genevisible; Q92752; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0072534; C:perineuronal net; IEA:Ensembl.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0008306; P:associative learning; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; NAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0035641; P:locomotory exploration behavior; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0048692; P:negative regulation of axon extension involved in regeneration; IEA:Ensembl.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IEA:Ensembl.
DR   GO; GO:0022029; P:telencephalon cell migration; IEA:Ensembl.
DR   CDD; cd00063; FN3; 9.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 8.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033079; TNR.
DR   PANTHER; PTHR19143:SF307; PTHR19143:SF307; 1.
DR   Pfam; PF07974; EGF_2; 1.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 9.
DR   SMART; SM00181; EGF; 4.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 9.
DR   SUPFAM; SSF49265; SSF49265; 5.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Coiled coil; Complete proteome;
KW   Disulfide bond; EGF-like domain; Extracellular matrix; Glycoprotein;
KW   Phosphoprotein; Polymorphism; Proteoglycan; Reference proteome;
KW   Repeat; Secreted; Sialic acid; Signal.
FT   SIGNAL        1     31       {ECO:0000255}.
FT   CHAIN        32   1358       Tenascin-R.
FT                                /FTId=PRO_0000007747.
FT   DOMAIN      188    199       EGF-like 1.
FT   DOMAIN      219    230       EGF-like 2.
FT   DOMAIN      250    261       EGF-like 3.
FT   DOMAIN      281    292       EGF-like 4.
FT   DOMAIN      312    323       EGF-like 5.
FT   DOMAIN      328    420       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      421    505       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      506    595       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      596    687       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      688    777       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      778    865       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      866    955       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      956   1042       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1043   1130       Fibronectin type-III 9.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1129   1344       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   COILED      127    157       {ECO:0000255}.
FT   COMPBIAS    155    314       Cys-rich.
FT   MOD_RES     724    724       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q05546}.
FT   CARBOHYD     36     36       O-linked (GalNAc...) threonine.
FT                                {ECO:0000305|PubMed:19838169}.
FT   CARBOHYD     37     37       O-linked (GalNAc...) threonine.
FT                                {ECO:0000305|PubMed:19838169}.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    180    180       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    392    392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    470    470       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    581    581       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    791    791       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    874    874       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1036   1036       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1046   1046       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1261   1261       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    292    301       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    297    312       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    314    323       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   VAR_SEQ     773    862       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8626505}.
FT                                /FTId=VSP_012993.
FT   VARIANT      17     17       I -> V (in dbSNP:rs859398).
FT                                {ECO:0000269|PubMed:8626505,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_021479.
FT   VARIANT     128    128       A -> S (in dbSNP:rs2239819).
FT                                /FTId=VAR_021906.
FT   VARIANT     293    293       G -> S (in dbSNP:rs3752516).
FT                                /FTId=VAR_021907.
FT   VARIANT     302    302       S -> N (in dbSNP:rs35736986).
FT                                /FTId=VAR_055780.
FT   VARIANT     643    643       R -> K (in dbSNP:rs859427).
FT                                /FTId=VAR_030737.
FT   CONFLICT    629    629       S -> I (in Ref. 2; CAA66709).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1358 AA;  149562 MW;  E4DE356B44D117E7 CRC64;
     MGADGETVVL KNMLIGINLI LLGSMIKPSE CQLEVTTERV QRQSVEEEGG IANYNTSSKE
     QPVVFNHVYN INVPLDNLCS SGLEASAEQE VSAEDETLAE YMGQTSDHES QVTFTHRINF
     PKKACPCASS AQVLQELLSR IEMLEREVSV LRDQCNANCC QESAATGQLD YIPHCSGHGN
     FSFESCGCIC NEGWFGKNCS EPYCPLGCSS RGVCVDGQCI CDSEYSGDDC SELRCPTDCS
     SRGLCVDGEC VCEEPYTGED CRELRCPGDC SGKGRCANGT CLCEEGYVGE DCGQRQCLNA
     CSGRGQCEEG LCVCEEGYQG PDCSAVAPPE DLRVAGISDR SIELEWDGPM AVTEYVISYQ
     PTALGGLQLQ QRVPGDWSGV TITELEPGLT YNISVYAVIS NILSLPITAK VATHLSTPQG
     LQFKTITETT VEVQWEPFSF SFDGWEISFI PKNNEGGVIA QVPSDVTSFN QTGLKPGEEY
     IVNVVALKEQ ARSPPTSASV STVIDGPTQI LVRDVSDTVA FVEWIPPRAK VDFILLKYGL
     VGGEGGRTTF RLQPPLSQYS VQALRPGSRY EVSVSAVRGT NESDSATTQF TTEIDAPKNL
     RVGSRTATSL DLEWDNSEAE VQEYKVVYST LAGEQYHEVL VPRGIGPTTR ATLTDLVPGT
     EYGVGISAVM NSQQSVPATM NARTELDSPR DLMVTASSET SISLIWTKAS GPIDHYRITF
     TPSSGIASEV TVPKDRTSYT LTDLEPGAEY IISVTAERGR QQSLESTVDA FTGFRPISHL
     HFSHVTSSSV NITWSDPSPP ADRLILNYSP RDEEEEMMEV SLDATKRHAV LMGLQPATEY
     IVNLVAVHGT VTSEPIVGSI TTGIDPPKDI TISNVTKDSV MVSWSPPVAS FDYYRVSYRP
     TQVGRLDSSV VPNTVTEFTI TRLNPATEYE ISLNSVRGRE ESERICTLVH TAMDNPVDLI
     ATNITPTEAL LQWKAPVGEV ENYVIVLTHF AVAGETILVD GVSEEFRLVD LLPSTHYTAT
     MYATNGPLTS GTISTNFSTL LDPPANLTAS EVTRQSALIS WQPPRAEIEN YVLTYKSTDG
     SRKELIVDAE DTWIRLEGLL ENTDYTVLLQ AAQDTTWSSI TSTAFTTGGR VFPHPQDCAQ
     HLMNGDTLSG VYPIFLNGEL SQKLQVYCDM TTDGGGWIVF QRRQNGQTDF FRKWADYRVG
     FGNVEDEFWL GLDNIHRITS QGRYELRVDM RDGQEAAFAS YDRFSVEDSR NLYKLRIGSY
     NGTAGDSLSY HQGRPFSTED RDNDVAVTNC AMSYKGAWWY KNCHRTNLNG KYGESRHSQG
     INWYHWKGHE FSIPFVEMKM RPYNHRLMAG RKRQSLQF
//
ID   ANGL7_HUMAN             Reviewed;         346 AA.
AC   O43827; B2R9B2; F1T0A6; Q4ZGK4;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   07-JUN-2017, entry version 125.
DE   RecName: Full=Angiopoietin-related protein 7;
DE   AltName: Full=Angiopoietin-like factor;
DE   AltName: Full=Angiopoietin-like protein 7;
DE   AltName: Full=Cornea-derived transcript 6 protein;
DE   Flags: Precursor;
GN   Name=ANGPTL7; Synonyms=CDT6; ORFNames=UNQ313/PRO356;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Cornea;
RX   PubMed=9727400;
RA   Peek R., van Gelderen B.E., Bruinenberg M., Kijlstra A.;
RT   "Molecular cloning of a new angiopoietin-like factor from the human
RT   cornea.";
RL   Invest. Ophthalmol. Vis. Sci. 39:1782-1788(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11426320; DOI=10.1038/sj.gene.6363745;
RA   Stover C., Endo Y., Takahashi M., Lynch N., Constantinescu C.,
RA   Vorup-Jensen T., Thiel S., Friedl H., Hankeln T., Hall R., Gregory S.,
RA   Fujita T., Schwaeble W.;
RT   "The human gene for mannan-binding lectin-associated serine protease-2
RT   (MASP-2), the effector component of the lectin route of complement
RT   activation, is part of a tightly linked gene cluster on chromosome
RT   1p36.2-3.";
RL   Genes Immun. 2:119-127(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASP-51; HIS-140 AND
RP   HIS-175.
RG   NIEHS SNPs program;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retinoblastoma;
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M.,
RA   Toyama S., Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 27-41.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=3; IntAct=EBI-12698369, EBI-77797;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly and specifically expressed in the
CC       cornea where is confined to the stromal layer.
CC       {ECO:0000269|PubMed:9727400}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/angptl7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y16132; CAA76078.1; -; mRNA.
DR   EMBL; AJ300188; CAC15571.1; -; Genomic_DNA.
DR   EMBL; AY358301; AAQ88668.1; -; mRNA.
DR   EMBL; BT009802; AAP88804.1; -; mRNA.
DR   EMBL; AK313716; BAG36459.1; -; mRNA.
DR   EMBL; DQ012507; AAY22173.1; -; Genomic_DNA.
DR   EMBL; AB593026; BAJ83980.1; -; mRNA.
DR   EMBL; AB593027; BAJ83981.1; -; mRNA.
DR   EMBL; AL049653; CAB44734.1; -; Genomic_DNA.
DR   EMBL; AL391561; CAB44734.1; JOINED; Genomic_DNA.
DR   EMBL; AL391561; CAI17229.1; -; Genomic_DNA.
DR   EMBL; AL049653; CAI17229.1; JOINED; Genomic_DNA.
DR   EMBL; CH471130; EAW71685.1; -; Genomic_DNA.
DR   EMBL; BC001881; AAH01881.1; -; mRNA.
DR   CCDS; CCDS128.1; -.
DR   RefSeq; NP_066969.1; NM_021146.3.
DR   UniGene; Hs.146559; -.
DR   ProteinModelPortal; O43827; -.
DR   SMR; O43827; -.
DR   BioGrid; 115513; 14.
DR   IntAct; O43827; 1.
DR   STRING; 9606.ENSP00000366015; -.
DR   iPTMnet; O43827; -.
DR   PhosphoSitePlus; O43827; -.
DR   PaxDb; O43827; -.
DR   PeptideAtlas; O43827; -.
DR   PRIDE; O43827; -.
DR   DNASU; 10218; -.
DR   Ensembl; ENST00000376819; ENSP00000366015; ENSG00000171819.
DR   GeneID; 10218; -.
DR   KEGG; hsa:10218; -.
DR   UCSC; uc001ase.5; human.
DR   CTD; 10218; -.
DR   DisGeNET; 10218; -.
DR   GeneCards; ANGPTL7; -.
DR   HGNC; HGNC:24078; ANGPTL7.
DR   neXtProt; NX_O43827; -.
DR   OpenTargets; ENSG00000171819; -.
DR   PharmGKB; PA134959516; -.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   GeneTree; ENSGT00760000118809; -.
DR   HOGENOM; HOG000037127; -.
DR   HOVERGEN; HBG001644; -.
DR   InParanoid; O43827; -.
DR   OMA; SFNRDWK; -.
DR   OrthoDB; EOG091G03M1; -.
DR   PhylomeDB; O43827; -.
DR   TreeFam; TF329953; -.
DR   GeneWiki; ANGPTL7; -.
DR   GenomeRNAi; 10218; -.
DR   PRO; PR:O43827; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171819; -.
DR   CleanEx; HS_ANGPTL7; -.
DR   Genevisible; O43827; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 3.90.215.10; -; 1.
DR   Gene3D; 4.10.530.10; -; 1.
DR   InterPro; IPR014716; Fibrinogen_a/b/g_C_1.
DR   InterPro; IPR014715; Fibrinogen_a/b/g_C_2.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   SMART; SM00186; FBG; 1.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     26       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        27    346       Angiopoietin-related protein 7.
FT                                /FTId=PRO_0000009131.
FT   DOMAIN      122    343       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   COILED       39    119       {ECO:0000255}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    253    253       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    131    162       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   DISULFID    285    298       {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   VARIANT      51     51       E -> D (in dbSNP:rs28990992).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025075.
FT   VARIANT     140    140       R -> H (in dbSNP:rs28991002).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025076.
FT   VARIANT     175    175       Q -> H (in dbSNP:rs28991009).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025077.
SQ   SEQUENCE   346 AA;  40018 MW;  AEC0A601CC498B43 CRC64;
     MLKKPLSAVT WLCIFIVAFV SHPAWLQKLS KHKTPAQPQL KAANCCEEVK ELKAQVANLS
     SLLSELNKKQ ERDWVSVVMQ VMELESNSKR MESRLTDAES KYSEMNNQID IMQLQAAQTV
     TQTSADAIYD CSSLYQKNYR ISGVYKLPPD DFLGSPELEV FCDMETSGGG WTIIQRRKSG
     LVSFYRDWKQ YKQGFGSIRG DFWLGNEHIH RLSRQPTRLR VEMEDWEGNL RYAEYSHFVL
     GNELNSYRLF LGNYTGNVGN DALQYHNNTA FSTKDKDNDN CLDKCAQLRK GGYWYNCCTD
     SNLNGVYYRL GEHNKHLDGI TWYGWHGSTY SLKRVEMKIR PEDFKP
//
ID   XCP2_ARATH              Reviewed;         356 AA.
AC   Q9LM66; Q0WT15; Q9SYQ2;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   07-JUN-2017, entry version 114.
DE   RecName: Full=Cysteine protease XCP2 {ECO:0000305};
DE            EC=3.4.22.-;
DE   AltName: Full=Xylem cysteine peptidase 2 {ECO:0000303|PubMed:10889267};
DE            Short=AtXCP2 {ECO:0000303|PubMed:10889267};
DE   Flags: Precursor;
GN   Name=XCP2 {ECO:0000303|PubMed:10889267}; OrderedLocusNames=At1g20850;
GN   ORFNames=F2D10.37, F9H16.17;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Xylem;
RX   PubMed=10889267; DOI=10.1104/pp.123.3.1185;
RA   Zhao C., Johnson B.J., Kositsup B., Beers E.P.;
RT   "Exploiting secondary growth in Arabidopsis. Construction of xylem and
RT   bark cDNA libraries and cloning of three xylem endopeptidases.";
RL   Plant Physiol. 123:1185-1196(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Totoki Y., Seki M., Ishida J., Nakajima M., Enju A., Kamiya A.,
RA   Narusaka M., Shin-i T., Nakagawa M., Sakamoto N., Oishi K., Kohara Y.,
RA   Kobayashi M., Toyoda A., Sakaki Y., Sakurai T., Iida K., Akiyama K.,
RA   Satou M., Toyoda T., Konagaya A., Carninci P., Kawai J.,
RA   Hayashizaki Y., Shinozaki K.;
RT   "Large-scale analysis of RIKEN Arabidopsis full-length (RAFL) cDNAs.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=11788755; DOI=10.1104/pp.128.1.84;
RA   Funk V., Kositsup B., Zhao C., Beers E.P.;
RT   "The Arabidopsis xylem peptidase XCP1 is a tracheary element vacuolar
RT   protein that may be a papain ortholog.";
RL   Plant Physiol. 128:84-94(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=18573193; DOI=10.1111/j.1365-313X.2008.03592.x;
RA   Avci U., Petzold H.E., Ismail I.O., Beers E.P., Haigler C.H.;
RT   "Cysteine proteases XCP1 and XCP2 aid micro-autolysis within the
RT   intact central vacuole during xylogenesis in Arabidopsis roots.";
RL   Plant J. 56:303-315(2008).
RN   [8]
RP   FUNCTION, INTERACTION WITH PRN2, AND DISRUPTION PHENOTYPE.
RX   PubMed=24947605; DOI=10.1111/tpj.12602;
RA   Zhang B., Tremousaygue D., Denance N., van Esse H.P., Hoerger A.C.,
RA   Dabos P., Goffner D., Thomma B.P., van der Hoorn R.A., Tuominen H.;
RT   "PIRIN2 stabilizes cysteine protease XCP2 and increases susceptibility
RT   to the vascular pathogen Ralstonia solanacearum in Arabidopsis.";
RL   Plant J. 79:1009-1019(2014).
CC   -!- FUNCTION: Cysteine protease involved in xylem tracheary element
CC       (TE) autolysis during xylogenesis in roots. Participates in micro
CC       autolysis within the intact central vacuole before mega autolysis
CC       is initiated by tonoplast implosion (PubMed:18573193). Involved in
CC       susceptibility to the bacterial plant pathogen Ralstonia
CC       solanacearum (PubMed:24947605). {ECO:0000269|PubMed:18573193,
CC       ECO:0000269|PubMed:24947605}.
CC   -!- SUBUNIT: Interacts with PRN2. {ECO:0000269|PubMed:24947605}.
CC   -!- SUBCELLULAR LOCATION: Vacuole {ECO:0000250|UniProtKB:O65493}. Cell
CC       membrane {ECO:0000250|UniProtKB:O65493}. Note=Predominantly
CC       vacuolar. May be associated to plasma membrane.
CC       {ECO:0000250|UniProtKB:O65493}.
CC   -!- TISSUE SPECIFICITY: Mostly expressed in roots, stems and flowers.
CC       Confined to tracheary elements, and specifically to xylem.
CC       {ECO:0000269|PubMed:10889267, ECO:0000269|PubMed:11788755}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype under normal growth
CC       conditions, but mutant plants show increased resistance to
CC       infection by the bacterial wilt pathogen Ralstonia solanacearum.
CC       {ECO:0000269|PubMed:24947605}.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF191028; AAF25832.1; -; mRNA.
DR   EMBL; AC007369; AAD30607.1; -; Genomic_DNA.
DR   EMBL; AC069251; AAF80626.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE30031.1; -; Genomic_DNA.
DR   EMBL; BT004822; AAO44088.1; -; mRNA.
DR   EMBL; AK227749; BAE99733.1; -; mRNA.
DR   PIR; A86341; A86341.
DR   RefSeq; NP_564126.1; NM_101938.5.
DR   UniGene; At.21316; -.
DR   ProteinModelPortal; Q9LM66; -.
DR   SMR; Q9LM66; -.
DR   BioGrid; 23916; 2.
DR   IntAct; Q9LM66; 2.
DR   STRING; 3702.AT1G20850.1; -.
DR   MEROPS; C01.065; -.
DR   PaxDb; Q9LM66; -.
DR   EnsemblPlants; AT1G20850.1; AT1G20850.1; AT1G20850.
DR   GeneID; 838677; -.
DR   Gramene; AT1G20850.1; AT1G20850.1; AT1G20850.
DR   KEGG; ath:AT1G20850; -.
DR   Araport; AT1G20850; -.
DR   TAIR; locus:2030427; AT1G20850.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   HOGENOM; HOG000230773; -.
DR   InParanoid; Q9LM66; -.
DR   KO; K16290; -.
DR   OMA; EMGLNHI; -.
DR   OrthoDB; EOG09360E3O; -.
DR   PhylomeDB; Q9LM66; -.
DR   Reactome; R-ATH-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-ATH-2132295; MHC class II antigen presentation.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:Q9LM66; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; Q9LM66; baseline and differential.
DR   Genevisible; Q9LM66; AT.
DR   GO; GO:0005618; C:cell wall; IDA:TAIR.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:UniProtKB.
DR   GO; GO:0010623; P:programmed cell death involved in cell development; IMP:TAIR.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Hydrolase; Membrane; Plant defense; Protease; Reference proteome;
KW   Signal; Thiol protease; Vacuole; Zymogen.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   PROPEP       27    137       Activation peptide. {ECO:0000305}.
FT                                /FTId=PRO_0000026469.
FT   CHAIN       138    356       Cysteine protease XCP2.
FT                                /FTId=PRO_0000026470.
FT   ACT_SITE    162    162       {ECO:0000255|PROSITE-ProRule:PRU10088}.
FT   ACT_SITE    298    298       {ECO:0000255|PROSITE-ProRule:PRU10089}.
FT   ACT_SITE    318    318       {ECO:0000255|PROSITE-ProRule:PRU10090}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    159    201       {ECO:0000250|UniProtKB:P84346}.
FT   DISULFID    193    234       {ECO:0000250|UniProtKB:P84346}.
FT   DISULFID    292    343       {ECO:0000250|UniProtKB:P84346}.
SQ   SEQUENCE   356 AA;  39708 MW;  503696D19B14C2BF CRC64;
     MALSSPSRIL CFALALSAAS LSLSFASSHD YSIVGYSPED LESHDKLIEL FENWISNFEK
     AYETVEEKFL RFEVFKDNLK HIDETNKKGK SYWLGLNEFA DLSHEEFKKM YLGLKTDIVR
     RDEERSYAEF AYRDVEAVPK SVDWRKKGAV AEVKNQGSCG SCWAFSTVAA VEGINKIVTG
     NLTTLSEQEL IDCDTTYNNG CNGGLMDYAF EYIVKNGGLR KEEDYPYSME EGTCEMQKDE
     SETVTINGHQ DVPTNDEKSL LKALAHQPLS VAIDASGREF QFYSGGVFDG RCGVDLDHGV
     AAVGYGSSKG SDYIIVKNSW GPKWGEKGYI RLKRNTGKPE GLCGINKMAS FPTKTK
//
ID   BROM1_ANACO             Reviewed;         351 AA.
AC   O23791;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   30-NOV-2016, entry version 58.
DE   RecName: Full=Fruit bromelain;
DE            EC=3.4.22.33;
DE   AltName: Allergen=Ana c 2;
DE   Flags: Precursor;
OS   Ananas comosus (Pineapple) (Ananas ananas).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Bromeliaceae;
OC   Bromelioideae; Ananas.
OX   NCBI_TaxID=4615;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. N67-10; TISSUE=Fruit;
RA   Muta E., Aramaki H., Takata Y., Kono A., Okamoto Y., Ota S.;
RT   "Cloning and sequencing of fruit bromelain.";
RL   Submitted (JAN-1993) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of proteins with broad specificity
CC       for peptide bonds. Bz-Phe-Val-Arg-|-NHMec is a good synthetic
CC       substrate, but there is no action on Z-Arg-Arg-|-NHMec (c.f. stem
CC       bromelain).
CC   -!- ALLERGEN: Causes an allergic reaction in human.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D14059; BAA21849.1; -; mRNA.
DR   PIR; T10503; T10503.
DR   ProteinModelPortal; O23791; -.
DR   SMR; O23791; -.
DR   Allergome; 3076; Ana c 2.0101.
DR   Allergome; 694; Ana c 2.
DR   MEROPS; C01.028; -.
DR   BRENDA; 3.4.22.33; 333.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   Allergen; Disulfide bond; Hydrolase; Protease; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   PROPEP       25    121       {ECO:0000250}.
FT                                /FTId=PRO_0000045809.
FT   CHAIN       122    351       Fruit bromelain.
FT                                /FTId=PRO_0000045810.
FT   ACT_SITE    147    147       {ECO:0000250}.
FT   ACT_SITE    279    279       {ECO:0000250}.
FT   DISULFID    144    184       {ECO:0000250}.
FT   DISULFID    178    217       {ECO:0000250}.
FT   DISULFID    273    325       {ECO:0000250}.
SQ   SEQUENCE   351 AA;  39055 MW;  33781C55144242B0 CRC64;
     MASKVQLVFL FLFLCAMWAS PSAASRDEPN DPMMKRFEEW MAEYGRVYKD DDEKMRRFQI
     FKNNVKHIET FNSRNENSYT LGINQFTDMT KSEFVAQYTG VSLPLNIERE PVVSFDDVNI
     SAVPQSIDWR DYGAVNEVKN QNPCGSCWSF AAIATVEGIY KIKTGYLVSL SEQEVLDCAV
     SYGCKGGWVN KAYDFIISNN GVTTEENYPY LAYQGTCNAN SFPNSAYITG YSYVRRNDER
     SMMYAVSNQP IAALIDASEN FQYYNGGVFS GPCGTSLNHA ITIIGYGQDS SGTKYWIVRN
     SWGSSWGEGG YVRMARGVSS SSGVCGIAMA PLFPTLQSGA NAEVIKMVSE T
//
ID   CYSP3_HOMAM             Reviewed;         321 AA.
AC   P25784;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   15-FEB-2017, entry version 77.
DE   RecName: Full=Digestive cysteine proteinase 3;
DE            EC=3.4.22.-;
DE   Flags: Precursor;
GN   Name=LCP3;
OS   Homarus americanus (American lobster).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Malacostraca;
OC   Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Astacidea;
OC   Nephropoidea; Nephropidae; Homarus.
OX   NCBI_TaxID=6706;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Digestive gland;
RX   PubMed=1959590; DOI=10.1016/0014-5793(91)80847-V;
RA   Laycock M.V., MacKay R.M., Di Fruscio M., Gallant J.W.;
RT   "Molecular cloning of three cDNAs that encode cysteine proteinases in
RT   the digestive gland of the American lobster (Homarus americanus).";
RL   FEBS Lett. 292:115-120(1991).
RN   [2]
RP   ERRATUM.
RX   PubMed=1451782; DOI=10.1016/0014-5793(92)80227-8;
RA   Laycock M.V., MacKay R.M., Di Fruscio M., Gallant J.W.;
RL   FEBS Lett. 301:125-125(1992).
CC   -!- ENZYME REGULATION: Inhibited by E-64, antipain, leupeptin, heavy
CC       metal ions, iodoacetic acid, dithionitrobenzene, p-hydroxymercuri-
CC       benzoate; activated by mercaptoethanol and dithiothreitol.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA45129.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63569; CAA45129.1; ALT_INIT; mRNA.
DR   PIR; S19651; S19651.
DR   ProteinModelPortal; P25784; -.
DR   SMR; P25784; -.
DR   MEROPS; I29.003; -.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Hydrolase; Protease; Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   PROPEP       17    106       Activation peptide.
FT                                /FTId=PRO_0000026396.
FT   CHAIN       107    321       Digestive cysteine proteinase 3.
FT                                /FTId=PRO_0000026397.
FT   ACT_SITE    130    130       {ECO:0000250}.
FT   ACT_SITE    268    268       {ECO:0000250}.
FT   ACT_SITE    288    288       {ECO:0000250}.
FT   DISULFID    127    170       {ECO:0000250}.
FT   DISULFID    161    203       {ECO:0000250}.
FT   DISULFID    261    310       {ECO:0000250}.
SQ   SEQUENCE   321 AA;  35366 MW;  72D202DBFEC787AD CRC64;
     MKVAALFLCG LALATASPSW DHFKTQYGRK YGDAKEELYR QRVFQQNEQL IEDFNKKFEN
     GEVTFKVAMN QFGDMTNEEF NAVMKGYKKG SRGEPKAVFT AEAGPMAADV DWRTKALVTP
     VKDQEQCGSC WAFSATGALE GQHFLKNDEL VSLSEQQLVD CSTDYGNDGC GGGWMTSAFD
     YIKDNGGIDT ESSYPYEAED RSCRFDANSI GAICTGSVEV QHTEEALQEA VSGVGPISVA
     IDASHFSFQF YSSGVYYEQN CSPTFLDHGV LAVGYGTEST KDYWLVKNSW GSSWGDAGYI
     KMSRNRDNNC GIASEPSYPT V
//
ID   RDL2_ARATH              Reviewed;         362 AA.
AC   Q9LT77; Q8GT77;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   05-JUL-2017, entry version 114.
DE   RecName: Full=Probable cysteine protease RDL2 {ECO:0000305};
DE            EC=3.4.22.- {ECO:0000305};
DE   AltName: Full=Probable cysteine proteinase At3g19400 {ECO:0000305};
DE   AltName: Full=RD21A-like protease 2 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=RDL2 {ECO:0000305}; OrderedLocusNames=At3g19400;
GN   ORFNames=MLD14.13;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10819329; DOI=10.1093/dnares/7.2.131;
RA   Sato S., Nakamura Y., Kaneko T., Katoh T., Asamizu E., Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 3. I. Sequence
RT   features of the regions of 4,504,864 bp covered by sixty P1 and TAC
RT   clones.";
RL   DNA Res. 7:131-135(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
CC   -!- FUNCTION: Probable thiol protease. {ECO:0000250|UniProtKB:P43297}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=Q9LT77-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB025624; BAB02464.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE76236.1; -; Genomic_DNA.
DR   EMBL; AK118509; BAC43113.1; -; mRNA.
DR   RefSeq; NP_566634.2; NM_112827.3. [Q9LT77-1]
DR   UniGene; At.38409; -.
DR   ProteinModelPortal; Q9LT77; -.
DR   SMR; Q9LT77; -.
DR   MEROPS; I29.003; -.
DR   PaxDb; Q9LT77; -.
DR   EnsemblPlants; AT3G19400.1; AT3G19400.1; AT3G19400. [Q9LT77-1]
DR   GeneID; 821474; -.
DR   Gramene; AT3G19400.1; AT3G19400.1; AT3G19400. [Q9LT77-1]
DR   KEGG; ath:AT3G19400; -.
DR   Araport; AT3G19400; -.
DR   TAIR; locus:2090629; AT3G19400.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   HOGENOM; HOG000230773; -.
DR   InParanoid; Q9LT77; -.
DR   OMA; ERYLYKE; -.
DR   OrthoDB; EOG093614UM; -.
DR   PhylomeDB; Q9LT77; -.
DR   Reactome; R-ATH-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-ATH-2132295; MHC class II antigen presentation.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:Q9LT77; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9LT77; baseline and differential.
DR   Genevisible; Q9LT77; AT.
DR   GO; GO:0005829; C:cytosol; IDA:TAIR.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Hydrolase; Protease; Reference proteome; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   PROPEP       29    129       Activation peptide. {ECO:0000305}.
FT                                /FTId=PRO_0000026459.
FT   CHAIN       130    362       Probable cysteine protease RDL2.
FT                                /FTId=PRO_0000026460.
FT   ACT_SITE    154    154       {ECO:0000255|PROSITE-ProRule:PRU10088}.
FT   ACT_SITE    293    293       {ECO:0000255|PROSITE-ProRule:PRU10089}.
FT   ACT_SITE    313    313       {ECO:0000255|PROSITE-ProRule:PRU10090}.
FT   CARBOHYD     36     36       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   CARBOHYD    234    234       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    151    194       {ECO:0000250|UniProtKB:P84346}.
FT   DISULFID    185    228       {ECO:0000250|UniProtKB:P84346}.
FT   DISULFID    287    338       {ECO:0000250|UniProtKB:P84346}.
FT   CONFLICT    113    113       T -> N (in Ref. 3; BAC43113).
FT                                {ECO:0000305}.
SQ   SEQUENCE   362 AA;  40290 MW;  56DFAA1FEE95A6B0 CRC64;
     MAATPIRVIV SALVILSVLL LSSSLGVATE TEIERNETEV RLMYEQWLVE NRKNYNGLGE
     KERRFKIFKD NLKFVDEHNS VPDRTFEVGL TRFADLTNEE FRAIYLRKKM ERTKDSVKTE
     RYLYKEGDVL PDEVDWRANG AVVSVKDQGN CGSCWAFSAV GAVEGINQIT TGELISLSEQ
     ELVDCDRGFV NAGCDGGIMN YAFEFIMKNG GIETDQDYPY NANDLGLCNA DKNNNTRVVT
     IDGYEDVPRD DEKSLKKAVA HQPVSVAIEA SSQAFQLYKS GVMTGTCGIS LDHGVVVVGY
     GSTSGEDYWI IRNSWGLNWG DSGYVKLQRN IDDPFGKCGI AMMPSYPTKS SFPSSFDLLS
     EI
//
ID   SAG39_ORYSJ             Reviewed;         339 AA.
AC   Q7XWK5; A0A0P0W7K3;
DT   29-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   07-JUN-2017, entry version 85.
DE   RecName: Full=Senescence-specific cysteine protease SAG39 {ECO:0000305};
DE            EC=3.4.22.- {ECO:0000305};
DE   AltName: Full=Cysteine proteinase SAG39 {ECO:0000305};
DE   AltName: Full=Protein SENESCENCE-ASSOCIATED GENE 39 {ECO:0000303|PubMed:20439547};
DE   Flags: Precursor;
GN   Name=SAG39 {ECO:0000303|PubMed:20439547};
GN   OrderedLocusNames=Os04g0206300 {ECO:0000305};
GN   ORFNames=OsJ_13822 {ECO:0000312|EMBL:EAZ29764.1},
GN   OSJNBa0052O21.11 {ECO:0000312|EMBL:CAD40026.2};
OS   Oryza sativa subsp. japonica (Rice).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; Liliopsida; Poales; Poaceae; BOP clade;
OC   Oryzoideae; Oryzeae; Oryzinae; Oryza.
OX   NCBI_TaxID=39947 {ECO:0000312};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=12447439; DOI=10.1038/nature01183;
RA   Feng Q., Zhang Y., Hao P., Wang S., Fu G., Huang Y., Li Y., Zhu J.,
RA   Liu Y., Hu X., Jia P., Zhang Y., Zhao Q., Ying K., Yu S., Tang Y.,
RA   Weng Q., Zhang L., Lu Y., Mu J., Lu Y., Zhang L.S., Yu Z., Fan D.,
RA   Liu X., Lu T., Li C., Wu Y., Sun T., Lei H., Li T., Hu H., Guan J.,
RA   Wu M., Zhang R., Zhou B., Chen Z., Chen L., Jin Z., Wang R., Yin H.,
RA   Cai Z., Ren S., Lv G., Gu W., Zhu G., Tu Y., Jia J., Zhang Y.,
RA   Chen J., Kang H., Chen X., Shao C., Sun Y., Hu Q., Zhang X., Zhang W.,
RA   Wang L., Ding C., Sheng H., Gu J., Chen S., Ni L., Zhu F., Chen W.,
RA   Lan L., Lai Y., Cheng Z., Gu M., Jiang J., Li J., Hong G., Xue Y.,
RA   Han B.;
RT   "Sequence and analysis of rice chromosome 4.";
RL   Nature 420:316-320(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=16100779; DOI=10.1038/nature03895;
RG   International rice genome sequencing project (IRGSP);
RT   "The map-based sequence of the rice genome.";
RL   Nature 436:793-800(2005).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=18089549; DOI=10.1093/nar/gkm978;
RG   The rice annotation project (RAP);
RT   "The rice annotation project database (RAP-DB): 2008 update.";
RL   Nucleic Acids Res. 36:D1028-D1033(2008).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=24280374; DOI=10.1186/1939-8433-6-4;
RA   Kawahara Y., de la Bastide M., Hamilton J.P., Kanamori H.,
RA   McCombie W.R., Ouyang S., Schwartz D.C., Tanaka T., Wu J., Zhou S.,
RA   Childs K.L., Davidson R.M., Lin H., Quesada-Ocampo L.,
RA   Vaillancourt B., Sakai H., Lee S.S., Kim J., Numa H., Itoh T.,
RA   Buell C.R., Matsumoto T.;
RT   "Improvement of the Oryza sativa Nipponbare reference genome using
RT   next generation sequence and optical map data.";
RL   Rice 6:4-4(2013).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Nipponbare;
RX   PubMed=15685292; DOI=10.1371/journal.pbio.0030038;
RA   Yu J., Wang J., Lin W., Li S., Li H., Zhou J., Ni P., Dong W., Hu S.,
RA   Zeng C., Zhang J., Zhang Y., Li R., Xu Z., Li S., Li X., Zheng H.,
RA   Cong L., Lin L., Yin J., Geng J., Li G., Shi J., Liu J., Lv H., Li J.,
RA   Wang J., Deng Y., Ran L., Shi X., Wang X., Wu Q., Li C., Ren X.,
RA   Wang J., Wang X., Li D., Liu D., Zhang X., Ji Z., Zhao W., Sun Y.,
RA   Zhang Z., Bao J., Han Y., Dong L., Ji J., Chen P., Wu S., Liu J.,
RA   Xiao Y., Bu D., Tan J., Yang L., Ye C., Zhang J., Xu J., Zhou Y.,
RA   Yu Y., Zhang B., Zhuang S., Wei H., Liu B., Lei M., Yu H., Li Y.,
RA   Xu H., Wei S., He X., Fang L., Zhang Z., Zhang Y., Huang X., Su Z.,
RA   Tong W., Li J., Tong Z., Li S., Ye J., Wang L., Fang L., Lei T.,
RA   Chen C.-S., Chen H.-C., Xu Z., Li H., Huang H., Zhang F., Xu H.,
RA   Li N., Zhao C., Li S., Dong L., Huang Y., Li L., Xi Y., Qi Q., Li W.,
RA   Zhang B., Hu W., Zhang Y., Tian X., Jiao Y., Liang X., Jin J., Gao L.,
RA   Zheng W., Hao B., Liu S.-M., Wang W., Yuan L., Cao M., McDermott J.,
RA   Samudrala R., Wang J., Wong G.K.-S., Yang H.;
RT   "The genomes of Oryza sativa: a history of duplications.";
RL   PLoS Biol. 3:266-281(2005).
RN   [6]
RP   TISSUE SPECIFICITY, INDUCTION BY SENESCENCE; ETHYLENE; GIBBERELLIN AND
RP   ABSCISIC ACID, DEVELOPMENTAL STAGE, AND BIOTECHNOLOGY.
RC   STRAIN=cv. Nipponbare;
RX   PubMed=20439547; DOI=10.1104/pp.110.157123;
RA   Liu L., Zhou Y., Szczerba M.W., Li X., Lin Y.;
RT   "Identification and application of a rice senescence-associated
RT   promoter.";
RL   Plant Physiol. 153:1239-1249(2010).
CC   -!- FUNCTION: Cysteine protease that may have a developmental
CC       senescence specific cell death function during apoptosis, heavy
CC       metal detoxification, and hypersensitive response.
CC       {ECO:0000250|UniProtKB:Q9FJ47}.
CC   -!- SUBCELLULAR LOCATION: Vacuole {ECO:0000250|UniProtKB:Q9FJ47}.
CC       Note=Localized in senescence-associated vacuoles (SAVs) with
CC       intense proteolytic activity that develop in the peripheral
CC       cytoplasm of mesophyll and guard cells.
CC       {ECO:0000250|UniProtKB:Q9FJ47}.
CC   -!- TISSUE SPECIFICITY: Low expression in mature leaves.
CC       {ECO:0000269|PubMed:20439547}.
CC   -!- DEVELOPMENTAL STAGE: Senescent tissues specific expression.
CC       {ECO:0000269|PubMed:20439547}.
CC   -!- INDUCTION: Accumulates progressively during senescence with
CC       maximum levels at late senescence stages. Induced by abscisic acid
CC       (ABA), ethylene (ACC) and gibberellin (GA(3)).
CC       {ECO:0000269|PubMed:20439547}.
CC   -!- BIOTECHNOLOGY: The senescence specific expression can be use to
CC       monitor cytokinin synthases (e.g. IPT) in order to promote yield
CC       and early maturation of panicles, and to delay senescence.
CC       {ECO:0000303|PubMed:20439547}.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL606590; CAD40026.2; -; Genomic_DNA.
DR   EMBL; AP008210; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP014960; BAS88099.1; -; Genomic_DNA.
DR   EMBL; CM000141; EAZ29764.1; -; Genomic_DNA.
DR   RefSeq; XP_015635487.1; XM_015780001.1.
DR   ProteinModelPortal; Q7XWK5; -.
DR   SMR; Q7XWK5; -.
DR   EnsemblPlants; OS04T0206300-00; OS04T0206300-00; OS04G0206300.
DR   GeneID; 107276017; -.
DR   Gramene; OS04T0206300-00; OS04T0206300-00; OS04G0206300.
DR   KEGG; osa:107276017; -.
DR   InParanoid; Q7XWK5; -.
DR   OMA; PKFDQNL; -.
DR   OrthoDB; EOG09360DAM; -.
DR   Reactome; R-OSA-1592389; Activation of Matrix Metalloproteinases.
DR   Reactome; R-OSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-OSA-6798695; Neutrophil degranulation.
DR   Proteomes; UP000059680; Chromosome 4.
DR   Genevisible; Q7XWK5; OS.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0010282; C:senescence-associated vacuole; ISS:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007568; P:aging; ISS:UniProtKB.
DR   GO; GO:0010150; P:leaf senescence; IEP:UniProtKB.
DR   GO; GO:0010623; P:programmed cell death involved in cell development; ISS:UniProtKB.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   GO; GO:0009737; P:response to abscisic acid; IEP:UniProtKB.
DR   GO; GO:0009723; P:response to ethylene; IEP:UniProtKB.
DR   GO; GO:0009739; P:response to gibberellin; IEP:UniProtKB.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Hydrolase; Protease; Reference proteome; Signal;
KW   Thiol protease; Vacuole.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    339       Senescence-specific cysteine protease
FT                                SAG39. {ECO:0000255}.
FT                                /FTId=PRO_0000430525.
FT   ACT_SITE    147    147       {ECO:0000255|PROSITE-ProRule:PRU10088}.
FT   ACT_SITE    282    282       {ECO:0000255|PROSITE-ProRule:PRU10089}.
FT   ACT_SITE    303    303       {ECO:0000255|PROSITE-ProRule:PRU10090}.
SQ   SEQUENCE   339 AA;  36872 MW;  136D71DF5E22E9CF CRC64;
     MAMAKALLFA ILGCLCLCSA VLAARELSDD AAMAARHERW MAQYGRVYRD DAEKARRFEV
     FKANVAFIES FNAGNHNFWL GVNQFADLTN DEFRWMKTNK GFIPSTTRVP TGFRYENVNI
     DALPATVDWR TKGAVTPIKD QGQCGCCWAF SAVAAMEGIV KLSTGKLISL SEQELVDCDV
     HGEDQGCEGG LMDDAFKFII KNGGLTTESN YPYAAADDKC KSVSNSVASI KGYEDVPANN
     EAALMKAVAN QPVSVAVDGG DMTFQFYKGG VMTGSCGTDL DHGIVAIGYG KASDGTKYWL
     LKNSWGTTWG ENGFLRMEKD ISDKRGMCGL AMEPSYPTA
//
ID   PAPA2_CARPA             Reviewed;         352 AA.
AC   P14080;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-NOV-2016, entry version 96.
DE   RecName: Full=Chymopapain;
DE            EC=3.4.22.6;
DE   AltName: Full=Papaya proteinase II;
DE            Short=PPII;
DE   Flags: Precursor;
OS   Carica papaya (Papaya).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Caricaceae; Carica.
OX   NCBI_TaxID=3649;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Leaf;
RA   Connerton I.F.;
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PROTEIN SEQUENCE OF 135-352.
RX   PubMed=2106878; DOI=10.1042/bj2660075;
RA   Watson D.C., Yaguchi M., Lynn K.R.;
RT   "The amino acid sequence of chymopapain from Carica papaya.";
RL   Biochem. J. 266:75-81(1990).
RN   [3]
RP   PROTEIN SEQUENCE OF 135-352.
RX   PubMed=2500950;
RA   Jacquet A., Kleinschmidt T., Schnek A.G., Looze Y., Braunitzer G.;
RT   "The thiol proteinases from the latex of Carica papaya L. III. The
RT   primary structure of chymopapain.";
RL   Biol. Chem. Hoppe-Seyler 370:425-434(1989).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS).
RX   PubMed=8973203; DOI=10.1021/bi961491w;
RA   Maes D., Bouckaert J., Poortmans F., Wyns L., Looze Y.;
RT   "Structure of chymopapain at 1.7-A resolution.";
RL   Biochemistry 35:16292-16298(1996).
CC   -!- CATALYTIC ACTIVITY: Specificity similar to that of papain.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97789; CAA66378.1; -; mRNA.
DR   PIR; T09760; T09760.
DR   PDB; 1YAL; X-ray; 1.70 A; A=135-352.
DR   PDBsum; 1YAL; -.
DR   ProteinModelPortal; P14080; -.
DR   SMR; P14080; -.
DR   Allergome; 1540; Car p Chymopapain.
DR   MEROPS; I29.003; -.
DR   KEGG; ag:CAA66378; -.
DR   KO; K20738; -.
DR   BRENDA; 3.4.22.6; 1191.
DR   EvolutionaryTrace; P14080; -.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond; Hydrolase;
KW   Protease; Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   PROPEP       19    134       Activation peptide.
FT                                {ECO:0000269|PubMed:2106878,
FT                                ECO:0000269|PubMed:2500950}.
FT                                /FTId=PRO_0000026408.
FT   CHAIN       135    352       Chymopapain.
FT                                /FTId=PRO_0000026409.
FT   ACT_SITE    159    159
FT   ACT_SITE    293    293
FT   ACT_SITE    313    313
FT   DISULFID    156    197
FT   DISULFID    190    229
FT   DISULFID    287    338
FT   TURN        141    145       {ECO:0000244|PDB:1YAL}.
FT   STRAND      155    157       {ECO:0000244|PDB:1YAL}.
FT   HELIX       159    176       {ECO:0000244|PDB:1YAL}.
FT   HELIX       184    190       {ECO:0000244|PDB:1YAL}.
FT   HELIX       202    212       {ECO:0000244|PDB:1YAL}.
FT   TURN        217    219       {ECO:0000244|PDB:1YAL}.
FT   HELIX       231    233       {ECO:0000244|PDB:1YAL}.
FT   STRAND      242    246       {ECO:0000244|PDB:1YAL}.
FT   STRAND      249    251       {ECO:0000244|PDB:1YAL}.
FT   HELIX       252    259       {ECO:0000244|PDB:1YAL}.
FT   STRAND      264    268       {ECO:0000244|PDB:1YAL}.
FT   HELIX       273    276       {ECO:0000244|PDB:1YAL}.
FT   STRAND      280    283       {ECO:0000244|PDB:1YAL}.
FT   STRAND      293    303       {ECO:0000244|PDB:1YAL}.
FT   STRAND      306    312       {ECO:0000244|PDB:1YAL}.
FT   STRAND      324    328       {ECO:0000244|PDB:1YAL}.
FT   STRAND      332    334       {ECO:0000244|PDB:1YAL}.
FT   HELIX       337    339       {ECO:0000244|PDB:1YAL}.
FT   STRAND      345    348       {ECO:0000244|PDB:1YAL}.
SQ   SEQUENCE   352 AA;  39415 MW;  50EA31EBFCF0AF9F CRC64;
     MATMSSISKI IFLATCLIIH MGLSSADFYT VGYSQDDLTS IERLIQLFDS WMLKHNKIYE
     SIDEKIYRFE IFRDNLMYID ETNKKNNSYW LGLNGFADLS NDEFKKKYVG FVAEDFTGLE
     HFDNEDFTYK HVTNYPQSID WRAKGAVTPV KNQGACGSCW AFSTIATVEG INKIVTGNLL
     ELSEQELVDC DKHSYGCKGG YQTTSLQYVA NNGVHTSKVY PYQAKQYKCR ATDKPGPKVK
     ITGYKRVPSN CETSFLGALA NQPLSVLVEA GGKPFQLYKS GVFDGPCGTK LDHAVTAVGY
     GTSDGKNYII IKNSWGPNWG EKGYMRLKRQ SGNSQGTCGV YKSSYYPFKG FA
//
ID   CYSP5_DICDI             Reviewed;         344 AA.
AC   P54640; Q558T9; Q8MNB1;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   05-JUL-2017, entry version 109.
DE   RecName: Full=Cysteine proteinase 5;
DE            EC=3.4.22.-;
DE   Flags: Precursor;
GN   Name=cprE; Synonyms=CP5; ORFNames=DDB_G0272815;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AX4;
RX   PubMed=7499424; DOI=10.1074/jbc.270.48.28938;
RA   Souza G.M., Hirai J., Mehta D.P., Freeze H.H.;
RT   "Identification of two novel Dictyostelium discoideum cysteine
RT   proteinases that carry N-acetylglucosamine-1-P-modification.";
RL   J. Biol. Chem. 270:28938-28945(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=12097910; DOI=10.1038/nature00847;
RA   Gloeckner G., Eichinger L., Szafranski K., Pachebat J.A.,
RA   Bankier A.T., Dear P.H., Lehmann R., Baumgart C., Parra G.,
RA   Abril J.F., Guigo R., Kumpf K., Tunggal B., Cox E.C., Quail M.A.,
RA   Platzer M., Rosenthal A., Noegel A.A.;
RT   "Sequence and analysis of chromosome 2 of Dictyostelium discoideum.";
RL   Nature 418:79-85(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- DEVELOPMENTAL STAGE: Present in the vegetative phase and decreases
CC       with the start development, reappears in low levels when the
CC       fruiting body is formed.
CC   -!- PTM: Glycosylated; contains GlcNAc-alpha-1-P-Ser residues.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36205; AAA92018.1; -; mRNA.
DR   EMBL; AAFI02000008; EAL71045.1; -; Genomic_DNA.
DR   RefSeq; XP_644977.1; XM_639885.1.
DR   ProteinModelPortal; P54640; -.
DR   SMR; P54640; -.
DR   STRING; 44689.DDB0185092; -.
DR   MEROPS; I29.003; -.
DR   PaxDb; P54640; -.
DR   EnsemblProtists; EAL71045; EAL71045; DDB_G0272815.
DR   GeneID; 8618654; -.
DR   KEGG; ddi:DDB_G0272815; -.
DR   dictyBase; DDB_G0272815; cprE.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   InParanoid; P54640; -.
DR   KO; K01365; -.
DR   OMA; EMGLNHI; -.
DR   PhylomeDB; P54640; -.
DR   Reactome; R-DDI-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-DDI-2132295; MHC class II antigen presentation.
DR   Reactome; R-DDI-6798695; Neutrophil degranulation.
DR   PRO; PR:P54640; -.
DR   Proteomes; UP000002195; Chromosome 2.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IBA:GO_Central.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Hydrolase; Lysosome;
KW   Phosphoprotein; Protease; Reference proteome; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   PROPEP       18    111       Activation peptide. {ECO:0000255}.
FT                                /FTId=PRO_0000026364.
FT   CHAIN       112    344       Cysteine proteinase 5.
FT                                /FTId=PRO_0000026365.
FT   COMPBIAS    196    340       Ser-rich.
FT   ACT_SITE    136    136       {ECO:0000250}.
FT   ACT_SITE    272    272       {ECO:0000250}.
FT   ACT_SITE    311    311       {ECO:0000250}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    133    174       {ECO:0000250}.
FT   DISULFID    167    207       {ECO:0000250}.
FT   DISULFID    265    333       {ECO:0000250}.
FT   CONFLICT     54     54       K -> T (in Ref. 1; AAA92018).
FT                                {ECO:0000305}.
FT   CONFLICT    108    110       FTT -> HTN (in Ref. 1; AAA92018).
FT                                {ECO:0000305}.
SQ   SEQUENCE   344 AA;  37237 MW;  1E77FBA4BD8337B7 CRC64;
     MKVLSFLCVL LVSVATAKQQ FSELQYRNAF TDWMITHQKS YTSEEFGARY NIFKANMDYV
     QQWNSKGSET VLGLNNFADI TNEEYRNTYL GTKFDASSLI GTQEEKVFTT SSAASKDWRS
     EGAVTPVKNQ GQCGGCWSFS TTGSTEGAHF QSKGELVSLS EQNLIDCSTE NSGCDGGLMT
     YAFEYIINNN GIDTESSYPY KAENGKCEYK SENSGATLSS YKTVTAGSES SLESAVNVNP
     VSVAIDASHQ SFQLYTSGIY YEPECSSENL DHGVLAVGYG SGSGSSSGQS SGQSSGNLSA
     SSSNEYWIVK NSWGTSWGIE GYILMSRNRD NNCGIASSAS FPVV
//
ID   ARF1_LOCMI              Reviewed;         182 AA.
AC   P61210; P35676; Q9VNQ2;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   12-APR-2017, entry version 61.
DE   RecName: Full=ADP-ribosylation factor 1;
DE   AltName: Full=lARF1;
GN   Name=ARF1;
OS   Locusta migratoria (Migratory locust).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Polyneoptera; Orthoptera; Caelifera; Acrididea;
OC   Acridomorpha; Acridoidea; Acrididae; Oedipodinae; Locusta.
OX   NCBI_TaxID=7004;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11122465; DOI=10.1046/j.1365-2583.2000.00219.x;
RA   Hannan F., Evans P.D.;
RT   "A locust type 1 ADP-ribosylation factor (lARF1) is 100% identical in
RT   amino acid sequence to Drosophila ARF1 despite obvious DNA sequence
RT   divergence.";
RL   Insect Mol. Biol. 9:559-563(2000).
CC   -!- FUNCTION: GTP-binding protein involved in protein trafficking; may
CC       modulate vesicle budding and uncoating within the Golgi apparatus.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Arf family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U90609; AAF21238.1; -; mRNA.
DR   ProteinModelPortal; P61210; -.
DR   SMR; P61210; -.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR024156; Small_GTPase_ARF.
DR   InterPro; IPR006689; Small_GTPase_ARF/SAR.
DR   Pfam; PF00025; Arf; 1.
DR   PRINTS; PR00328; SAR1GTPBP.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51417; ARF; 1.
PE   2: Evidence at transcript level;
KW   ER-Golgi transport; Golgi apparatus; GTP-binding; Lipoprotein;
KW   Myristate; Nucleotide-binding; Protein transport; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000255}.
FT   CHAIN         2    182       ADP-ribosylation factor 1.
FT                                /FTId=PRO_0000207442.
FT   NP_BIND      24     31       GTP. {ECO:0000250}.
FT   NP_BIND      67     71       GTP. {ECO:0000250}.
FT   NP_BIND     126    129       GTP. {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000255}.
SQ   SEQUENCE   182 AA;  20688 MW;  9E87E24DFAEA3674 CRC64;
     MGNVFANLFK GLFGKKEMRI LMVGLDAAGK TTILYKLKLG EIVTTIPTIG FNVETVEYKN
     ISFTVWDVGG QDKIRPLWRH YFQNTQGLIF VVDSNDRERI GEAREELMRM LAEDELRDAV
     LLIFANKQDL PNAMNAAEIT DKLGLHSLRN RNWYIQATCA TSGDGLYEGL DWLSNQLKNA
     NR
//
ID   ARF_DUGJA               Reviewed;         183 AA.
AC   P91924;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-APR-2017, entry version 77.
DE   RecName: Full=ADP-ribosylation factor;
OS   Dugesia japonica (Planarian).
OC   Eukaryota; Metazoa; Platyhelminthes; Rhabditophora; Seriata;
OC   Tricladida; Continenticola; Geoplanoidea; Dugesiidae; Dugesia.
OX   NCBI_TaxID=6161;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8982257; DOI=10.1016/S0167-4781(96)00174-1;
RA   Saitoh O., Oshima T., Agata K., Watanabe K., Nakata H.;
RT   "Molecular cloning of a novel ADP-ribosylation factor (ARF) expressed
RT   in planarians.";
RL   Biochim. Biophys. Acta 1309:205-210(1996).
CC   -!- FUNCTION: GTP-binding protein involved in protein trafficking; may
CC       modulate vesicle budding and uncoating within the Golgi apparatus.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Arf family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB001051; BAA19225.1; -; mRNA.
DR   ProteinModelPortal; P91924; -.
DR   SMR; P91924; -.
DR   PRIDE; P91924; -.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:UniProtKB-KW.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR024156; Small_GTPase_ARF.
DR   InterPro; IPR006689; Small_GTPase_ARF/SAR.
DR   Pfam; PF00025; Arf; 1.
DR   PRINTS; PR00328; SAR1GTPBP.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51417; ARF; 1.
PE   2: Evidence at transcript level;
KW   ER-Golgi transport; Golgi apparatus; GTP-binding; Lipoprotein;
KW   Myristate; Nucleotide-binding; Protein transport; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000255}.
FT   CHAIN         2    183       ADP-ribosylation factor.
FT                                /FTId=PRO_0000207446.
FT   NP_BIND      24     31       GTP. {ECO:0000250}.
FT   NP_BIND      67     71       GTP. {ECO:0000250}.
FT   NP_BIND     126    129       GTP. {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000255}.
SQ   SEQUENCE   183 AA;  20948 MW;  DB994ADDD5CDFE28 CRC64;
     MGNLVTHLLD RLFGKKEMRI LMVGLDAAGK TTILYKLKLG EIVTTIPTIG FNVETVEYKN
     ISFTVWDVGG QDKIRPLWRH YFQNTQGLIF VVDSNDRERV NEAREELMRM LNEDELRDAV
     LLVFANKQDL PNAMNPAEIT DKLGLHSLRN RSWYIQATCA TSGDGLYEGL DWLSTTLKNR
     SKK
//
